activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
Not Active	1650090	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1650090	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Kd			CHEMBL4225	Homo sapiens	Kd		
	1650091	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	700.0	CHEMBL4225	Homo sapiens	Kd	uM	0.7
Not Active	1650092	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253		Kd			CHEMBL4225	Homo sapiens	Kd		
	1650093	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	190.0	CHEMBL4225	Homo sapiens	Kd	uM	0.19
	1650094	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	1900.0	CHEMBL4225	Homo sapiens	Kd	uM	1.9
Not Active	1650095	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1650096	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336		Kd			CHEMBL4225	Homo sapiens	Kd		
	1650097	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	470.0	CHEMBL4225	Homo sapiens	Kd	uM	0.47
	1650098	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	1400.0	CHEMBL4225	Homo sapiens	Kd	uM	1.4
	1651973	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	12.0	CHEMBL4225	Homo sapiens	Kd	uM	0.012
Not Active	1651974	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1651975	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1651976	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1651977	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667		Kd			CHEMBL4225	Homo sapiens	Kd		
	1651978	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Kd	nM	300.0	CHEMBL4225	Homo sapiens	Kd	uM	0.3
Not Active	1651979	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1651980	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1651981	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1651982	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828		Kd			CHEMBL4225	Homo sapiens	Kd		
Not Active	1651983	CHEMBL860773	Average Binding Constant for CLK2; NA=Not Active at 10 uM	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965		Kd			CHEMBL4225	Homo sapiens	Kd		
	2051604	CHEMBL942745	Inhibition of CLK2	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	8753.0	CHEMBL4225	Homo sapiens	Ki	uM	8.753
	2206815	CHEMBL990517	Inhibition of CLK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	190.0	CHEMBL4225	Homo sapiens	Kd	nM	190.0
	2470131	CHEMBL1032274	Inhibition of CLK2 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	=	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
Not Evaluated	2476759	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL4225	Homo sapiens	Activity		
Not Evaluated	2478598	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL4225	Homo sapiens	Activity		
	2478801	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	11.5	CHEMBL4225	Homo sapiens	Activity	%	11.5
	2479554	CHEMBL988946	Binding affinity to human CLK2	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Kd	nM	10.0	CHEMBL4225	Homo sapiens	Kd	nM	10.0
	2479656	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312	=	Activity	%	0.9	CHEMBL4225	Homo sapiens	Activity	%	0.9
	2479859	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	26.7	CHEMBL4225	Homo sapiens	Activity	%	26.7
Active	2480656	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409		Activity			CHEMBL4225	Homo sapiens	Activity		
Not Evaluated	2480858	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878		Activity			CHEMBL4225	Homo sapiens	Activity		
	2577277	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901	=	Activity	%	0.2	CHEMBL4225	Homo sapiens	Activity	%	0.2
	2577480	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	24.6	CHEMBL4225	Homo sapiens	Activity	%	24.6
	2593685	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	8.5	CHEMBL4225	Homo sapiens	Activity	%	8.5
Not Evaluated	2593951	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519		Activity			CHEMBL4225	Homo sapiens	Activity		
Not Evaluated	2594154	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466		Activity			CHEMBL4225	Homo sapiens	Activity		
Not Evaluated	2594894	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL4225	Homo sapiens	Activity		
Not Evaluated	2595097	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL4225	Homo sapiens	Activity		
Not Evaluated	2596294	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL4225	Homo sapiens	Activity		
	2596497	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019	=	Activity	%	6.2	CHEMBL4225	Homo sapiens	Activity	%	6.2
Not Evaluated	2597766	CHEMBL983557	Binding affinity to human CLK2 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL4225	Homo sapiens	Activity		
	2902294	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902295	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902296	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1800.0	CHEMBL4225	Homo sapiens	Kd	nM	1800.0
	2902297	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902298	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902299	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1100.0	CHEMBL4225	Homo sapiens	Kd	nM	1100.0
	2902300	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1700.0	CHEMBL4225	Homo sapiens	Kd	nM	1700.0
	2902301	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902302	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902303	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902304	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902305	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902306	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	=	Kd	nM	1800.0	CHEMBL4225	Homo sapiens	Kd	nM	1800.0
	2902307	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902308	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2200.0	CHEMBL4225	Homo sapiens	Kd	nM	2200.0
	2902309	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902310	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902311	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902312	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902313	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	290.0	CHEMBL4225	Homo sapiens	Kd	nM	290.0
	2902314	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902315	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	420.0	CHEMBL4225	Homo sapiens	Kd	nM	420.0
	2902316	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902317	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3200.0	CHEMBL4225	Homo sapiens	Kd	nM	3200.0
	2902318	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902319	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	860.0	CHEMBL4225	Homo sapiens	Kd	nM	860.0
	2902320	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902321	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Kd	nM	700.0	CHEMBL4225	Homo sapiens	Kd	nM	700.0
	2902322	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902323	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902324	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902325	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902326	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	8.2	CHEMBL4225	Homo sapiens	Kd	nM	8.2
	2902327	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	150.0	CHEMBL4225	Homo sapiens	Kd	nM	150.0
	2902328	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	20.0	CHEMBL4225	Homo sapiens	Kd	nM	20.0
	2902329	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902330	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2902331	CHEMBL1061139	Binding constant for CLK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	2921397	CHEMBL1052895	Inhibition of CLK2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4225	Homo sapiens	Activity	%	100.0
	2995384	CHEMBL1039034	Binding affinity to Clk2 assessed as dissociation constant	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Kd	nM	95.0	CHEMBL4225	Homo sapiens	Kd	nM	95.0
	2996571	CHEMBL1039034	Binding affinity to Clk2 assessed as dissociation constant	B	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL567331	=	Kd	nM	680.0	CHEMBL4225	Homo sapiens	Kd	nM	680.0
	3203255	CHEMBL1102982	Inhibition of CLK2	B	Cn1cc(C2=C(c3cccc(NCC(O)CO)c3)C(=O)NC2=O)c2cc(F)ccc21		CHEMBL1082152	=	Kd	nM	10.0	CHEMBL4225	Homo sapiens	Kd	uM	0.01
	3213910	CHEMBL1114866	Inhibition of CLK2 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	3.0	CHEMBL4225	Homo sapiens	INH	%	3.0
	3224782	CHEMBL1102776	Inhibition of CLK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3225032	CHEMBL1102776	Inhibition of CLK2 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3331874	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3333289	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3334694	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3336114	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3337481	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3337729	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3339061	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3340363	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3340642	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3342058	CHEMBL1168833	Inhibition of CLK2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	3358506	CHEMBL1174178	Inhibition of CLK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	88.0	CHEMBL4225	Homo sapiens	INH	%	88.0
	3358948	CHEMBL1174178	Inhibition of CLK2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	100.0	CHEMBL4225	Homo sapiens	INH	%	100.0
	3443361	CHEMBL1244394	Inhibition of CLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	57.0	CHEMBL4225	Homo sapiens	INH	%	57.0
	3443578	CHEMBL1244394	Inhibition of CLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	45.0	CHEMBL4225	Homo sapiens	INH	%	45.0
	3444733	CHEMBL1244394	Inhibition of CLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	10.0	CHEMBL4225	Homo sapiens	INH	%	10.0
	3445069	CHEMBL1244771	Binding affinity to CLK2	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	44.0	CHEMBL4225	Homo sapiens	Kd	nM	44.0
	3445357	CHEMBL1244394	Inhibition of CLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	10.0	CHEMBL4225	Homo sapiens	INH	%	10.0
	3445574	CHEMBL1244394	Inhibition of CLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	9.0	CHEMBL4225	Homo sapiens	INH	%	9.0
	3445787	CHEMBL1244394	Inhibition of CLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	23.0	CHEMBL4225	Homo sapiens	INH	%	23.0
	3445977	CHEMBL1244394	Inhibition of CLK2 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	2.0	CHEMBL4225	Homo sapiens	INH	%	2.0
	3448381	CHEMBL1244771	Binding affinity to CLK2	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	3448897	CHEMBL1244771	Binding affinity to CLK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	860.0	CHEMBL4225	Homo sapiens	Kd	nM	860.0
	3449134	CHEMBL1244771	Binding affinity to CLK2	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	20.0	CHEMBL4225	Homo sapiens	Kd	nM	20.0
	3449607	CHEMBL1244771	Binding affinity to CLK2	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	3450030	CHEMBL1244771	Binding affinity to CLK2	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	3450947	CHEMBL1244771	Binding affinity to CLK2	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	uM	10.0
	3463194	CHEMBL1252282	Inhibition of CLK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	97.0	CHEMBL4225	Homo sapiens	INH	%	97.0
	3463413	CHEMBL1252282	Inhibition of CLK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	85.0	CHEMBL4225	Homo sapiens	INH	%	85.0
	3463957	CHEMBL1252282	Inhibition of CLK2 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	70.0	CHEMBL4225	Homo sapiens	INH	%	70.0
	5089632	CHEMBL1633352	Inhibition of CLK2 at 10 uM	B	C(#Cc1n[nH]c2ccccc12)c1ccncc1		CHEMBL1631892	>=	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	5120359	CHEMBL1648373	Inhibition of human CLK2 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	104.0	CHEMBL4225	Homo sapiens	INH	%	104.0
Active	5803279	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NC[C@@H]2CCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1726934		Potency_Clk2_uM	uM	1.136	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	1.136
Active	5803280	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCNC(=O)c1ccc(-c2ccc3ncnc(NCc4nccs4)c3c2)o1		CHEMBL1707614		Potency_Clk2_uM	uM	18.91	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	18.91
Active	5803281	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1occc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1476499		Potency_Clk2_uM	uM	2.725	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	2.725
Active	5803282	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCOC(=O)c1ccc(-c2ccc3ncnc(NCc4cccs4)c3c2)o1		CHEMBL1535925		Potency_Clk2_uM	uM	8.51	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	8.51
Active	5803283	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCCc2c[nH]cn2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1515868		Potency_Clk2_uM	uM	2.219	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	2.219
Active	5803284	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCNC(=O)c1ccc(-c2ccc3ncnc(N4CCOCC4)c3c2)o1		CHEMBL1718647		Potency_Clk2_uM	uM	16.27	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	16.27
Active	5803285	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1ccc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)s1		CHEMBL1599314		Potency_Clk2_uM	uM	15.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	15.0
Active	5803286	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CC(Nc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12)c1ccco1		CHEMBL1569869		Potency_Clk2_uM	uM	8.373	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	8.373
Active	5803287	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCCc2c[nH]cn2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1515868		Potency_Clk2_uM	uM	2.219	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	2.219
Active	5803288	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN(C)CCNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1436394		Potency_Clk2_uM	uM	15.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	15.0
Active	5803289	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	NCCCNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1395649		Potency_Clk2_uM	uM	8.336	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	8.336
Active	5803290	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Fc1c(-c2ccc3ncnc(NCc4cccs4)c3c2)ccc2c1OCO2		CHEMBL1555138		Potency_Clk2_uM	uM	4.4	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	4.4
Active	5803291	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1ccsc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396654		Potency_Clk2_uM	uM	2.163	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	2.163
inactive	5803292	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CC(O)c1ccc(-c2ccc3ncnc(NCc4nccs4)c3c2)o1		CHEMBL1730241		Potency_Clk2_uM	uM	50.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	50.0
Active	5803293	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1700905		Potency_Clk2_uM	uM	0.543	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.543
Active	5803294	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1730209		Potency_Clk2_uM	uM	0.86	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.86
Active	5803295	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1cc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c(C)o1		CHEMBL1605479		Potency_Clk2_uM	uM	15.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	15.0
Active	5803296	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL567331		Potency_Clk2_uM	uM	0.574	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.574
inactive	5803297	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	OCc1ccc(-c2ccc3ncnc(NCC4CCCO4)c3c2)o1		CHEMBL1731122		Potency_Clk2_uM	uM	50.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	50.0
Active	5803298	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1ccc(CNc2ncnc3ccc(-c4ccc(CO)o4)cc23)o1		CHEMBL1604618		Potency_Clk2_uM	uM	1.648	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	1.648
Active	5803299	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCNC(=O)c1ccc(-c2ccc3ncnc(NCc4ccc(C)o4)c3c2)o1		CHEMBL1711465		Potency_Clk2_uM	uM	4.164	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	4.164
Active	5803300	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	NCCNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1519866		Potency_Clk2_uM	uM	6.424	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	6.424
Active	5803301	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCCCN2CCOCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1394673		Potency_Clk2_uM	uM	15.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	15.0
Active	5803302	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1c[nH]c(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1407164		Potency_Clk2_uM	uM	3.594	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	3.594
Active	5803303	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN(Cc1cncn1C)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1317856		Potency_Clk2_uM	uM	15.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	15.0
Active	5803304	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	O=C(O)c1ccc(-c2ccc3ncnc(N4CCOCC4)c3c2)o1		CHEMBL1731904		Potency_Clk2_uM	uM	32.56	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	32.56
Active	5803305	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	COc1ccc2ncnc(NCc3cccs3)c2c1-c1ccc2c(c1)OCO2		CHEMBL1358567		Potency_Clk2_uM	uM	4.424	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	4.424
Active	5803306	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CC(C)(C)CNc1ncnc2ccc(-c3ccc(C(=O)O)o3)cc12		CHEMBL1702571		Potency_Clk2_uM	uM	9.885	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	9.885
Active	5803307	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1nnc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)o1		CHEMBL1437638		Potency_Clk2_uM	uM	3.118	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	3.118
Active	5803308	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1712751		Potency_Clk2_uM	uM	0.715	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.715
Active	5803309	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	COc1ccc(-c2ccc3ncnc(N(C)Cc4csc(C)n4)c3c2)cc1OC		CHEMBL1554684		Potency_Clk2_uM	uM	15.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	15.0
Active	5803310	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1coc(CCNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1357975		Potency_Clk2_uM	uM	0.801	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.801
Active	5803311	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1515144		Potency_Clk2_uM	uM	0.447	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.447
Active	5803312	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN1CCCC1CCNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1367901		Potency_Clk2_uM	uM	8.559	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	8.559
Active	5803313	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN(Cc1cccs1)c1ncnc2ccc(-c3ccc4cnn(C)c4c3)cc12		CHEMBL1434052		Potency_Clk2_uM	uM	15.0	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	15.0
Active	5803314	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	OCc1ccc(-c2ccc3ncnc(NCc4cccs4)c3c2)o1		CHEMBL1733003		Potency_Clk2_uM	uM	3.944	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	3.944
Active	5803315	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	O=C(O)c1ccc(-c2ccc3ncnc(NCc4nccs4)c3c2)o1		CHEMBL1723315		Potency_Clk2_uM	uM	27.42	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	27.42
Active	5803316	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CC(O)c1ccc(-c2ccc3ncnc(N4CCOCC4)c3c2)o1		CHEMBL1704406		Potency_Clk2_uM	uM	19.04	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	19.04
Active	5803317	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCNC(=O)c1ccc(-c2ccc3ncnc(NCC(C)(C)C)c3c2)o1		CHEMBL1723994		Potency_Clk2_uM	uM	8.48	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	8.48
Active	5803318	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1ccc(CNc2ncnc3ccc(-c4ccc(C(=O)O)o4)cc23)o1		CHEMBL1724489		Potency_Clk2_uM	uM	1.361	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	1.361
Active	5803319	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(N2CCOCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1714708		Potency_Clk2_uM	uM	1.672	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	1.672
Active	5803320	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	OCc1ccc(-c2ccc3ncnc(NCc4nccs4)c3c2)o1		CHEMBL1734029		Potency_Clk2_uM	uM	23.57	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	23.57
Active	5803321	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1734733		Potency_Clk2_uM	uM	0.882	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.882
Active	5803322	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1csc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1704879		Potency_Clk2_uM	uM	0.195	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.195
Active	5803323	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1591577		Potency_Clk2_uM	uM	0.173	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.173
Active	5803324	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1csc(CNc2ncnc3ccc(-c4ccc(CO)o4)cc23)n1		CHEMBL1704854		Potency_Clk2_uM	uM	14.72	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	14.72
Active	5803325	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1705549		Potency_Clk2_uM	uM	0.414	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.414
Active	5803326	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCN(C)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1705397		Potency_Clk2_uM	uM	1.557	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	1.557
Active	5803327	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1coc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1725513		Potency_Clk2_uM	uM	0.301	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.301
Active	5803328	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	O=C(O)c1ccc(-c2ccc3ncnc(NCC4CCCO4)c3c2)o1		CHEMBL1705736		Potency_Clk2_uM	uM	20.05	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	20.05
Active	5803329	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CC(=O)c1ccc(-c2ccc3ncnc(NCc4ccc(C)o4)c3c2)o1		CHEMBL1716050		Potency_Clk2_uM	uM	6.853	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	6.853
Active	5803330	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1csc(CNc2ncnc3ccc(-c4ccc(C(=O)O)o4)cc23)n1		CHEMBL1735438		Potency_Clk2_uM	uM	9.459	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	9.459
Active	5803331	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCNC(=O)c1ccc(-c2ccc3ncnc(NCc4nc(C)cs4)c3c2)o1		CHEMBL1715786		Potency_Clk2_uM	uM	3.445	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	3.445
Active	5803332	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CN(Cc1nccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396483		Potency_Clk2_uM	uM	0.588	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.588
Active	5803333	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	O=C(O)c1ccc(-c2ccc3ncnc(NCc4cccs4)c3c2)o1		CHEMBL1707127		Potency_Clk2_uM	uM	2.806	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	2.806
Active	5803334	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1318637		Potency_Clk2_uM	uM	0.963	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.963
Active	5803335	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	OCc1ccc(-c2ccc3ncnc(N4CCOCC4)c3c2)o1		CHEMBL1706971		Potency_Clk2_uM	uM	14.25	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	14.25
Active	5803336	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CCNC(=O)c1ccc(-c2ccc3ncnc(NCC4CCCO4)c3c2)o1		CHEMBL1726139		Potency_Clk2_uM	uM	8.073	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	8.073
Active	5803337	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCC2CCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1552755		Potency_Clk2_uM	uM	1.81	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	1.81
Active	5803338	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	c1nc(NCc2ccoc2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL566900		Potency_Clk2_uM	uM	0.877	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	0.877
Active	5803339	CHEMBL1738309	PUBCHEM_BIOASSAY: Kinase Inhibition Study on Inhibitors of CDC-like Kinase 2 (Reaction Biology data). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1459, AID1487, AID1498, AID1770, AID1970, AID1997, AID488872, AID488883, AID488887, AID493204]	F	CC(C)(C)CNc1ncnc2ccc(-c3ccc(CO)o3)cc12		CHEMBL1736375		Potency_Clk2_uM	uM	8.118	CHEMBL4225	Homo sapiens	Potency_Clk2_uM	uM	8.118
	6176652	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCCC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1354134	=	IC50	nM	486.0	CHEMBL4225	Homo sapiens	IC50	nM	486.0
	6176658	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CC(C)(C)CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1551169	=	IC50	nM	584.0	CHEMBL4225	Homo sapiens	IC50	nM	584.0
	6176659	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1nccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396483	=	IC50	nM	589.0	CHEMBL4225	Homo sapiens	IC50	nM	589.0
	6176662	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)o1		CHEMBL1473127	=	IC50	nM	651.0	CHEMBL4225	Homo sapiens	IC50	nM	651.0
	6176663	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1ccco1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1374544	=	IC50	nM	692.0	CHEMBL4225	Homo sapiens	IC50	nM	692.0
	6176667	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1coc(CCNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1357975	=	IC50	nM	801.0	CHEMBL4225	Homo sapiens	IC50	nM	801.0
	6176670	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCc2ccoc2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL566900	=	IC50	nM	877.0	CHEMBL4225	Homo sapiens	IC50	nM	877.0
	6176671	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1734733	=	IC50	nM	882.0	CHEMBL4225	Homo sapiens	IC50	nM	882.0
	6176673	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccc(CO)o3)cc12		CHEMBL1476609	=	IC50	nM	889.0	CHEMBL4225	Homo sapiens	IC50	nM	889.0
	6176678	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1318637	=	IC50	nM	962.0	CHEMBL4225	Homo sapiens	IC50	nM	962.0
	6176680	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1436585	=	IC50	nM	1055.0	CHEMBL4225	Homo sapiens	IC50	nM	1055.0
	6176685	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CN(C)c1ncnc2ccc(-c3ccoc3)cc12		CHEMBL1612677	=	IC50	nM	1209.0	CHEMBL4225	Homo sapiens	IC50	nM	1209.0
	6176688	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1nc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1435542	=	IC50	nM	1327.0	CHEMBL4225	Homo sapiens	IC50	nM	1327.0
	6176689	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc(C(=O)O)o4)cc23)o1		CHEMBL1724489	=	IC50	nM	1361.0	CHEMBL4225	Homo sapiens	IC50	nM	1361.0
	6176696	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc(CO)o4)cc23)o1		CHEMBL1604618	=	IC50	nM	1648.0	CHEMBL4225	Homo sapiens	IC50	nM	1648.0
	6176699	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCC2CCCO2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1552755	=	IC50	nM	1810.0	CHEMBL4225	Homo sapiens	IC50	nM	1810.0
	6176700	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL567331	=	IC50	nM	1902.0	CHEMBL4225	Homo sapiens	IC50	nM	1902.0
	6176704	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccsc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1396654	=	IC50	nM	2163.0	CHEMBL4225	Homo sapiens	IC50	nM	2163.0
	6176705	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1nc(NCCc2c[nH]cn2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1515868	=	IC50	nM	2219.0	CHEMBL4225	Homo sapiens	IC50	nM	2219.0
	6176708	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1occc1CNc1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1476499	=	IC50	nM	2725.0	CHEMBL4225	Homo sapiens	IC50	nM	2725.0
	6176710	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1nnc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)o1		CHEMBL1437638	=	IC50	nM	3118.0	CHEMBL4225	Homo sapiens	IC50	nM	3118.0
	6176713	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1ncc[nH]1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1397614	=	IC50	nM	3331.0	CHEMBL4225	Homo sapiens	IC50	nM	3331.0
	6176716	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1c[nH]c(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1407164	=	IC50	nM	3594.0	CHEMBL4225	Homo sapiens	IC50	nM	3594.0
	6176734	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCOC(=O)c1ccc(-c2ccc3ncnc(NCc4ccc(C)o4)c3c2)o1		CHEMBL1329627	=	IC50	nM	6181.0	CHEMBL4225	Homo sapiens	IC50	nM	6181.0
	6176742	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCNCc1ccc(-c2ccc3ncnc(NCC(C)(C)C)c3c2)o1		CHEMBL1770624	=	IC50	nM	8480.0	CHEMBL4225	Homo sapiens	IC50	nM	8480.0
	6176743	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCOC(=O)c1ccc(-c2ccc3ncnc(NCc4cccs4)c3c2)o1		CHEMBL1535925	=	IC50	nM	8510.0	CHEMBL4225	Homo sapiens	IC50	nM	8510.0
	6176760	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1ccc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)s1		CHEMBL1599314	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	nM	10000.0
	6183724	CHEMBL1772039	Binding affinity to human Clk2 	B	Cc1nc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1474834	=	Kd	nM	59.0	CHEMBL4225	Homo sapiens	Kd	nM	59.0
	6183766	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1591577	=	IC50	nM	173.0	CHEMBL4225	Homo sapiens	IC50	nM	173.0
	6183771	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1nc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1474834	=	IC50	nM	186.0	CHEMBL4225	Homo sapiens	IC50	nM	186.0
	6183775	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	Cc1csc(CN(C)c2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1704879	=	IC50	nM	195.0	CHEMBL4225	Homo sapiens	IC50	nM	195.0
	6183789	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1coc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)c1		CHEMBL1725513	=	IC50	nM	301.0	CHEMBL4225	Homo sapiens	IC50	nM	301.0
	6183793	CHEMBL1772039	Binding affinity to human Clk2 	B	c1nc(NCC2CCOC2)c2cc(-c3ccc4c(c3)OCO4)ccc2n1		CHEMBL1436585	=	Kd	nM	320.0	CHEMBL4225	Homo sapiens	Kd	nM	320.0
	6183800	CHEMBL1772039	Binding affinity to human Clk2 	B	Cc1nc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)cs1		CHEMBL1435542	=	Kd	nM	380.0	CHEMBL4225	Homo sapiens	Kd	nM	380.0
	6183802	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	c1csc(CNc2ncnc3ccc(-c4ccc5c(c4)OCO5)cc23)n1		CHEMBL1705549	=	IC50	nM	414.0	CHEMBL4225	Homo sapiens	IC50	nM	414.0
	6183808	CHEMBL1772035	Inhibition of Clk2 kinase using ATP as substrate by 33P radiolabeled kinase assay	B	CCN(Cc1cccs1)c1ncnc2ccc(-c3ccc4c(c3)OCO4)cc12		CHEMBL1515144	=	IC50	nM	447.0	CHEMBL4225	Homo sapiens	IC50	nM	447.0
Active	6268869	CHEMBL1805118	Inhibition of recombinant CLK2-mediated SR 9G8 protein phosphorylation at 10 uM after 30 mins by SDS-PAGE followed by autoradiography	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	6268872	CHEMBL1805391	Inhibition of CLK2-mediated SRp55 protein phosphorylation in TNFalpha-stimulated human HMEC1 cells after 1 hr by Western blot analysis	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	6268876	CHEMBL1805395	Inhibition of CLK2-mediated SRp75 protein phosphorylation in TNFalpha-stimulated human HMEC1 cells after 1 hr by Western blot analysis	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	6339889	CHEMBL1826187	Activity of CLK2 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	47.0	CHEMBL4225	Homo sapiens	Activity	%	47.0
	7567330	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7567789	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7568286	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7568718	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	150.0	CHEMBL4225	Homo sapiens	Kd	nM	150.0
	7569303	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7569763	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7569793	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7570256	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	410.0	CHEMBL4225	Homo sapiens	Kd	nM	410.0
	7570683	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	20.0	CHEMBL4225	Homo sapiens	Kd	nM	20.0
	7571279	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	460.0	CHEMBL4225	Homo sapiens	Kd	nM	460.0
	7571770	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	460.0	CHEMBL4225	Homo sapiens	Kd	nM	460.0
	7572233	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Kd	nM	5500.0	CHEMBL4225	Homo sapiens	Kd	nM	5500.0
	7572649	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	82.0	CHEMBL4225	Homo sapiens	Kd	nM	82.0
	7573275	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7573751	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	940.0	CHEMBL4225	Homo sapiens	Kd	nM	940.0
	7574220	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	860.0	CHEMBL4225	Homo sapiens	Kd	nM	860.0
	7574628	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	43.0	CHEMBL4225	Homo sapiens	Kd	nM	43.0
	7574796	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	760.0	CHEMBL4225	Homo sapiens	Kd	nM	760.0
	7575257	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7575728	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7576193	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	2600.0	CHEMBL4225	Homo sapiens	Kd	nM	2600.0
	7576601	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	2300.0	CHEMBL4225	Homo sapiens	Kd	nM	2300.0
	7576770	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7577229	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7577707	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	93.0	CHEMBL4225	Homo sapiens	Kd	nM	93.0
	7578177	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1000.0	CHEMBL4225	Homo sapiens	Kd	nM	1000.0
	7578582	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7578778	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	Kd	nM	0.51	CHEMBL4225	Homo sapiens	Kd	nM	0.51
	7579152	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7579602	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2200.0	CHEMBL4225	Homo sapiens	Kd	nM	2200.0
	7580076	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7581136	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7581521	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7581966	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7582437	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	430.0	CHEMBL4225	Homo sapiens	Kd	nM	430.0
	7582459	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7582859	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7583482	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7583879	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	1100.0	CHEMBL4225	Homo sapiens	Kd	nM	1100.0
	7584324	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	600.0	CHEMBL4225	Homo sapiens	Kd	nM	600.0
	7584815	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1600.0	CHEMBL4225	Homo sapiens	Kd	nM	1600.0
	7585219	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7585812	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7586220	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7586695	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	420.0	CHEMBL4225	Homo sapiens	Kd	nM	420.0
	7587149	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	=	Kd	nM	80.0	CHEMBL4225	Homo sapiens	Kd	nM	80.0
	7587773	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7588203	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7588674	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	=	Kd	nM	2300.0	CHEMBL4225	Homo sapiens	Kd	nM	2300.0
	7589125	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7589720	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	44.0	CHEMBL4225	Homo sapiens	Kd	nM	44.0
	7590187	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	16.0	CHEMBL4225	Homo sapiens	Kd	nM	16.0
	7590661	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	6500.0	CHEMBL4225	Homo sapiens	Kd	nM	6500.0
	7591112	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7591269	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7591691	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	1700.0	CHEMBL4225	Homo sapiens	Kd	nM	1700.0
	7592163	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7592636	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	3200.0	CHEMBL4225	Homo sapiens	Kd	nM	3200.0
	7593089	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1700.0	CHEMBL4225	Homo sapiens	Kd	nM	1700.0
	7593236	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	1800.0	CHEMBL4225	Homo sapiens	Kd	nM	1800.0
	7593671	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7594143	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	=	Kd	nM	730.0	CHEMBL4225	Homo sapiens	Kd	nM	730.0
	7594616	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7595068	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7595204	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	=	Kd	nM	1700.0	CHEMBL4225	Homo sapiens	Kd	nM	1700.0
	7595648	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7596122	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7596593	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7597176	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7597629	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7598102	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4225	Homo sapiens	Kd	nM	10000.0
	7598572	CHEMBL1908629	Binding constant for CLK2 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	8.2	CHEMBL4225	Homo sapiens	Kd	nM	8.2
	7969706	CHEMBL1930962	Inhibition of CLK2 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay	B	Cc1ccc(F)cc1-c1nc2[nH]nc(N)c2c2c1CCCC2		CHEMBL1927262	=	Activity	%	45.0	CHEMBL4225	Homo sapiens	Activity	%	45.0
	7989243	CHEMBL1936343	Inhibition of human CLK2 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)C(C)(C)CNC4=O)nc1C(=O)NC1CCCC1		CHEMBL1933142	>=	Inhibition	%	80.0	CHEMBL4225	Homo sapiens	INH	%	80.0
	7989244	CHEMBL1936343	Inhibition of human CLK2 at 3 uM	B	Cc1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)on1		CHEMBL1933143	>=	Inhibition	%	80.0	CHEMBL4225	Homo sapiens	INH	%	80.0
	7989245	CHEMBL1936343	Inhibition of human CLK2 at 3 uM	B	Cn1cc(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)cn1		CHEMBL1933148	>=	Inhibition	%	80.0	CHEMBL4225	Homo sapiens	INH	%	80.0
	7989246	CHEMBL1936343	Inhibition of human CLK2 at 3 uM	B	Cn1c(NC(=O)c2ccc3cc4n(c3c2)CCCNC4=O)nc2ccccc21		CHEMBL1933279	>=	Inhibition	%	80.0	CHEMBL4225	Homo sapiens	INH	%	80.0
	7989387	CHEMBL1937081	Inhibition of human CLK2	B	C[C@@H]1CCNC(=O)c2cc3ccc(C(=O)Nc4nc5ccccc5n4CCCN(C)C)cc3n21		CHEMBL1933288	=	IC50	nM	112.0	CHEMBL4225	Homo sapiens	IC50	nM	112.0
Not Active	8042239	CHEMBL1952707	Inhibition of CLK2 assessed as [gamma-33P]ATP incorporation into AKRRRLSSLRA substrate at 10 uM after 40 mins by liquid scintillation counting	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC1=O		CHEMBL1950043		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Not Active	8042242	CHEMBL1952707	Inhibition of CLK2 assessed as [gamma-33P]ATP incorporation into AKRRRLSSLRA substrate at 10 uM after 40 mins by liquid scintillation counting	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@@H](N)CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H]2CCCN2C1=O		CHEMBL1950044		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	8046133	CHEMBL1958832	Inhibition of CLK2 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	=	Inhibition	%	100.0	CHEMBL4225	Homo sapiens	INH	%	100.0
	8061297	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.01	CHEMBL4225	Homo sapiens	Inhibition	%	2.01
	8061474	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	3.62	CHEMBL4225	Homo sapiens	Inhibition	%	3.62
	8061805	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.56	CHEMBL4225	Homo sapiens	Inhibition	%	1.56
	8061996	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	3.28	CHEMBL4225	Homo sapiens	Inhibition	%	3.28
	8062336	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.9	CHEMBL4225	Homo sapiens	Inhibition	%	2.9
	8062498	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	3.04	CHEMBL4225	Homo sapiens	Inhibition	%	3.04
	8062722	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.14	CHEMBL4225	Homo sapiens	Inhibition	%	4.14
	8062820	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.92	CHEMBL4225	Homo sapiens	Inhibition	%	3.92
	8063176	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.72	CHEMBL4225	Homo sapiens	Inhibition	%	0.72
	8063343	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.95	CHEMBL4225	Homo sapiens	Inhibition	%	0.95
	8063567	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.59	CHEMBL4225	Homo sapiens	Inhibition	%	1.59
	8063675	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.23	CHEMBL4225	Homo sapiens	Inhibition	%	1.23
	8063857	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	13.71	CHEMBL4225	Homo sapiens	Inhibition	%	13.71
	8064081	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.11	CHEMBL4225	Homo sapiens	Inhibition	%	1.11
	8064196	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	10.29	CHEMBL4225	Homo sapiens	Inhibition	%	10.29
	8064406	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.95	CHEMBL4225	Homo sapiens	Inhibition	%	0.95
	8064630	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.08	CHEMBL4225	Homo sapiens	Inhibition	%	-0.08
	8064768	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.23	CHEMBL4225	Homo sapiens	Inhibition	%	0.23
	8065158	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.68	CHEMBL4225	Homo sapiens	Inhibition	%	0.68
	8065274	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.07	CHEMBL4225	Homo sapiens	Inhibition	%	1.07
	8065673	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.64	CHEMBL4225	Homo sapiens	Inhibition	%	0.64
	8065788	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	-0.04	CHEMBL4225	Homo sapiens	Inhibition	%	-0.04
	8066012	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.15	CHEMBL4225	Homo sapiens	Inhibition	%	1.15
	8066222	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.1	CHEMBL4225	Homo sapiens	Inhibition	%	1.1
	8066358	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	5.9	CHEMBL4225	Homo sapiens	Inhibition	%	5.9
	8066748	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	1.56	CHEMBL4225	Homo sapiens	Inhibition	%	1.56
	8066872	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	0.85	CHEMBL4225	Homo sapiens	Inhibition	%	0.85
	8067096	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.48	CHEMBL4225	Homo sapiens	Inhibition	%	1.48
	8067271	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.38	CHEMBL4225	Homo sapiens	Inhibition	%	0.38
	8067616	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.24	CHEMBL4225	Homo sapiens	Inhibition	%	0.24
	8067826	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	2.67	CHEMBL4225	Homo sapiens	Inhibition	%	2.67
	8067961	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	99.2	CHEMBL4225	Homo sapiens	Inhibition	%	99.2
	8068185	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	99.86	CHEMBL4225	Homo sapiens	Inhibition	%	99.86
	8068349	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.44	CHEMBL4225	Homo sapiens	Inhibition	%	1.44
	8068698	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-1.0	CHEMBL4225	Homo sapiens	Inhibition	%	-1.0
	8068872	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.96	CHEMBL4225	Homo sapiens	Inhibition	%	1.96
	8069221	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.47	CHEMBL4225	Homo sapiens	Inhibition	%	1.47
	8069516	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	104.01	CHEMBL4225	Homo sapiens	Inhibition	%	104.01
	8069677	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	9.1	CHEMBL4225	Homo sapiens	Inhibition	%	9.1
	8070027	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.4	CHEMBL4225	Homo sapiens	Inhibition	%	1.4
	8070199	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.22	CHEMBL4225	Homo sapiens	Inhibition	%	0.22
	8070423	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.33	CHEMBL4225	Homo sapiens	Inhibition	%	1.33
	8070548	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.9	CHEMBL4225	Homo sapiens	Inhibition	%	0.9
	8070846	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	100.15	CHEMBL4225	Homo sapiens	Inhibition	%	100.15
	8071003	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.86	CHEMBL4225	Homo sapiens	Inhibition	%	0.86
	8071227	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.34	CHEMBL4225	Homo sapiens	Inhibition	%	2.34
	8071353	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	-0.31	CHEMBL4225	Homo sapiens	Inhibition	%	-0.31
	8071750	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	1.95	CHEMBL4225	Homo sapiens	Inhibition	%	1.95
	8071875	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.14	CHEMBL4225	Homo sapiens	Inhibition	%	-0.14
	8072099	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.47	CHEMBL4225	Homo sapiens	Inhibition	%	0.47
	8072189	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.8	CHEMBL4225	Homo sapiens	Inhibition	%	-0.8
	8072570	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.75	CHEMBL4225	Homo sapiens	Inhibition	%	1.75
	8072695	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.44	CHEMBL4225	Homo sapiens	Inhibition	%	3.44
	8072919	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.32	CHEMBL4225	Homo sapiens	Inhibition	%	-0.32
	8073086	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.79	CHEMBL4225	Homo sapiens	Inhibition	%	2.79
	8073435	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	3.04	CHEMBL4225	Homo sapiens	Inhibition	%	3.04
	8073554	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.98	CHEMBL4225	Homo sapiens	Inhibition	%	1.98
	8073787	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.04	CHEMBL4225	Homo sapiens	Inhibition	%	1.04
	8074011	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.92	CHEMBL4225	Homo sapiens	Inhibition	%	-0.92
	8074163	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	-1.36	CHEMBL4225	Homo sapiens	Inhibition	%	-1.36
	8074517	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.04	CHEMBL4225	Homo sapiens	Inhibition	%	2.04
	8074674	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.69	CHEMBL4225	Homo sapiens	Inhibition	%	1.69
	8075025	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	4.18	CHEMBL4225	Homo sapiens	Inhibition	%	4.18
	8075136	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	3.06	CHEMBL4225	Homo sapiens	Inhibition	%	3.06
	8075360	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	1.11	CHEMBL4225	Homo sapiens	Inhibition	%	1.11
	8075597	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.46	CHEMBL4225	Homo sapiens	Inhibition	%	1.46
	8075738	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.2	CHEMBL4225	Homo sapiens	Inhibition	%	3.2
	8076104	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.34	CHEMBL4225	Homo sapiens	Inhibition	%	0.34
	8076252	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.11	CHEMBL4225	Homo sapiens	Inhibition	%	2.11
	8076476	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.3	CHEMBL4225	Homo sapiens	Inhibition	%	1.3
	8076610	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	20.74	CHEMBL4225	Homo sapiens	Inhibition	%	20.74
	8076936	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.52	CHEMBL4225	Homo sapiens	Inhibition	%	2.52
	8077183	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	10.24	CHEMBL4225	Homo sapiens	Inhibition	%	10.24
	8077311	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	0.9	CHEMBL4225	Homo sapiens	Inhibition	%	0.9
	8077535	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.15	CHEMBL4225	Homo sapiens	Inhibition	%	1.15
	8077686	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	5.08	CHEMBL4225	Homo sapiens	Inhibition	%	5.08
	8078053	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.64	CHEMBL4225	Homo sapiens	Inhibition	%	2.64
	8078192	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	1.17	CHEMBL4225	Homo sapiens	Inhibition	%	1.17
	8078518	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.05	CHEMBL4225	Homo sapiens	Inhibition	%	2.05
	8078768	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	56.31	CHEMBL4225	Homo sapiens	Inhibition	%	56.31
	8079108	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.94	CHEMBL4225	Homo sapiens	Inhibition	%	-0.94
	8079266	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	1.72	CHEMBL4225	Homo sapiens	Inhibition	%	1.72
	8079632	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.05	CHEMBL4225	Homo sapiens	Inhibition	%	1.05
	8079771	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	3.95	CHEMBL4225	Homo sapiens	Inhibition	%	3.95
	8079995	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	59.08	CHEMBL4225	Homo sapiens	Inhibition	%	59.08
	8080100	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.07	CHEMBL4225	Homo sapiens	Inhibition	%	-0.07
	8080352	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	19.23	CHEMBL4225	Homo sapiens	Inhibition	%	19.23
	8080691	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.07	CHEMBL4225	Homo sapiens	Inhibition	%	1.07
	8080855	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	7.52	CHEMBL4225	Homo sapiens	Inhibition	%	7.52
	8081079	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.07	CHEMBL4225	Homo sapiens	Inhibition	%	2.07
	8081214	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.69	CHEMBL4225	Homo sapiens	Inhibition	%	0.69
	8081582	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	93.81	CHEMBL4225	Homo sapiens	Inhibition	%	93.81
	8081685	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	4.59	CHEMBL4225	Homo sapiens	Inhibition	%	4.59
	8081909	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	26.06	CHEMBL4225	Homo sapiens	Inhibition	%	26.06
	8081937	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	72.17	CHEMBL4225	Homo sapiens	Inhibition	%	72.17
	8082161	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	3.99	CHEMBL4225	Homo sapiens	Inhibition	%	3.99
	8082274	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.25	CHEMBL4225	Homo sapiens	Inhibition	%	0.25
	8082671	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	11.87	CHEMBL4225	Homo sapiens	Inhibition	%	11.87
	8082794	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	0.82	CHEMBL4225	Homo sapiens	Inhibition	%	0.82
	8083174	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	15.58	CHEMBL4225	Homo sapiens	Inhibition	%	15.58
	8083497	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.8	CHEMBL4225	Homo sapiens	Inhibition	%	2.8
	8083751	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	39.17	CHEMBL4225	Homo sapiens	Inhibition	%	39.17
	8083861	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.8	CHEMBL4225	Homo sapiens	Inhibition	%	2.8
	8084085	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	13.76	CHEMBL4225	Homo sapiens	Inhibition	%	13.76
	8084270	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	19.26	CHEMBL4225	Homo sapiens	Inhibition	%	19.26
	8084388	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.37	CHEMBL4225	Homo sapiens	Inhibition	%	1.37
	8084612	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.87	CHEMBL4225	Homo sapiens	Inhibition	%	0.87
	8084773	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	66.09	CHEMBL4225	Homo sapiens	Inhibition	%	66.09
	8085095	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.81	CHEMBL4225	Homo sapiens	Inhibition	%	3.81
	8085351	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.27	CHEMBL4225	Homo sapiens	Inhibition	%	-0.27
	8085683	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	1.64	CHEMBL4225	Homo sapiens	Inhibition	%	1.64
	8085872	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	72.34	CHEMBL4225	Homo sapiens	Inhibition	%	72.34
	8086211	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	-0.06	CHEMBL4225	Homo sapiens	Inhibition	%	-0.06
	8086373	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.03	CHEMBL4225	Homo sapiens	Inhibition	%	2.03
	8086696	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.93	CHEMBL4225	Homo sapiens	Inhibition	%	3.93
	8086907	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	2.47	CHEMBL4225	Homo sapiens	Inhibition	%	2.47
	8087289	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.05	CHEMBL4225	Homo sapiens	Inhibition	%	0.05
	8087627	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.98	CHEMBL4225	Homo sapiens	Inhibition	%	0.98
	8087765	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.11	CHEMBL4225	Homo sapiens	Inhibition	%	-0.11
	8088131	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	5.8	CHEMBL4225	Homo sapiens	Inhibition	%	5.8
	8088279	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.11	CHEMBL4225	Homo sapiens	Inhibition	%	0.11
	8088631	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.33	CHEMBL4225	Homo sapiens	Inhibition	%	0.33
	8088948	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	4.78	CHEMBL4225	Homo sapiens	Inhibition	%	4.78
	8089076	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	9.9	CHEMBL4225	Homo sapiens	Inhibition	%	9.9
	8089300	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	49.28	CHEMBL4225	Homo sapiens	Inhibition	%	49.28
	8089448	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.69	CHEMBL4225	Homo sapiens	Inhibition	%	1.69
	8089792	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.19	CHEMBL4225	Homo sapiens	Inhibition	%	4.19
	8089972	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-2.43	CHEMBL4225	Homo sapiens	Inhibition	%	-2.43
	8090137	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	6.86	CHEMBL4225	Homo sapiens	Inhibition	%	6.86
	8090361	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	45.39	CHEMBL4225	Homo sapiens	Inhibition	%	45.39
	8090528	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.46	CHEMBL4225	Homo sapiens	Inhibition	%	3.46
	8090891	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	1.61	CHEMBL4225	Homo sapiens	Inhibition	%	1.61
	8091096	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.03	CHEMBL4225	Homo sapiens	Inhibition	%	0.03
	8091233	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.66	CHEMBL4225	Homo sapiens	Inhibition	%	5.66
	8091457	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	38.21	CHEMBL4225	Homo sapiens	Inhibition	%	38.21
	8091612	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	-0.08	CHEMBL4225	Homo sapiens	Inhibition	%	-0.08
	8091952	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.86	CHEMBL4225	Homo sapiens	Inhibition	%	0.86
	8092089	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.8	CHEMBL4225	Homo sapiens	Inhibition	%	0.8
	8092313	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.83	CHEMBL4225	Homo sapiens	Inhibition	%	-0.83
	8092464	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.41	CHEMBL4225	Homo sapiens	Inhibition	%	2.41
	8092612	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	2.34	CHEMBL4225	Homo sapiens	Inhibition	%	2.34
	8092836	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.58	CHEMBL4225	Homo sapiens	Inhibition	%	1.58
	8092965	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.86	CHEMBL4225	Homo sapiens	Inhibition	%	0.86
	8093277	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.1	CHEMBL4225	Homo sapiens	Inhibition	%	0.1
	8093641	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.81	CHEMBL4225	Homo sapiens	Inhibition	%	0.81
	8093780	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	7.38	CHEMBL4225	Homo sapiens	Inhibition	%	7.38
	8094124	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	34.12	CHEMBL4225	Homo sapiens	Inhibition	%	34.12
	8094304	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-1.47	CHEMBL4225	Homo sapiens	Inhibition	%	-1.47
	8094703	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	37.3	CHEMBL4225	Homo sapiens	Inhibition	%	37.3
	8094859	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	10.12	CHEMBL4225	Homo sapiens	Inhibition	%	10.12
	8095223	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-2.84	CHEMBL4225	Homo sapiens	Inhibition	%	-2.84
	8095426	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	0.73	CHEMBL4225	Homo sapiens	Inhibition	%	0.73
	8095791	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	88.93	CHEMBL4225	Homo sapiens	Inhibition	%	88.93
	8095939	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	-0.74	CHEMBL4225	Homo sapiens	Inhibition	%	-0.74
	8096280	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.24	CHEMBL4225	Homo sapiens	Inhibition	%	1.24
	8096643	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.72	CHEMBL4225	Homo sapiens	Inhibition	%	-0.72
	8096799	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.14	CHEMBL4225	Homo sapiens	Inhibition	%	2.14
	8097170	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.69	CHEMBL4225	Homo sapiens	Inhibition	%	1.69
	8097477	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.15	CHEMBL4225	Homo sapiens	Inhibition	%	1.15
	8097851	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.4	CHEMBL4225	Homo sapiens	Inhibition	%	2.4
	8097984	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.17	CHEMBL4225	Homo sapiens	Inhibition	%	2.17
	8098208	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.77	CHEMBL4225	Homo sapiens	Inhibition	%	0.77
	8098328	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.48	CHEMBL4225	Homo sapiens	Inhibition	%	0.48
	8098508	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-2.94	CHEMBL4225	Homo sapiens	Inhibition	%	-2.94
	8098732	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.31	CHEMBL4225	Homo sapiens	Inhibition	%	0.31
	8098917	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	88.43	CHEMBL4225	Homo sapiens	Inhibition	%	88.43
	8099061	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.24	CHEMBL4225	Homo sapiens	Inhibition	%	3.24
	8099285	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	1.86	CHEMBL4225	Homo sapiens	Inhibition	%	1.86
	8099427	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.9	CHEMBL4225	Homo sapiens	Inhibition	%	0.9
	8099621	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.43	CHEMBL4225	Homo sapiens	Inhibition	%	-0.43
	8099845	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-1.71	CHEMBL4225	Homo sapiens	Inhibition	%	-1.71
	8099992	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-0.41	CHEMBL4225	Homo sapiens	Inhibition	%	-0.41
	8100138	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.84	CHEMBL4225	Homo sapiens	Inhibition	%	0.84
	8100362	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	5.36	CHEMBL4225	Homo sapiens	Inhibition	%	5.36
	8100478	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.21	CHEMBL4225	Homo sapiens	Inhibition	%	0.21
	8100842	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.49	CHEMBL4225	Homo sapiens	Inhibition	%	0.49
	8101002	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	0.6	CHEMBL4225	Homo sapiens	Inhibition	%	0.6
	8101226	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.96	CHEMBL4225	Homo sapiens	Inhibition	%	2.96
	8101368	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.35	CHEMBL4225	Homo sapiens	Inhibition	%	0.35
	8101553	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.43	CHEMBL4225	Homo sapiens	Inhibition	%	0.43
	8101777	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.2	CHEMBL4225	Homo sapiens	Inhibition	%	0.2
	8101806	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.83	CHEMBL4225	Homo sapiens	Inhibition	%	2.83
	8102030	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	20.45	CHEMBL4225	Homo sapiens	Inhibition	%	20.45
	8102185	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	1.19	CHEMBL4225	Homo sapiens	Inhibition	%	1.19
	8102540	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	4.15	CHEMBL4225	Homo sapiens	Inhibition	%	4.15
	8102660	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.3	CHEMBL4225	Homo sapiens	Inhibition	%	1.3
	8103062	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.79	CHEMBL4225	Homo sapiens	Inhibition	%	-0.79
	8103258	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.87	CHEMBL4225	Homo sapiens	Inhibition	%	1.87
	8103620	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	0.31	CHEMBL4225	Homo sapiens	Inhibition	%	0.31
	8103770	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.63	CHEMBL4225	Homo sapiens	Inhibition	%	-0.63
	8104179	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.9	CHEMBL4225	Homo sapiens	Inhibition	%	-1.9
	8104327	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.42	CHEMBL4225	Homo sapiens	Inhibition	%	6.42
	8104697	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	35.94	CHEMBL4225	Homo sapiens	Inhibition	%	35.94
	8104811	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	1.0	CHEMBL4225	Homo sapiens	Inhibition	%	1.0
	8105035	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.9	CHEMBL4225	Homo sapiens	Inhibition	%	-0.9
	8105175	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.13	CHEMBL4225	Homo sapiens	Inhibition	%	0.13
	8105565	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.05	CHEMBL4225	Homo sapiens	Inhibition	%	3.05
	8105703	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	3.33	CHEMBL4225	Homo sapiens	Inhibition	%	3.33
	8105983	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.3	CHEMBL4225	Homo sapiens	Inhibition	%	2.3
	8106372	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.26	CHEMBL4225	Homo sapiens	Inhibition	%	1.26
	8106528	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	27.76	CHEMBL4225	Homo sapiens	Inhibition	%	27.76
	8106881	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	40.31	CHEMBL4225	Homo sapiens	Inhibition	%	40.31
	8107002	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.56	CHEMBL4225	Homo sapiens	Inhibition	%	-0.56
	8107226	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-2.09	CHEMBL4225	Homo sapiens	Inhibition	%	-2.09
	8107398	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.89	CHEMBL4225	Homo sapiens	Inhibition	%	0.89
	8107599	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	12.09	CHEMBL4225	Homo sapiens	Inhibition	%	12.09
	8107958	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	5.73	CHEMBL4225	Homo sapiens	Inhibition	%	5.73
	8108116	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.74	CHEMBL4225	Homo sapiens	Inhibition	%	1.74
	8108340	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	-1.57	CHEMBL4225	Homo sapiens	Inhibition	%	-1.57
	8108515	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.67	CHEMBL4225	Homo sapiens	Inhibition	%	-1.67
	8108662	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.46	CHEMBL4225	Homo sapiens	Inhibition	%	1.46
	8108886	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	7.9	CHEMBL4225	Homo sapiens	Inhibition	%	7.9
	8109028	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.59	CHEMBL4225	Homo sapiens	Inhibition	%	-0.59
	8109366	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.68	CHEMBL4225	Homo sapiens	Inhibition	%	-0.68
	8109496	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.74	CHEMBL4225	Homo sapiens	Inhibition	%	0.74
	8109720	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-0.81	CHEMBL4225	Homo sapiens	Inhibition	%	-0.81
	8109891	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	6.53	CHEMBL4225	Homo sapiens	Inhibition	%	6.53
	8110023	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.97	CHEMBL4225	Homo sapiens	Inhibition	%	2.97
	8110247	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.12	CHEMBL4225	Homo sapiens	Inhibition	%	2.12
	8110302	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.56	CHEMBL4225	Homo sapiens	Inhibition	%	1.56
	8110526	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.01	CHEMBL4225	Homo sapiens	Inhibition	%	2.01
	8110692	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.07	CHEMBL4225	Homo sapiens	Inhibition	%	-0.07
	8110850	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.13	CHEMBL4225	Homo sapiens	Inhibition	%	1.13
	8111074	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.74	CHEMBL4225	Homo sapiens	Inhibition	%	0.74
	8111197	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	0.09	CHEMBL4225	Homo sapiens	Inhibition	%	0.09
	8111548	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.88	CHEMBL4225	Homo sapiens	Inhibition	%	1.88
	8111714	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	0.1	CHEMBL4225	Homo sapiens	Inhibition	%	0.1
	8111919	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.65	CHEMBL4225	Homo sapiens	Inhibition	%	1.65
	8112143	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.78	CHEMBL4225	Homo sapiens	Inhibition	%	4.78
	8112280	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-2.05	CHEMBL4225	Homo sapiens	Inhibition	%	-2.05
	8112672	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.7	CHEMBL4225	Homo sapiens	Inhibition	%	2.7
	8112844	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.36	CHEMBL4225	Homo sapiens	Inhibition	%	0.36
	8113220	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.52	CHEMBL4225	Homo sapiens	Inhibition	%	1.52
	8113356	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	1.39	CHEMBL4225	Homo sapiens	Inhibition	%	1.39
	8113704	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.35	CHEMBL4225	Homo sapiens	Inhibition	%	-0.35
	8114044	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.21	CHEMBL4225	Homo sapiens	Inhibition	%	-1.21
	8114220	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.99	CHEMBL4225	Homo sapiens	Inhibition	%	0.99
	8114576	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.15	CHEMBL4225	Homo sapiens	Inhibition	%	1.15
	8114852	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.19	CHEMBL4225	Homo sapiens	Inhibition	%	2.19
	8115018	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-0.16	CHEMBL4225	Homo sapiens	Inhibition	%	-0.16
	8115407	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.62	CHEMBL4225	Homo sapiens	Inhibition	%	0.62
	8115527	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.38	CHEMBL4225	Homo sapiens	Inhibition	%	1.38
	8115884	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	9.59	CHEMBL4225	Homo sapiens	Inhibition	%	9.59
	8116043	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	11.83	CHEMBL4225	Homo sapiens	Inhibition	%	11.83
	8116267	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	61.89	CHEMBL4225	Homo sapiens	Inhibition	%	61.89
	8116470	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.21	CHEMBL4225	Homo sapiens	Inhibition	%	2.21
	8116604	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.8	CHEMBL4225	Homo sapiens	Inhibition	%	0.8
	8116828	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.26	CHEMBL4225	Homo sapiens	Inhibition	%	-0.26
	8117000	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	-0.72	CHEMBL4225	Homo sapiens	Inhibition	%	-0.72
	8117171	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-2.93	CHEMBL4225	Homo sapiens	Inhibition	%	-2.93
	8117395	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	0.9	CHEMBL4225	Homo sapiens	Inhibition	%	0.9
	8117553	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.81	CHEMBL4225	Homo sapiens	Inhibition	%	3.81
	8117683	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	2.2	CHEMBL4225	Homo sapiens	Inhibition	%	2.2
	8117907	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	1.75	CHEMBL4225	Homo sapiens	Inhibition	%	1.75
	8118045	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.86	CHEMBL4225	Homo sapiens	Inhibition	%	0.86
	8118385	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.22	CHEMBL4225	Homo sapiens	Inhibition	%	3.22
	8118557	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.97	CHEMBL4225	Homo sapiens	Inhibition	%	1.97
	8118917	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-0.23	CHEMBL4225	Homo sapiens	Inhibition	%	-0.23
	8119188	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	45.38	CHEMBL4225	Homo sapiens	Inhibition	%	45.38
	8119347	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.32	CHEMBL4225	Homo sapiens	Inhibition	%	2.32
	8119571	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.39	CHEMBL4225	Homo sapiens	Inhibition	%	3.39
	8119738	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.84	CHEMBL4225	Homo sapiens	Inhibition	%	0.84
	8119857	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.29	CHEMBL4225	Homo sapiens	Inhibition	%	0.29
	8120081	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	2.89	CHEMBL4225	Homo sapiens	Inhibition	%	2.89
	8120220	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	1.25	CHEMBL4225	Homo sapiens	Inhibition	%	1.25
	8120604	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.51	CHEMBL4225	Homo sapiens	Inhibition	%	-1.51
	8120805	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	18.01	CHEMBL4225	Homo sapiens	Inhibition	%	18.01
	8121157	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-1.61	CHEMBL4225	Homo sapiens	Inhibition	%	-1.61
	8121329	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	0.36	CHEMBL4225	Homo sapiens	Inhibition	%	0.36
	8121720	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.17	CHEMBL4225	Homo sapiens	Inhibition	%	4.17
	8121883	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.89	CHEMBL4225	Homo sapiens	Inhibition	%	1.89
	8122228	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.05	CHEMBL4225	Homo sapiens	Inhibition	%	0.05
	8122366	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.42	CHEMBL4225	Homo sapiens	Inhibition	%	-0.42
	8122590	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	11.6	CHEMBL4225	Homo sapiens	Inhibition	%	11.6
	8122710	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	5.16	CHEMBL4225	Homo sapiens	Inhibition	%	5.16
	8122877	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.73	CHEMBL4225	Homo sapiens	Inhibition	%	1.73
	8123101	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	3.47	CHEMBL4225	Homo sapiens	Inhibition	%	3.47
	8123243	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.94	CHEMBL4225	Homo sapiens	Inhibition	%	1.94
	8123521	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	88.77	CHEMBL4225	Homo sapiens	Inhibition	%	88.77
	8123895	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	9.02	CHEMBL4225	Homo sapiens	Inhibition	%	9.02
	8124062	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	3.04	CHEMBL4225	Homo sapiens	Inhibition	%	3.04
	8124405	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	93.89	CHEMBL4225	Homo sapiens	Inhibition	%	93.89
	8124544	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.4	CHEMBL4225	Homo sapiens	Inhibition	%	-0.4
	8124768	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	2.51	CHEMBL4225	Homo sapiens	Inhibition	%	2.51
	8124933	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-0.74	CHEMBL4225	Homo sapiens	Inhibition	%	-0.74
	8125134	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.29	CHEMBL4225	Homo sapiens	Inhibition	%	1.29
	8125488	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	5.98	CHEMBL4225	Homo sapiens	Inhibition	%	5.98
	8125656	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.46	CHEMBL4225	Homo sapiens	Inhibition	%	-0.46
	8126044	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.21	CHEMBL4225	Homo sapiens	Inhibition	%	-0.21
	8126208	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.2	CHEMBL4225	Homo sapiens	Inhibition	%	5.2
	8126547	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.92	CHEMBL4225	Homo sapiens	Inhibition	%	0.92
	8126907	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	64.14	CHEMBL4225	Homo sapiens	Inhibition	%	64.14
	8127029	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.06	CHEMBL4225	Homo sapiens	Inhibition	%	2.06
	8127420	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	13.0	CHEMBL4225	Homo sapiens	Inhibition	%	13.0
	8127562	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	6.82	CHEMBL4225	Homo sapiens	Inhibition	%	6.82
	8127786	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	0.14	CHEMBL4225	Homo sapiens	Inhibition	%	0.14
	8127850	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.86	CHEMBL4225	Homo sapiens	Inhibition	%	0.86
	8128226	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.35	CHEMBL4225	Homo sapiens	Inhibition	%	2.35
	8128393	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	5.72	CHEMBL4225	Homo sapiens	Inhibition	%	5.72
	8128736	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	98.21	CHEMBL4225	Homo sapiens	Inhibition	%	98.21
	8129097	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	12.52	CHEMBL4225	Homo sapiens	Inhibition	%	12.52
	8129268	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.73	CHEMBL4225	Homo sapiens	Inhibition	%	0.73
	8129457	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.58	CHEMBL4225	Homo sapiens	Inhibition	%	3.58
	8129681	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	0.17	CHEMBL4225	Homo sapiens	Inhibition	%	0.17
	8129820	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	43.42	CHEMBL4225	Homo sapiens	Inhibition	%	43.42
	8129981	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	5.19	CHEMBL4225	Homo sapiens	Inhibition	%	5.19
	8130205	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	51.0	CHEMBL4225	Homo sapiens	Inhibition	%	51.0
	8130377	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	2.56	CHEMBL4225	Homo sapiens	Inhibition	%	2.56
	8130537	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	50.07	CHEMBL4225	Homo sapiens	Inhibition	%	50.07
	8130761	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	91.72	CHEMBL4225	Homo sapiens	Inhibition	%	91.72
	8130877	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.95	CHEMBL4225	Homo sapiens	Inhibition	%	0.95
	8131240	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.18	CHEMBL4225	Homo sapiens	Inhibition	%	1.18
	8131360	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	4.62	CHEMBL4225	Homo sapiens	Inhibition	%	4.62
	8131584	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.73	CHEMBL4225	Homo sapiens	Inhibition	%	1.73
	8131751	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	63.1	CHEMBL4225	Homo sapiens	Inhibition	%	63.1
	8132116	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	2.59	CHEMBL4225	Homo sapiens	Inhibition	%	2.59
	8132178	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.28	CHEMBL4225	Homo sapiens	Inhibition	%	3.28
	8132402	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	2.65	CHEMBL4225	Homo sapiens	Inhibition	%	2.65
	8132549	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.69	CHEMBL4225	Homo sapiens	Inhibition	%	2.69
	8132717	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.38	CHEMBL4225	Homo sapiens	Inhibition	%	-0.38
	8132941	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.35	CHEMBL4225	Homo sapiens	Inhibition	%	0.35
	8133062	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.28	CHEMBL4225	Homo sapiens	Inhibition	%	7.28
	8133424	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	5.35	CHEMBL4225	Homo sapiens	Inhibition	%	5.35
	8133596	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.28	CHEMBL4225	Homo sapiens	Inhibition	%	-1.28
	8134000	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	3.57	CHEMBL4225	Homo sapiens	Inhibition	%	3.57
	8134148	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.46	CHEMBL4225	Homo sapiens	Inhibition	%	0.46
	8134532	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.43	CHEMBL4225	Homo sapiens	Inhibition	%	0.43
	8134716	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-0.68	CHEMBL4225	Homo sapiens	Inhibition	%	-0.68
	8135100	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	0.95	CHEMBL4225	Homo sapiens	Inhibition	%	0.95
	8135215	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.63	CHEMBL4225	Homo sapiens	Inhibition	%	-0.63
	8135439	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.79	CHEMBL4225	Homo sapiens	Inhibition	%	0.79
	8135580	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.48	CHEMBL4225	Homo sapiens	Inhibition	%	0.48
	8135925	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	5.31	CHEMBL4225	Homo sapiens	Inhibition	%	5.31
	8136093	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.01	CHEMBL4225	Homo sapiens	Inhibition	%	0.01
	8136461	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.55	CHEMBL4225	Homo sapiens	Inhibition	%	0.55
	8136751	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	12.55	CHEMBL4225	Homo sapiens	Inhibition	%	12.55
	8136886	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.09	CHEMBL4225	Homo sapiens	Inhibition	%	0.09
	8137273	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.08	CHEMBL4225	Homo sapiens	Inhibition	%	3.08
	8137393	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	43.57	CHEMBL4225	Homo sapiens	Inhibition	%	43.57
	8137617	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.58	CHEMBL4225	Homo sapiens	Inhibition	%	0.58
	8137765	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	29.87	CHEMBL4225	Homo sapiens	Inhibition	%	29.87
	8137931	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.95	CHEMBL4225	Homo sapiens	Inhibition	%	-1.95
	8138155	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.15	CHEMBL4225	Homo sapiens	Inhibition	%	-0.15
	8138334	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-2.75	CHEMBL4225	Homo sapiens	Inhibition	%	-2.75
	8138482	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	2.78	CHEMBL4225	Homo sapiens	Inhibition	%	2.78
	8138706	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.1	CHEMBL4225	Homo sapiens	Inhibition	%	-1.1
	8138864	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-2.64	CHEMBL4225	Homo sapiens	Inhibition	%	-2.64
	8139049	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	3.62	CHEMBL4225	Homo sapiens	Inhibition	%	3.62
	8139273	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.63	CHEMBL4225	Homo sapiens	Inhibition	%	1.63
	8139432	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.77	CHEMBL4225	Homo sapiens	Inhibition	%	1.77
	8139770	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-2.13	CHEMBL4225	Homo sapiens	Inhibition	%	-2.13
	8139911	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.02	CHEMBL4225	Homo sapiens	Inhibition	%	1.02
	8140258	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	0.79	CHEMBL4225	Homo sapiens	Inhibition	%	0.79
	8140417	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.99	CHEMBL4225	Homo sapiens	Inhibition	%	0.99
	8140641	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.77	CHEMBL4225	Homo sapiens	Inhibition	%	1.77
	8140784	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.01	CHEMBL4225	Homo sapiens	Inhibition	%	0.01
	8141086	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	7.85	CHEMBL4225	Homo sapiens	Inhibition	%	7.85
	8141216	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	4.18	CHEMBL4225	Homo sapiens	Inhibition	%	4.18
	8141440	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.38	CHEMBL4225	Homo sapiens	Inhibition	%	-0.38
	8141600	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	10.94	CHEMBL4225	Homo sapiens	Inhibition	%	10.94
	8141943	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	-1.19	CHEMBL4225	Homo sapiens	Inhibition	%	-1.19
	8142104	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.37	CHEMBL4225	Homo sapiens	Inhibition	%	0.37
	8142496	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	1.74	CHEMBL4225	Homo sapiens	Inhibition	%	1.74
	8142672	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	1.02	CHEMBL4225	Homo sapiens	Inhibition	%	1.02
	8143045	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.78	CHEMBL4225	Homo sapiens	Inhibition	%	-0.78
	8143200	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.14	CHEMBL4225	Homo sapiens	Inhibition	%	0.14
	8143611	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	4.77	CHEMBL4225	Homo sapiens	Inhibition	%	4.77
	8143770	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	-0.15	CHEMBL4225	Homo sapiens	Inhibition	%	-0.15
	8144108	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.39	CHEMBL4225	Homo sapiens	Inhibition	%	1.39
	8144247	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-0.02	CHEMBL4225	Homo sapiens	Inhibition	%	-0.02
	8144471	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	-0.22	CHEMBL4225	Homo sapiens	Inhibition	%	-0.22
	8144601	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	4.14	CHEMBL4225	Homo sapiens	Inhibition	%	4.14
	8144978	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.42	CHEMBL4225	Homo sapiens	Inhibition	%	2.42
	8145115	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.01	CHEMBL4225	Homo sapiens	Inhibition	%	0.01
	8145428	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	44.39	CHEMBL4225	Homo sapiens	Inhibition	%	44.39
	8145776	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	-0.4	CHEMBL4225	Homo sapiens	Inhibition	%	-0.4
	8145937	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	3.63	CHEMBL4225	Homo sapiens	Inhibition	%	3.63
	8146281	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.38	CHEMBL4225	Homo sapiens	Inhibition	%	1.38
	8146441	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.98	CHEMBL4225	Homo sapiens	Inhibition	%	0.98
	8146665	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	15.57	CHEMBL4225	Homo sapiens	Inhibition	%	15.57
	8146832	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	9.73	CHEMBL4225	Homo sapiens	Inhibition	%	9.73
	8147001	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.85	CHEMBL4225	Homo sapiens	Inhibition	%	1.85
	8147367	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	57.17	CHEMBL4225	Homo sapiens	Inhibition	%	57.17
	8147520	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-1.31	CHEMBL4225	Homo sapiens	Inhibition	%	-1.31
	8147744	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.06	CHEMBL4225	Homo sapiens	Inhibition	%	0.06
	8147931	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	8.63	CHEMBL4225	Homo sapiens	Inhibition	%	8.63
	8148089	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.76	CHEMBL4225	Homo sapiens	Inhibition	%	2.76
	8148313	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	0.96	CHEMBL4225	Homo sapiens	Inhibition	%	0.96
	8148427	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.17	CHEMBL4225	Homo sapiens	Inhibition	%	-1.17
	8148790	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.28	CHEMBL4225	Homo sapiens	Inhibition	%	0.28
	8148928	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.44	CHEMBL4225	Homo sapiens	Inhibition	%	1.44
	8149152	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.51	CHEMBL4225	Homo sapiens	Inhibition	%	6.51
	8149311	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	1.05	CHEMBL4225	Homo sapiens	Inhibition	%	1.05
	8149445	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.31	CHEMBL4225	Homo sapiens	Inhibition	%	1.31
	8149669	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.2	CHEMBL4225	Homo sapiens	Inhibition	%	1.2
	8149767	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.89	CHEMBL4225	Homo sapiens	Inhibition	%	1.89
	8150116	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.35	CHEMBL4225	Homo sapiens	Inhibition	%	0.35
	8150276	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	5.49	CHEMBL4225	Homo sapiens	Inhibition	%	5.49
	8150500	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.38	CHEMBL4225	Homo sapiens	Inhibition	%	0.38
	8150620	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	-0.84	CHEMBL4225	Homo sapiens	Inhibition	%	-0.84
	8151009	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	72.0	CHEMBL4225	Homo sapiens	Inhibition	%	72.0
	8151172	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.0	CHEMBL4225	Homo sapiens	Inhibition	%	-1.0
	8151349	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.87	CHEMBL4225	Homo sapiens	Inhibition	%	2.87
	8151573	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.1	CHEMBL4225	Homo sapiens	Inhibition	%	0.1
	8151711	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	92.06	CHEMBL4225	Homo sapiens	Inhibition	%	92.06
	8152089	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-1.44	CHEMBL4225	Homo sapiens	Inhibition	%	-1.44
	8152277	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	50.09	CHEMBL4225	Homo sapiens	Inhibition	%	50.09
	8152659	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.74	CHEMBL4225	Homo sapiens	Inhibition	%	3.74
	8152773	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.8	CHEMBL4225	Homo sapiens	Inhibition	%	0.8
	8152997	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	0.04	CHEMBL4225	Homo sapiens	Inhibition	%	0.04
	8153136	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	-0.35	CHEMBL4225	Homo sapiens	Inhibition	%	-0.35
	8153497	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.04	CHEMBL4225	Homo sapiens	Inhibition	%	2.04
	8153654	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.64	CHEMBL4225	Homo sapiens	Inhibition	%	0.64
	8154011	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	10.46	CHEMBL4225	Homo sapiens	Inhibition	%	10.46
	8154108	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.38	CHEMBL4225	Homo sapiens	Inhibition	%	4.38
	8154332	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.35	CHEMBL4225	Homo sapiens	Inhibition	%	2.35
	8154458	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.71	CHEMBL4225	Homo sapiens	Inhibition	%	0.71
	8154841	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.72	CHEMBL4225	Homo sapiens	Inhibition	%	2.72
	8154961	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.26	CHEMBL4225	Homo sapiens	Inhibition	%	0.26
	8155185	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.06	CHEMBL4225	Homo sapiens	Inhibition	%	1.06
	8155361	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	1.36	CHEMBL4225	Homo sapiens	Inhibition	%	1.36
	8155522	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	0.36	CHEMBL4225	Homo sapiens	Inhibition	%	0.36
	8155924	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.21	CHEMBL4225	Homo sapiens	Inhibition	%	3.21
	8156062	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	24.18	CHEMBL4225	Homo sapiens	Inhibition	%	24.18
	8156286	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	94.28	CHEMBL4225	Homo sapiens	Inhibition	%	94.28
	8156498	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	-0.87	CHEMBL4225	Homo sapiens	Inhibition	%	-0.87
	8156648	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	82.79	CHEMBL4225	Homo sapiens	Inhibition	%	82.79
	8157015	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.67	CHEMBL4225	Homo sapiens	Inhibition	%	1.67
	8157135	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.85	CHEMBL4225	Homo sapiens	Inhibition	%	1.85
	8157359	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	9.04	CHEMBL4225	Homo sapiens	Inhibition	%	9.04
	8157500	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.78	CHEMBL4225	Homo sapiens	Inhibition	%	3.78
	8157854	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	7.88	CHEMBL4225	Homo sapiens	Inhibition	%	7.88
	8158015	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.66	CHEMBL4225	Homo sapiens	Inhibition	%	1.66
	8158265	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	-1.59	CHEMBL4225	Homo sapiens	Inhibition	%	-1.59
	8158489	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	5.07	CHEMBL4225	Homo sapiens	Inhibition	%	5.07
	8158647	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	1.8	CHEMBL4225	Homo sapiens	Inhibition	%	1.8
	8158816	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.48	CHEMBL4225	Homo sapiens	Inhibition	%	-0.48
	8159040	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.29	CHEMBL4225	Homo sapiens	Inhibition	%	1.29
	8159175	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.15	CHEMBL4225	Homo sapiens	Inhibition	%	-0.15
	8159519	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.14	CHEMBL4225	Homo sapiens	Inhibition	%	0.14
	8159650	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.54	CHEMBL4225	Homo sapiens	Inhibition	%	2.54
	8159874	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	67.32	CHEMBL4225	Homo sapiens	Inhibition	%	67.32
	8160015	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	-1.18	CHEMBL4225	Homo sapiens	Inhibition	%	-1.18
	8160152	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.09	CHEMBL4225	Homo sapiens	Inhibition	%	1.09
	8160376	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.7	CHEMBL4225	Homo sapiens	Inhibition	%	2.7
	8160526	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.54	CHEMBL4225	Homo sapiens	Inhibition	%	1.54
	8160820	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	6.08	CHEMBL4225	Homo sapiens	Inhibition	%	6.08
	8160970	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	-0.8	CHEMBL4225	Homo sapiens	Inhibition	%	-0.8
	8161194	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.52	CHEMBL4225	Homo sapiens	Inhibition	%	2.52
	8161337	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	90.08	CHEMBL4225	Homo sapiens	Inhibition	%	90.08
	8161686	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.29	CHEMBL4225	Homo sapiens	Inhibition	%	4.29
	8161824	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	21.86	CHEMBL4225	Homo sapiens	Inhibition	%	21.86
	8162048	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.65	CHEMBL4225	Homo sapiens	Inhibition	%	1.65
	8162178	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	49.2	CHEMBL4225	Homo sapiens	Inhibition	%	49.2
	8162338	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.17	CHEMBL4225	Homo sapiens	Inhibition	%	2.17
	8162562	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.41	CHEMBL4225	Homo sapiens	Inhibition	%	1.41
	8162815	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	21.63	CHEMBL4225	Homo sapiens	Inhibition	%	21.63
	8162963	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	28.3	CHEMBL4225	Homo sapiens	Inhibition	%	28.3
	8163356	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.29	CHEMBL4225	Homo sapiens	Inhibition	%	1.29
	8163490	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.4	CHEMBL4225	Homo sapiens	Inhibition	%	-0.4
	8163837	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.05	CHEMBL4225	Homo sapiens	Inhibition	%	0.05
	8164195	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	93.79	CHEMBL4225	Homo sapiens	Inhibition	%	93.79
	8164335	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.85	CHEMBL4225	Homo sapiens	Inhibition	%	0.85
	8164714	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	98.86	CHEMBL4225	Homo sapiens	Inhibition	%	98.86
	8164858	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.55	CHEMBL4225	Homo sapiens	Inhibition	%	0.55
	8165152	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	54.29	CHEMBL4225	Homo sapiens	Inhibition	%	54.29
	8165517	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.44	CHEMBL4225	Homo sapiens	Inhibition	%	3.44
	8165660	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	97.62	CHEMBL4225	Homo sapiens	Inhibition	%	97.62
	8166010	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	36.88	CHEMBL4225	Homo sapiens	Inhibition	%	36.88
	8166372	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.0	CHEMBL4225	Homo sapiens	Inhibition	%	1.0
	8166502	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	1.81	CHEMBL4225	Homo sapiens	Inhibition	%	1.81
	8166827	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.36	CHEMBL4225	Homo sapiens	Inhibition	%	2.36
	8167139	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-0.98	CHEMBL4225	Homo sapiens	Inhibition	%	-0.98
	8167280	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	79.98	CHEMBL4225	Homo sapiens	Inhibition	%	79.98
	8167504	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	29.01	CHEMBL4225	Homo sapiens	Inhibition	%	29.01
	8167668	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.3	CHEMBL4225	Homo sapiens	Inhibition	%	0.3
	8167801	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.5	CHEMBL4225	Homo sapiens	Inhibition	%	2.5
	8168025	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	0.59	CHEMBL4225	Homo sapiens	Inhibition	%	0.59
	8168149	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.24	CHEMBL4225	Homo sapiens	Inhibition	%	-0.24
	8168514	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.88	CHEMBL4225	Homo sapiens	Inhibition	%	2.88
	8168650	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.02	CHEMBL4225	Homo sapiens	Inhibition	%	0.02
	8168874	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.55	CHEMBL4225	Homo sapiens	Inhibition	%	-0.55
	8169038	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	96.94	CHEMBL4225	Homo sapiens	Inhibition	%	96.94
	8169180	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	0.87	CHEMBL4225	Homo sapiens	Inhibition	%	0.87
	8169404	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.05	CHEMBL4225	Homo sapiens	Inhibition	%	3.05
	8169484	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	93.08	CHEMBL4225	Homo sapiens	Inhibition	%	93.08
	8169842	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	12.27	CHEMBL4225	Homo sapiens	Inhibition	%	12.27
	8169987	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.31	CHEMBL4225	Homo sapiens	Inhibition	%	0.31
	8170211	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	2.87	CHEMBL4225	Homo sapiens	Inhibition	%	2.87
	8170336	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.48	CHEMBL4225	Homo sapiens	Inhibition	%	1.48
	8170700	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	5.25	CHEMBL4225	Homo sapiens	Inhibition	%	5.25
	8170835	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.52	CHEMBL4225	Homo sapiens	Inhibition	%	4.52
	8171059	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	14.03	CHEMBL4225	Homo sapiens	Inhibition	%	14.03
	8171256	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.62	CHEMBL4225	Homo sapiens	Inhibition	%	1.62
	8171473	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	-0.12	CHEMBL4225	Homo sapiens	Inhibition	%	-0.12
	8171838	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	79.48	CHEMBL4225	Homo sapiens	Inhibition	%	79.48
	8171991	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.25	CHEMBL4225	Homo sapiens	Inhibition	%	2.25
	8172347	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	6.03	CHEMBL4225	Homo sapiens	Inhibition	%	6.03
	8172475	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.68	CHEMBL4225	Homo sapiens	Inhibition	%	0.68
	8172699	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.61	CHEMBL4225	Homo sapiens	Inhibition	%	0.61
	8172841	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.32	CHEMBL4225	Homo sapiens	Inhibition	%	2.32
	8173201	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.78	CHEMBL4225	Homo sapiens	Inhibition	%	-0.78
	8173366	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.97	CHEMBL4225	Homo sapiens	Inhibition	%	4.97
	8173731	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	32.16	CHEMBL4225	Homo sapiens	Inhibition	%	32.16
	8173818	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	46.53	CHEMBL4225	Homo sapiens	Inhibition	%	46.53
	8174042	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	91.88	CHEMBL4225	Homo sapiens	Inhibition	%	91.88
	8174174	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-0.85	CHEMBL4225	Homo sapiens	Inhibition	%	-0.85
	8174546	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	-0.19	CHEMBL4225	Homo sapiens	Inhibition	%	-0.19
	8174668	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.98	CHEMBL4225	Homo sapiens	Inhibition	%	2.98
	8174892	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.63	CHEMBL4225	Homo sapiens	Inhibition	%	1.63
	8175035	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	29.41	CHEMBL4225	Homo sapiens	Inhibition	%	29.41
	8175395	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	65.35	CHEMBL4225	Homo sapiens	Inhibition	%	65.35
	8175651	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	21.62	CHEMBL4225	Homo sapiens	Inhibition	%	21.62
	8175814	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.73	CHEMBL4225	Homo sapiens	Inhibition	%	0.73
	8176191	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	6.2	CHEMBL4225	Homo sapiens	Inhibition	%	6.2
	8176340	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.15	CHEMBL4225	Homo sapiens	Inhibition	%	1.15
	8176696	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	30.36	CHEMBL4225	Homo sapiens	Inhibition	%	30.36
	8177050	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.21	CHEMBL4225	Homo sapiens	Inhibition	%	1.21
	8177192	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.78	CHEMBL4225	Homo sapiens	Inhibition	%	2.78
	8177554	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	5.12	CHEMBL4225	Homo sapiens	Inhibition	%	5.12
	8177718	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	34.97	CHEMBL4225	Homo sapiens	Inhibition	%	34.97
	8178082	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	84.59	CHEMBL4225	Homo sapiens	Inhibition	%	84.59
	8178394	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	-0.97	CHEMBL4225	Homo sapiens	Inhibition	%	-0.97
	8178521	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	2.84	CHEMBL4225	Homo sapiens	Inhibition	%	2.84
	8178745	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.52	CHEMBL4225	Homo sapiens	Inhibition	%	2.52
	8178894	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	1.77	CHEMBL4225	Homo sapiens	Inhibition	%	1.77
	8179241	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.34	CHEMBL4225	Homo sapiens	Inhibition	%	2.34
	8179385	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.87	CHEMBL4225	Homo sapiens	Inhibition	%	2.87
	8179746	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.46	CHEMBL4225	Homo sapiens	Inhibition	%	1.46
	8180003	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.34	CHEMBL4225	Homo sapiens	Inhibition	%	1.34
	8180157	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	0.86	CHEMBL4225	Homo sapiens	Inhibition	%	0.86
	8180381	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	0.06	CHEMBL4225	Homo sapiens	Inhibition	%	0.06
	8180537	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	28.69	CHEMBL4225	Homo sapiens	Inhibition	%	28.69
	8180685	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.72	CHEMBL4225	Homo sapiens	Inhibition	%	1.72
	8180909	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	10.98	CHEMBL4225	Homo sapiens	Inhibition	%	10.98
	8181042	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.47	CHEMBL4225	Homo sapiens	Inhibition	%	2.47
	8181397	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	0.33	CHEMBL4225	Homo sapiens	Inhibition	%	0.33
	8181537	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	1.31	CHEMBL4225	Homo sapiens	Inhibition	%	1.31
	8181761	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.71	CHEMBL4225	Homo sapiens	Inhibition	%	1.71
	8181900	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	20.34	CHEMBL4225	Homo sapiens	Inhibition	%	20.34
	8182063	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	2.98	CHEMBL4225	Homo sapiens	Inhibition	%	2.98
	8182287	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	8.8	CHEMBL4225	Homo sapiens	Inhibition	%	8.8
	8182427	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	2.15	CHEMBL4225	Homo sapiens	Inhibition	%	2.15
	8182743	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.42	CHEMBL4225	Homo sapiens	Inhibition	%	0.42
	8183089	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	4.42	CHEMBL4225	Homo sapiens	Inhibition	%	4.42
	8183238	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	34.78	CHEMBL4225	Homo sapiens	Inhibition	%	34.78
	8183591	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.1	CHEMBL4225	Homo sapiens	Inhibition	%	2.1
	8183733	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	36.76	CHEMBL4225	Homo sapiens	Inhibition	%	36.76
	8183957	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.8	CHEMBL4225	Homo sapiens	Inhibition	%	0.8
	8184093	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.75	CHEMBL4225	Homo sapiens	Inhibition	%	0.75
	8184359	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.3	CHEMBL4225	Homo sapiens	Inhibition	%	2.3
	8184730	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.33	CHEMBL4225	Homo sapiens	Inhibition	%	-0.33
	8184887	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.15	CHEMBL4225	Homo sapiens	Inhibition	%	1.15
	8185260	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.0	CHEMBL4225	Homo sapiens	Inhibition	%	1.0
	8185391	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	7.17	CHEMBL4225	Homo sapiens	Inhibition	%	7.17
	8185615	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.01	CHEMBL4225	Homo sapiens	Inhibition	%	1.01
	8185746	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.45	CHEMBL4225	Homo sapiens	Inhibition	%	2.45
	8186109	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.28	CHEMBL4225	Homo sapiens	Inhibition	%	2.28
	8186250	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	-1.03	CHEMBL4225	Homo sapiens	Inhibition	%	-1.03
	8186638	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	0.19	CHEMBL4225	Homo sapiens	Inhibition	%	0.19
	8186777	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.63	CHEMBL4225	Homo sapiens	Inhibition	%	1.63
	8187001	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	0.9	CHEMBL4225	Homo sapiens	Inhibition	%	0.9
	8187099	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	-0.7	CHEMBL4225	Homo sapiens	Inhibition	%	-0.7
	8187447	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	95.36	CHEMBL4225	Homo sapiens	Inhibition	%	95.36
	8187595	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	85.97	CHEMBL4225	Homo sapiens	Inhibition	%	85.97
	8187819	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	-1.55	CHEMBL4225	Homo sapiens	Inhibition	%	-1.55
	8187948	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	2.93	CHEMBL4225	Homo sapiens	Inhibition	%	2.93
	8188315	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.45	CHEMBL4225	Homo sapiens	Inhibition	%	2.45
	8188450	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	8.7	CHEMBL4225	Homo sapiens	Inhibition	%	8.7
	8188724	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.37	CHEMBL4225	Homo sapiens	Inhibition	%	2.37
	8188948	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.21	CHEMBL4225	Homo sapiens	Inhibition	%	1.21
	8189096	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.4	CHEMBL4225	Homo sapiens	Inhibition	%	3.4
	8189252	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.21	CHEMBL4225	Homo sapiens	Inhibition	%	1.21
	8189476	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	2.13	CHEMBL4225	Homo sapiens	Inhibition	%	2.13
	8189625	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.78	CHEMBL4225	Homo sapiens	Inhibition	%	-0.78
	8189981	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.36	CHEMBL4225	Homo sapiens	Inhibition	%	1.36
	8190113	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	1.63	CHEMBL4225	Homo sapiens	Inhibition	%	1.63
	8190477	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.45	CHEMBL4225	Homo sapiens	Inhibition	%	1.45
	8190614	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.41	CHEMBL4225	Homo sapiens	Inhibition	%	0.41
	8190838	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.02	CHEMBL4225	Homo sapiens	Inhibition	%	1.02
	8191002	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	7.06	CHEMBL4225	Homo sapiens	Inhibition	%	7.06
	8191364	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.79	CHEMBL4225	Homo sapiens	Inhibition	%	3.79
	8191460	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	2.41	CHEMBL4225	Homo sapiens	Inhibition	%	2.41
	8191684	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.46	CHEMBL4225	Homo sapiens	Inhibition	%	0.46
	8191806	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	98.35	CHEMBL4225	Homo sapiens	Inhibition	%	98.35
	8192179	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	3.8	CHEMBL4225	Homo sapiens	Inhibition	%	3.8
	8192308	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.99	CHEMBL4225	Homo sapiens	Inhibition	%	0.99
	8192532	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.3	CHEMBL4225	Homo sapiens	Inhibition	%	2.3
	8192676	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.83	CHEMBL4225	Homo sapiens	Inhibition	%	2.83
	8192812	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	18.37	CHEMBL4225	Homo sapiens	Inhibition	%	18.37
	8193036	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	81.17	CHEMBL4225	Homo sapiens	Inhibition	%	81.17
	8193308	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.69	CHEMBL4225	Homo sapiens	Inhibition	%	0.69
	8193453	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	23.18	CHEMBL4225	Homo sapiens	Inhibition	%	23.18
	8193834	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	13.72	CHEMBL4225	Homo sapiens	Inhibition	%	13.72
	8193983	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.76	CHEMBL4225	Homo sapiens	Inhibition	%	-0.76
	8194338	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.85	CHEMBL4225	Homo sapiens	Inhibition	%	1.85
	8194469	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	5.09	CHEMBL4225	Homo sapiens	Inhibition	%	5.09
	8194693	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	-0.03	CHEMBL4225	Homo sapiens	Inhibition	%	-0.03
	8194836	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.33	CHEMBL4225	Homo sapiens	Inhibition	%	1.33
	8195193	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	2.41	CHEMBL4225	Homo sapiens	Inhibition	%	2.41
	8195357	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	64.61	CHEMBL4225	Homo sapiens	Inhibition	%	64.61
	8195720	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.74	CHEMBL4225	Homo sapiens	Inhibition	%	1.74
	8196042	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	-0.11	CHEMBL4225	Homo sapiens	Inhibition	%	-0.11
	8196159	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	1.26	CHEMBL4225	Homo sapiens	Inhibition	%	1.26
	8196383	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	2.0	CHEMBL4225	Homo sapiens	Inhibition	%	2.0
	8196533	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.31	CHEMBL4225	Homo sapiens	Inhibition	%	2.31
	8196885	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.46	CHEMBL4225	Homo sapiens	Inhibition	%	2.46
	8197026	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.46	CHEMBL4225	Homo sapiens	Inhibition	%	2.46
	8197387	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	96.35	CHEMBL4225	Homo sapiens	Inhibition	%	96.35
	8197662	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.24	CHEMBL4225	Homo sapiens	Inhibition	%	1.24
	8197802	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.87	CHEMBL4225	Homo sapiens	Inhibition	%	1.87
	8198026	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	3.23	CHEMBL4225	Homo sapiens	Inhibition	%	3.23
	8198183	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.78	CHEMBL4225	Homo sapiens	Inhibition	%	1.78
	8198321	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.67	CHEMBL4225	Homo sapiens	Inhibition	%	-0.67
	8198545	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.53	CHEMBL4225	Homo sapiens	Inhibition	%	2.53
	8198675	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	0.29	CHEMBL4225	Homo sapiens	Inhibition	%	0.29
	8199030	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	0.46	CHEMBL4225	Homo sapiens	Inhibition	%	0.46
	8199178	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.08	CHEMBL4225	Homo sapiens	Inhibition	%	2.08
	8199402	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	1.7	CHEMBL4225	Homo sapiens	Inhibition	%	1.7
	8199536	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.45	CHEMBL4225	Homo sapiens	Inhibition	%	1.45
	8199699	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	95.7	CHEMBL4225	Homo sapiens	Inhibition	%	95.7
	8199923	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.65	CHEMBL4225	Homo sapiens	Inhibition	%	0.65
	8200061	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	4.27	CHEMBL4225	Homo sapiens	Inhibition	%	4.27
	8200389	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	-0.96	CHEMBL4225	Homo sapiens	Inhibition	%	-0.96
	8200728	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.37	CHEMBL4225	Homo sapiens	Inhibition	%	2.37
	8200878	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.23	CHEMBL4225	Homo sapiens	Inhibition	%	2.23
	8201232	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	6.46	CHEMBL4225	Homo sapiens	Inhibition	%	6.46
	8201367	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.98	CHEMBL4225	Homo sapiens	Inhibition	%	0.98
	8201591	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.04	CHEMBL4225	Homo sapiens	Inhibition	%	2.04
	8201724	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.09	CHEMBL4225	Homo sapiens	Inhibition	%	1.09
	8202003	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.58	CHEMBL4225	Homo sapiens	Inhibition	%	0.58
	8202367	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	1.02	CHEMBL4225	Homo sapiens	Inhibition	%	1.02
	8202534	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.05	CHEMBL4225	Homo sapiens	Inhibition	%	0.05
	8202883	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	2.71	CHEMBL4225	Homo sapiens	Inhibition	%	2.71
	8203013	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	2.47	CHEMBL4225	Homo sapiens	Inhibition	%	2.47
	8203237	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	10.39	CHEMBL4225	Homo sapiens	Inhibition	%	10.39
	8203368	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.61	CHEMBL4225	Homo sapiens	Inhibition	%	1.61
	8203738	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.77	CHEMBL4225	Homo sapiens	Inhibition	%	1.77
	8203872	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	2.09	CHEMBL4225	Homo sapiens	Inhibition	%	2.09
	8204262	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.81	CHEMBL4225	Homo sapiens	Inhibition	%	0.81
	8204399	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.89	CHEMBL4225	Homo sapiens	Inhibition	%	1.89
	8204728	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.58	CHEMBL4225	Homo sapiens	Inhibition	%	1.58
	8205067	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	28.59	CHEMBL4225	Homo sapiens	Inhibition	%	28.59
	8205216	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	9.32	CHEMBL4225	Homo sapiens	Inhibition	%	9.32
	8205440	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	52.03	CHEMBL4225	Homo sapiens	Inhibition	%	52.03
	8205576	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.77	CHEMBL4225	Homo sapiens	Inhibition	%	1.77
	8205939	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.47	CHEMBL4225	Homo sapiens	Inhibition	%	0.47
	8206071	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	1.03	CHEMBL4225	Homo sapiens	Inhibition	%	1.03
	8206347	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.13	CHEMBL4225	Homo sapiens	Inhibition	%	0.13
	8206714	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.39	CHEMBL4225	Homo sapiens	Inhibition	%	2.39
	8206894	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.66	CHEMBL4225	Homo sapiens	Inhibition	%	2.66
	8207244	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.6	CHEMBL4225	Homo sapiens	Inhibition	%	2.6
	8207598	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	1.45	CHEMBL4225	Homo sapiens	Inhibition	%	1.45
	8207730	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	0.97	CHEMBL4225	Homo sapiens	Inhibition	%	0.97
	8208099	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	6.81	CHEMBL4225	Homo sapiens	Inhibition	%	6.81
	8208231	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	0.77	CHEMBL4225	Homo sapiens	Inhibition	%	0.77
	8208455	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	0.26	CHEMBL4225	Homo sapiens	Inhibition	%	0.26
	8208621	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.34	CHEMBL4225	Homo sapiens	Inhibition	%	1.34
	8208754	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.5	CHEMBL4225	Homo sapiens	Inhibition	%	3.5
	8208978	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	0.67	CHEMBL4225	Homo sapiens	Inhibition	%	0.67
	8209083	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	5.83	CHEMBL4225	Homo sapiens	Inhibition	%	5.83
	8209423	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	-0.01	CHEMBL4225	Homo sapiens	Inhibition	%	-0.01
	8209797	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.09	CHEMBL4225	Homo sapiens	Inhibition	%	1.09
	8209933	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.91	CHEMBL4225	Homo sapiens	Inhibition	%	1.91
	8210298	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	0.08	CHEMBL4225	Homo sapiens	Inhibition	%	0.08
	8210434	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.44	CHEMBL4225	Homo sapiens	Inhibition	%	-1.44
	8210658	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	2.75	CHEMBL4225	Homo sapiens	Inhibition	%	2.75
	8210693	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	-0.33	CHEMBL4225	Homo sapiens	Inhibition	%	-0.33
	8210917	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.92	CHEMBL4225	Homo sapiens	Inhibition	%	0.92
	8211061	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.6	CHEMBL4225	Homo sapiens	Inhibition	%	1.6
	8211231	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.51	CHEMBL4225	Homo sapiens	Inhibition	%	2.51
	8211455	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.29	CHEMBL4225	Homo sapiens	Inhibition	%	1.29
	8211578	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	9.25	CHEMBL4225	Homo sapiens	Inhibition	%	9.25
	8211931	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.65	CHEMBL4225	Homo sapiens	Inhibition	%	5.65
	8212063	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.16	CHEMBL4225	Homo sapiens	Inhibition	%	1.16
	8212287	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.27	CHEMBL4225	Homo sapiens	Inhibition	%	1.27
	8212428	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.75	CHEMBL4225	Homo sapiens	Inhibition	%	0.75
	8212785	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.61	CHEMBL4225	Homo sapiens	Inhibition	%	1.61
	8212955	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.42	CHEMBL4225	Homo sapiens	Inhibition	%	2.42
	8213308	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	17.04	CHEMBL4225	Homo sapiens	Inhibition	%	17.04
	8213412	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	36.93	CHEMBL4225	Homo sapiens	Inhibition	%	36.93
	8213636	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-0.15	CHEMBL4225	Homo sapiens	Inhibition	%	-0.15
	8213749	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.69	CHEMBL4225	Homo sapiens	Inhibition	%	0.69
	8214120	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	-0.2	CHEMBL4225	Homo sapiens	Inhibition	%	-0.2
	8214257	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.38	CHEMBL4225	Homo sapiens	Inhibition	%	3.38
	8214481	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.22	CHEMBL4225	Homo sapiens	Inhibition	%	5.22
	8214615	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	1.32	CHEMBL4225	Homo sapiens	Inhibition	%	1.32
	8214991	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	2.87	CHEMBL4225	Homo sapiens	Inhibition	%	2.87
	8215242	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.47	CHEMBL4225	Homo sapiens	Inhibition	%	0.47
	8215395	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	2.65	CHEMBL4225	Homo sapiens	Inhibition	%	2.65
	8215783	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.52	CHEMBL4225	Homo sapiens	Inhibition	%	0.52
	8215902	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	29.36	CHEMBL4225	Homo sapiens	Inhibition	%	29.36
	8216126	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	82.93	CHEMBL4225	Homo sapiens	Inhibition	%	82.93
	8216245	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	3.14	CHEMBL4225	Homo sapiens	Inhibition	%	3.14
	8216605	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	2.81	CHEMBL4225	Homo sapiens	Inhibition	%	2.81
	8216743	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.48	CHEMBL4225	Homo sapiens	Inhibition	%	0.48
	8217101	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.14	CHEMBL4225	Homo sapiens	Inhibition	%	1.14
	8217275	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.16	CHEMBL4225	Homo sapiens	Inhibition	%	-0.16
	8217499	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	-0.28	CHEMBL4225	Homo sapiens	Inhibition	%	-0.28
	8217630	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	0.22	CHEMBL4225	Homo sapiens	Inhibition	%	0.22
	8217955	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	1.55	CHEMBL4225	Homo sapiens	Inhibition	%	1.55
	8218070	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	-1.13	CHEMBL4225	Homo sapiens	Inhibition	%	-1.13
	8218294	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.18	CHEMBL4225	Homo sapiens	Inhibition	%	2.18
	8218421	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	21.62	CHEMBL4225	Homo sapiens	Inhibition	%	21.62
	8218788	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	3.66	CHEMBL4225	Homo sapiens	Inhibition	%	3.66
	8218919	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	6.94	CHEMBL4225	Homo sapiens	Inhibition	%	6.94
	8219303	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.2	CHEMBL4225	Homo sapiens	Inhibition	%	3.2
	8219553	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.74	CHEMBL4225	Homo sapiens	Inhibition	%	0.74
	8219714	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.15	CHEMBL4225	Homo sapiens	Inhibition	%	3.15
	8219938	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.42	CHEMBL4225	Homo sapiens	Inhibition	%	3.42
	8220107	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.42	CHEMBL4225	Homo sapiens	Inhibition	%	3.42
	8220460	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.51	CHEMBL4225	Homo sapiens	Inhibition	%	0.51
	8220574	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	27.59	CHEMBL4225	Homo sapiens	Inhibition	%	27.59
	8220936	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	13.62	CHEMBL4225	Homo sapiens	Inhibition	%	13.62
	8221072	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	3.19	CHEMBL4225	Homo sapiens	Inhibition	%	3.19
	8221296	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	18.98	CHEMBL4225	Homo sapiens	Inhibition	%	18.98
	8221429	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.61	CHEMBL4225	Homo sapiens	Inhibition	%	5.61
	8221818	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.24	CHEMBL4225	Homo sapiens	Inhibition	%	0.24
	8221949	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	10.85	CHEMBL4225	Homo sapiens	Inhibition	%	10.85
	8222271	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	28.55	CHEMBL4225	Homo sapiens	Inhibition	%	28.55
	8222629	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.81	CHEMBL4225	Homo sapiens	Inhibition	%	1.81
	8222747	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	73.73	CHEMBL4225	Homo sapiens	Inhibition	%	73.73
	8223115	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	26.65	CHEMBL4225	Homo sapiens	Inhibition	%	26.65
	8223244	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	0.71	CHEMBL4225	Homo sapiens	Inhibition	%	0.71
	8223468	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.05	CHEMBL4225	Homo sapiens	Inhibition	%	1.05
	8223629	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.03	CHEMBL4225	Homo sapiens	Inhibition	%	2.03
	8223879	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.85	CHEMBL4225	Homo sapiens	Inhibition	%	0.85
	8224265	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.05	CHEMBL4225	Homo sapiens	Inhibition	%	3.05
	8224435	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.66	CHEMBL4225	Homo sapiens	Inhibition	%	0.66
	8224794	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.24	CHEMBL4225	Homo sapiens	Inhibition	%	2.24
	8224908	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.17	CHEMBL4225	Homo sapiens	Inhibition	%	1.17
	8225132	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	4.84	CHEMBL4225	Homo sapiens	Inhibition	%	4.84
	8225266	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	3.77	CHEMBL4225	Homo sapiens	Inhibition	%	3.77
	8225628	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.44	CHEMBL4225	Homo sapiens	Inhibition	%	0.44
	8225763	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	40.97	CHEMBL4225	Homo sapiens	Inhibition	%	40.97
	8226145	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.02	CHEMBL4225	Homo sapiens	Inhibition	%	2.02
	8226270	CHEMBL1962032	GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.79	CHEMBL4225	Homo sapiens	Inhibition	%	2.79
	8226494	CHEMBL1962033	GSK_PKIS: CLK2 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	14.17	CHEMBL4225	Homo sapiens	Inhibition	%	14.17
active	9507476	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9507477	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(O)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1998551	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507478	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507479	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9507480	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
inactive	9507481	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9507482	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507483	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507484	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507485	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507486	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9507487	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9507488	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507489	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9507490	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9507491	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507492	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507493	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507494	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(Cl)cc1		CHEMBL1987073	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9507495	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507496	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	50.12	CHEMBL4225	Homo sapiens	pKi		7.3
inactive	9507497	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507498	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1995712	=	Ki	nM	158.49	CHEMBL4225	Homo sapiens	pKi		6.8
inactive	9507499	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507500	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9507501	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507502	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507503	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507504	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507505	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCNc1cc2cc(-c3ccncc3)ccc2cn1		CHEMBL1998435	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9507506	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9507507	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507508	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9507509	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9507510	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507511	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9507512	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9507513	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9507514	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	6.31	CHEMBL4225	Homo sapiens	pKi		8.2
active	9507515	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9507516	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	FC(F)(F)Oc1ccc(-c2ccc3[nH]cc(C4=CCNCC4)c3c2)cc1		CHEMBL1987982	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507517	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507518	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507519	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507520	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
inactive	9507521	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507522	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9507523	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507524	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9507525	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9507526	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507527	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507528	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507529	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9507530	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1980562	=	Ki	nM	31.62	CHEMBL4225	Homo sapiens	pKi		7.5
inactive	9507531	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507532	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9507533	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507534	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507535	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507536	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507537	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9507538	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2nc(Cl)sc12		CHEMBL1991867	=	Ki	nM	39810.72	CHEMBL4225	Homo sapiens	pKi		4.4
inactive	9507539	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2cccc(F)c2)n1		CHEMBL1979933	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507540	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507541	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507542	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507543	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507544	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507545	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507546	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OC1CCCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1976936	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9507547	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507548	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507549	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507550	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9507551	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507552	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9507553	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507554	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL1972988	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9507555	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9507556	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507557	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9507558	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507559	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9507560	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507561	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507562	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507563	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1987448	=	Ki	nM	3.981	CHEMBL4225	Homo sapiens	pKi		8.4
inactive	9507564	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507565	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507566	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507567	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507568	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9507569	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
active	9507570	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	=	Ki	nM	25.12	CHEMBL4225	Homo sapiens	pKi		7.6
inactive	9507571	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507572	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507573	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507574	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005216	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9507575	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507576	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507577	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9507578	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507579	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	19952.62	CHEMBL4225	Homo sapiens	pKi		4.7
inactive	9507580	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507581	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	=	Ki	nM	12.59	CHEMBL4225	Homo sapiens	pKi		7.9
inactive	9507582	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cncc(C=Cc2ccncc2)c1		CHEMBL1972568	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507583	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9507584	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1cccc2c1n(CC)c(=N)n2CC(=O)c1ccc(Cl)cc1		CHEMBL2004601	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9507585	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507586	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507587	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9507588	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507589	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	3.162	CHEMBL4225	Homo sapiens	pKi		8.5
active	9507590	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	25118.86	CHEMBL4225	Homo sapiens	pKi		4.6
active	9507591	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	7.943	CHEMBL4225	Homo sapiens	pKi		8.1
active	9507592	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2c1C(c1ccccc1Br)C(C#N)=C(N)O2		CHEMBL2005214	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507593	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507594	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1988995	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507595	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507596	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507597	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507598	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9507599	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507600	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507601	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507602	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
inactive	9507603	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507604	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507605	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9507606	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507607	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507608	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507609	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507610	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507611	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9507612	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9507613	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507614	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507615	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507616	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507617	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507618	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL31	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507619	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507620	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9507621	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	=	Ki	nM	7.943	CHEMBL4225	Homo sapiens	pKi		8.1
inactive	9507622	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507623	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507624	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9507625	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	=	Ki	nM	158.49	CHEMBL4225	Homo sapiens	pKi		6.8
inactive	9507626	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507627	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507628	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507629	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	3.981	CHEMBL4225	Homo sapiens	pKi		8.4
active	9507630	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9507631	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9507632	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507633	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9507634	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9507635	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9507636	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507637	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2sccc12		CHEMBL1972934	=	Ki	nM	50118.72	CHEMBL4225	Homo sapiens	pKi		4.3
inactive	9507638	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507639	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9507640	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507641	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9507642	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507643	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9507644	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCCN4)cc3F)nc12		CHEMBL1089101	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507645	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507646	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9507647	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9507648	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#CC(=Cc1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL1974157	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507649	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507650	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507651	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9507652	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507653	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507654	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507655	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507656	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9507657	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)c1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1992363	=	Ki	nM	79.43	CHEMBL4225	Homo sapiens	pKi		7.1
inactive	9507658	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9507659	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	=	Ki	nM	63.1	CHEMBL4225	Homo sapiens	pKi		7.2
inactive	9507660	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507661	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9507662	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507663	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507664	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
inactive	9507665	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507666	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1982271	=	Ki	nM	10.0	CHEMBL4225	Homo sapiens	pKi		8.0
active	9507667	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9507668	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507669	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507670	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507671	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	158.49	CHEMBL4225	Homo sapiens	pKi		6.8
inactive	9507672	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507673	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507674	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9507675	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507676	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507677	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507678	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9507679	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507680	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507681	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	19.95	CHEMBL4225	Homo sapiens	pKi		7.7
active	9507682	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9507683	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9507684	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507685	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507686	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507687	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9507688	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9507689	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507690	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9507691	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9507692	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9507693	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507694	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	=	Ki	nM	100000.0	CHEMBL4225	Homo sapiens	pKi		4.0
active	9507695	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9507696	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9507697	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507698	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL1986666	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507699	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507700	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9507701	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9507702	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507703	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9507704	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	19.95	CHEMBL4225	Homo sapiens	pKi		7.7
inactive	9507705	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507706	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9507707	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9507708	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507709	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507710	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507711	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9507712	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	12.59	CHEMBL4225	Homo sapiens	pKi		7.9
inactive	9507713	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9507714	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507715	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9507716	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507717	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9507718	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9511631	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511632	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(c1ccccc1CNc1nc(N)nc2[nH]ccc12)S(C)(=O)=O		CHEMBL1970006	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9511633	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511634	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511635	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9511636	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511637	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511638	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9511639	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9511640	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511641	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511642	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
inactive	9511643	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511644	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1		CHEMBL1990162	=	Ki	nM	39.81	CHEMBL4225	Homo sapiens	pKi		7.4
active	9511645	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1992220	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
active	9511646	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	7.943	CHEMBL4225	Homo sapiens	pKi		8.1
active	9511647	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9511648	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9511649	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9511650	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511651	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511652	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9511653	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	10.0	CHEMBL4225	Homo sapiens	pKi		8.0
inactive	9511654	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511655	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
active	9511656	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9511657	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511658	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9511659	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9511660	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511661	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511662	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1987948	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
active	9511663	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9511664	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9511665	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511666	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9511667	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9511668	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9511669	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9511670	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9511671	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511672	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511673	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	=	Ki	nM	63.1	CHEMBL4225	Homo sapiens	pKi		7.2
active	9511674	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	50118.72	CHEMBL4225	Homo sapiens	pKi		4.3
inactive	9511675	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511676	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9511677	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9511678	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9511679	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511680	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	=	Ki	nM	158.49	CHEMBL4225	Homo sapiens	pKi		6.8
active	9511681	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
active	9511682	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9511683	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9511684	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
active	9511685	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CN)CNc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1968930	=	Ki	nM	50.12	CHEMBL4225	Homo sapiens	pKi		7.3
active	9511686	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511687	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9511688	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511689	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511690	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
inactive	9511691	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511692	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9511693	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9511694	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9511695	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511696	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511697	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511698	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511699	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9511700	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511701	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511702	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511703	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9511704	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
active	9511705	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9511706	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9511707	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1c2c([nH]c3cc(-c4ccco4)nn13)CSC2		CHEMBL1972152	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511708	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9511709	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511710	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511711	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511712	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9511713	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	=	Ki	nM	79.43	CHEMBL4225	Homo sapiens	pKi		7.1
active	9511714	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9511715	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511716	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511717	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	63.1	CHEMBL4225	Homo sapiens	pKi		7.2
active	9511718	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9511719	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511720	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511721	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
inactive	9511722	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511723	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9511724	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2005509	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
inactive	9511725	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511726	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511727	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511728	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9511729	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511730	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511731	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NNc1cc(N2CCOCC2)nc(OCCc2ccccn2)n1		CHEMBL1996208	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9511732	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511733	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9511734	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511735	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511736	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
inactive	9511737	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511738	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9511739	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511740	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511741	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511742	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(CNc2cc(-c3c[nH]c4ncccc34)cc(F)n2)cc1		CHEMBL1986855	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
inactive	9511743	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9511744	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9511745	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)OC(=O)n1cc(-c2cncn2C2CCCCC2)c2ccccc21		CHEMBL1975357	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511746	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
active	9511747	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
inactive	9511748	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511749	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9511750	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9511751	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511752	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9511753	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511754	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511755	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9511756	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511757	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	50.12	CHEMBL4225	Homo sapiens	pKi		7.3
inactive	9511758	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511759	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9511760	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9511761	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9511762	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9511763	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9511764	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9511765	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9511766	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
active	9511767	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9511768	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nn(C)c(C)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)O)[nH]c12		CHEMBL1984039	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9511769	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9511770	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9561336	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)c(OC)c1		CHEMBL2003768	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561337	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9561338	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9561339	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9561340	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9561341	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
inactive	9561342	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561343	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1980435	=	Ki	nM	31.62	CHEMBL4225	Homo sapiens	pKi		7.5
inactive	9561344	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561345	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9561346	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561347	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9561348	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	0.7943	CHEMBL4225	Homo sapiens	pKi		9.1
inactive	9561349	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561350	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9561351	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
active	9561352	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	5.012	CHEMBL4225	Homo sapiens	pKi		8.3
inactive	9561353	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9561354	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561355	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	39.81	CHEMBL4225	Homo sapiens	pKi		7.4
active	9561356	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9561357	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9561358	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9561359	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9561360	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561361	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9561362	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9561363	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	7.943	CHEMBL4225	Homo sapiens	pKi		8.1
inactive	9561364	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9561365	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9561366	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	5.012	CHEMBL4225	Homo sapiens	pKi		8.3
active	9561367	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9561368	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9561369	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9561370	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)CNS(C)(=O)=O		CHEMBL1971172	=	Ki	nM	31.62	CHEMBL4225	Homo sapiens	pKi		7.5
active	9561371	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9561372	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9561373	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9561374	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565283	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9565284	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9565285	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565286	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565287	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
inactive	9565288	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL4225	Homo sapiens	pKi		4.1
active	9565289	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	31622.78	CHEMBL4225	Homo sapiens	pKi		4.5
inactive	9565290	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565291	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9565292	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565293	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	50.12	CHEMBL4225	Homo sapiens	pKi		7.3
inactive	9565294	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565295	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565296	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565297	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565298	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565299	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9565300	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565301	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9565302	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1983589	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
active	9565303	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9565304	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565305	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9565306	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2005718	=	Ki	nM	39.81	CHEMBL4225	Homo sapiens	pKi		7.4
inactive	9565307	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9565308	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9565309	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9565310	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565311	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565312	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	25.12	CHEMBL4225	Homo sapiens	pKi		7.6
active	9565313	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565314	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	19952.62	CHEMBL4225	Homo sapiens	pKi		4.7
active	9565315	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9565316	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9565317	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565318	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9565319	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565320	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565321	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9565322	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9565323	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565324	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565325	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9565326	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565327	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9565328	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]cc(I)c2nc(-c3ccccc3)cn12		CHEMBL2001668	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9565329	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565330	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9565331	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565332	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565333	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
inactive	9565334	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565335	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(F)n1		CHEMBL1987261	=	Ki	nM	25.12	CHEMBL4225	Homo sapiens	pKi		7.6
active	9565336	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9565337	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565338	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9565339	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565340	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565341	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9565342	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	=	Ki	nM	31.62	CHEMBL4225	Homo sapiens	pKi		7.5
inactive	9565343	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565344	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565345	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565346	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9565347	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9565348	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565349	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9565350	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9565351	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9565352	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565353	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2)C1		CHEMBL1971132	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565354	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565355	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CN)CNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1985723	=	Ki	nM	31.62	CHEMBL4225	Homo sapiens	pKi		7.5
active	9565356	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9565357	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565358	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565359	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	=	Ki	nM	5.012	CHEMBL4225	Homo sapiens	pKi		8.3
inactive	9565360	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565361	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9565362	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565363	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1cccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL1977128	=	Ki	nM	79.43	CHEMBL4225	Homo sapiens	pKi		7.1
inactive	9565364	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565365	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565366	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9565367	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9565368	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)C1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1965702	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
inactive	9565369	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	<	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9565370	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565371	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCc2c(Br)cccc21		CHEMBL1984500	<	Ki	nM	79432.82	CHEMBL4225	Homo sapiens	pKi		4.1
active	9565372	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565373	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1=NN(c2cccc(Br)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2005112	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565374	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9565375	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565376	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCOc1ccc(-c2nc3c(C(N)=O)cccc3[nH]2)cc1		CHEMBL1984044	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9565377	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565378	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	=	Ki	nM	39.81	CHEMBL4225	Homo sapiens	pKi		7.4
inactive	9565379	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565380	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9565381	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565382	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCOn1c2ccc(Cl)cc2c(=O)c2c(C)nn(C)c21		CHEMBL207253	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565383	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565384	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1CCCN1CCc1cc2cc(-c3ccc(OC(F)(F)F)cc3)ccc2[nH]1		CHEMBL1990635	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9565385	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565386	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(Cl)c1-c1cccc2c(CCCOc3cccc4ccccc34)c(C(=O)NCCOCCOCCN)[nH]c12		CHEMBL2002682	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9565387	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565388	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565389	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565390	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)CNC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL2006456	=	Ki	nM	39.81	CHEMBL4225	Homo sapiens	pKi		7.4
active	9565391	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565392	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565393	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9565394	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565395	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565396	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9565397	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9565398	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565399	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	50118.72	CHEMBL4225	Homo sapiens	pKi		4.3
active	9565400	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9565401	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9565402	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
inactive	9565403	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565404	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9565405	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9565406	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565407	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565408	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCCC1		CHEMBL2006481	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565409	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565410	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	19952.62	CHEMBL4225	Homo sapiens	pKi		4.7
active	9565411	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9565412	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9565413	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9565414	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCNc1nc2cc(Cl)c(OC)cc2nc1NCC		CHEMBL1995927	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565415	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOC(=O)Cc1nc2c(N)cccc2[nH]1		CHEMBL1981671	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565416	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9565417	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
active	9565418	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
inactive	9565419	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565420	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565421	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565422	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565423	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565424	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565425	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565426	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9565427	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9565428	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565429	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9565430	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565431	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9565432	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccc3ccccc3c2)n1		CHEMBL2002240	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565433	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565434	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-n2nc(C)c3c(=O)c4cc(Cl)ccc4n(O)c32)cc1		CHEMBL1991143	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565435	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565436	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1980178	=	Ki	nM	50.12	CHEMBL4225	Homo sapiens	pKi		7.3
active	9565437	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9565438	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565439	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
active	9565440	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9565441	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9565442	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565443	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9565444	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9565445	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9565446	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	25118.86	CHEMBL4225	Homo sapiens	pKi		4.6
inactive	9565447	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1C(=NNc2cccc3c(=O)[nH][nH]c(=O)c23)C(c2ccccc2)=NN1c1ccccc1		CHEMBL1984274	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565448	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565449	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565450	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	<	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9565451	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565452	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565453	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565454	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565455	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	15848.93	CHEMBL4225	Homo sapiens	pKi		4.8
inactive	9565456	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565457	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9565458	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
active	9565459	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2nc3ccccc3n12		CHEMBL1983884	=	Ki	nM	39810.72	CHEMBL4225	Homo sapiens	pKi		4.4
active	9565460	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9565461	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565462	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565463	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9565464	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565465	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565466	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565467	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565468	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565469	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565470	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9565471	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565472	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565473	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565474	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565475	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9565476	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9565477	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565478	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565479	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCNc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1972290	=	Ki	nM	19.95	CHEMBL4225	Homo sapiens	pKi		7.7
inactive	9565480	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565481	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9565482	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565483	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9565484	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565485	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565486	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565487	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565488	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9565489	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565490	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	19.95	CHEMBL4225	Homo sapiens	pKi		7.7
active	9565491	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(Nc2ncc(Cl)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1984548	=	Ki	nM	10.0	CHEMBL4225	Homo sapiens	pKi		8.0
active	9565492	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	5.012	CHEMBL4225	Homo sapiens	pKi		8.3
inactive	9565493	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9565494	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9565495	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565496	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565497	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565498	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
active	9565499	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565500	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565501	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
inactive	9565502	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9565503	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	31622.78	CHEMBL4225	Homo sapiens	pKi		4.5
inactive	9565504	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nsc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL2002553	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565505	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9565506	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
inactive	9565507	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565508	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565509	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	50.12	CHEMBL4225	Homo sapiens	pKi		7.3
active	9565510	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565511	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565512	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565513	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9565514	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565515	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565516	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565517	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C(=O)Nc2nc3ccc(Cl)cc3s2)c(OC)c1		CHEMBL1983309	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565518	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9565519	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565520	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1=NN(c2ccccc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1999126	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565521	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9565522	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1972339	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
active	9565523	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9565524	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565525	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9565526	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569442	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569443	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2ccccc2Nc2ccccc21		CHEMBL1727312	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569444	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569445	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569446	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569447	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569448	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9569449	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9569450	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569451	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569452	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9569453	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(Cl)c1		CHEMBL1983595	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
active	9569454	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	79.43	CHEMBL4225	Homo sapiens	pKi		7.1
inactive	9569455	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569456	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9569457	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9569458	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9569459	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569460	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9569461	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCOCC2)n1		CHEMBL1980253	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
active	9569462	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9569463	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569464	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9569465	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9569466	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
active	9569467	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9569468	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569469	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
inactive	9569470	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569471	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9569472	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569473	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
active	9569474	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569475	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
inactive	9569476	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569477	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569478	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569479	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
active	9569480	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNCC(=O)NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1996980	=	Ki	nM	3.162	CHEMBL4225	Homo sapiens	pKi		8.5
inactive	9569481	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569482	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569483	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(Nc2ncc(Br)c(Nc3ccccc3C(N)=O)n2)cn1		CHEMBL1994669	=	Ki	nM	3.981	CHEMBL4225	Homo sapiens	pKi		8.4
active	9569484	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9569485	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569486	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	25118.86	CHEMBL4225	Homo sapiens	pKi		4.6
active	9569487	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9569488	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569489	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569490	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
active	9569491	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9569492	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9569493	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569494	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9569495	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9569496	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569497	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569498	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
active	9569499	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9569500	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	39.81	CHEMBL4225	Homo sapiens	pKi		7.4
active	9569501	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
inactive	9569502	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569503	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9569504	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569505	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569506	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569507	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCCn1c(C)c(C)sc1=NC(=O)c1cc(SC)ccc1Cl		CHEMBL1988000	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9569508	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569509	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569510	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
inactive	9569511	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569512	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569513	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569514	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ncnc(Nc2ccc(F)cc2)n1		CHEMBL1992231	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569515	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	630.96	CHEMBL4225	Homo sapiens	pKi		6.2
active	9569516	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569517	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCc1ccc(Cl)cc1)Nc1cccc2[nH]ncc12		CHEMBL1977713	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569518	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9569519	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569520	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9569521	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569522	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
inactive	9569523	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569524	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569525	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569526	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569527	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569528	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	63.1	CHEMBL4225	Homo sapiens	pKi		7.2
inactive	9569529	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569530	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9569531	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	39810.72	CHEMBL4225	Homo sapiens	pKi		4.4
active	9569532	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	15848.93	CHEMBL4225	Homo sapiens	pKi		4.8
inactive	9569533	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9569534	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569535	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569536	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1CCCCC1Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL1994438	=	Ki	nM	398.11	CHEMBL4225	Homo sapiens	pKi		6.4
active	9569537	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9569538	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569539	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	100.0	CHEMBL4225	Homo sapiens	pKi		7.0
inactive	9569540	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569541	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	2.512	CHEMBL4225	Homo sapiens	pKi		8.6
inactive	9569542	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569543	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2Br)C1		CHEMBL2004647	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569544	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9569545	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	=	Ki	nM	79.43	CHEMBL4225	Homo sapiens	pKi		7.1
inactive	9569546	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9569547	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569548	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9569549	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569550	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9569551	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569552	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569553	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569554	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569555	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569556	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	2.512	CHEMBL4225	Homo sapiens	pKi		8.6
active	9569557	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9569558	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569559	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9569560	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569561	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569562	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9569563	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	=	Ki	nM	79.43	CHEMBL4225	Homo sapiens	pKi		7.1
active	9569564	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	=	Ki	nM	39.81	CHEMBL4225	Homo sapiens	pKi		7.4
active	9569565	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
active	9569566	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COC(=O)c1c(N)nc2ccccn12		CHEMBL1981492	=	Ki	nM	63095.73	CHEMBL4225	Homo sapiens	pKi		4.2
active	9569567	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9569568	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569569	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
active	9569570	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	=	Ki	nM	50.12	CHEMBL4225	Homo sapiens	pKi		7.3
active	9569571	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9569572	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
inactive	9569573	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9569574	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Ki	nM	1258.93	CHEMBL4225	Homo sapiens	pKi		5.9
inactive	9569575	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569576	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569577	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9569578	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
active	9569579	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9569580	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569581	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(OC)cc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)c1		CHEMBL2002613	=	Ki	nM	31.62	CHEMBL4225	Homo sapiens	pKi		7.5
inactive	9569582	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569583	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569584	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569585	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9569586	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9569587	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9569588	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569589	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
inactive	9569590	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCNc1cc2cc(-c3ccccc3)ccc2cn1		CHEMBL1989957	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569591	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569592	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569593	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569594	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569595	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9569596	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569597	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC1CCCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)C1		CHEMBL1998432	=	Ki	nM	15.85	CHEMBL4225	Homo sapiens	pKi		7.8
inactive	9569598	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569599	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL86066	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9569600	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569601	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569602	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=c1[nH]c2ccc(Br)cc2n1-c1cc(Cl)c(O)cc1O		CHEMBL1996473	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569603	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
active	9569604	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9569605	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	=	Ki	nM	79.43	CHEMBL4225	Homo sapiens	pKi		7.1
active	9569606	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9569607	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569608	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569609	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	316.23	CHEMBL4225	Homo sapiens	pKi		6.5
active	9569610	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	12589.25	CHEMBL4225	Homo sapiens	pKi		4.9
active	9569611	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	=	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569612	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569613	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569614	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	=	Ki	nM	39810.72	CHEMBL4225	Homo sapiens	pKi		4.4
active	9569615	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
active	9569616	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1ccc2c(-c3ccccc3F)nc(N(C(N)=O)c3c(F)cccc3F)nc21		CHEMBL1981723	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569617	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
inactive	9569618	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9569619	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569620	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(C(N)=O)n2nc(C(C)(C)C)cc2n1		CHEMBL1986684	=	Ki	nM	50118.72	CHEMBL4225	Homo sapiens	pKi		4.3
inactive	9569621	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569622	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9569623	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	=	Ki	nM	158.49	CHEMBL4225	Homo sapiens	pKi		6.8
inactive	9569624	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569625	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	Ki	nM	10.0	CHEMBL4225	Homo sapiens	pKi		8.0
inactive	9569626	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569627	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
inactive	9569628	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569629	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9569630	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)c(F)c3n21		CHEMBL1977604	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569631	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
active	9569632	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
active	9569633	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL1985507	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569634	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569635	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
active	9569636	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	25.12	CHEMBL4225	Homo sapiens	pKi		7.6
active	9569637	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(F)c2)n1		CHEMBL243298	=	Ki	nM	199.53	CHEMBL4225	Homo sapiens	pKi		6.7
active	9569638	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	=	Ki	nM	501.19	CHEMBL4225	Homo sapiens	pKi		6.3
inactive	9569639	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569640	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9569641	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569642	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9569643	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	=	Ki	nM	2511.89	CHEMBL4225	Homo sapiens	pKi		5.6
active	9569644	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	1000.0	CHEMBL4225	Homo sapiens	pKi		6.0
inactive	9569645	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569646	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569647	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	=	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
active	9569648	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccc(F)cc1		CHEMBL1966204	=	Ki	nM	25.12	CHEMBL4225	Homo sapiens	pKi		7.6
inactive	9569649	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
inactive	9569650	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569651	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569652	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	1995.26	CHEMBL4225	Homo sapiens	pKi		5.7
active	9569653	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	794.33	CHEMBL4225	Homo sapiens	pKi		6.1
active	9569654	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
inactive	9569655	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569656	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569657	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	5.012	CHEMBL4225	Homo sapiens	pKi		8.3
active	9569658	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	31.62	CHEMBL4225	Homo sapiens	pKi		7.5
active	9569659	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1ccc(C2CCc3[nH]ncc3C2)cc1		CHEMBL2000879	=	Ki	nM	79432.82	CHEMBL4225	Homo sapiens	pKi		4.1
inactive	9569660	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9569661	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COC(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2004513	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569662	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569663	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569664	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9569665	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	6309.57	CHEMBL4225	Homo sapiens	pKi		5.2
inactive	9569666	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569667	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569668	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569669	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
active	9569670	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	=	Ki	nM	251.19	CHEMBL4225	Homo sapiens	pKi		6.6
inactive	9569671	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569672	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569673	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569674	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569675	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569676	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569677	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9569678	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	3981.07	CHEMBL4225	Homo sapiens	pKi		5.4
inactive	9569679	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
active	9569680	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	=	Ki	nM	1584.89	CHEMBL4225	Homo sapiens	pKi		5.8
active	9569681	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	=	Ki	nM	7943.28	CHEMBL4225	Homo sapiens	pKi		5.1
inactive	9569682	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9569683	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	=	Ki	nM	3162.28	CHEMBL4225	Homo sapiens	pKi		5.5
active	9569684	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	125.89	CHEMBL4225	Homo sapiens	pKi		6.9
inactive	9569685	CHEMBL1963691	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	5011.87	CHEMBL4225	Homo sapiens	pKi		5.3
	10838685	CHEMBL2014911	Inhibition of CLK2 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	99.0	CHEMBL4225	Homo sapiens	INH	%	99.0
	10839586	CHEMBL2015844	Inhibition of CLK2 assessed as residual activity at 1 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	14.0	CHEMBL4225	Homo sapiens	Activity	%	14.0
	10840502	CHEMBL2015000	Inhibition of CLK2 assessed as residual activity at 10 uM relative to control	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Activity	%	3.0	CHEMBL4225	Homo sapiens	Activity	%	3.0
	10996324	CHEMBL2073011	Inhibition of CLK2	B	CCn1nnc(CCNC(=O)Nc2nc(C)c(-c3ccc(S(C)(=O)=O)c(F)c3)s2)n1		CHEMBL2071342	=	IC50	nM	117.0	CHEMBL4225	Homo sapiens	IC50	nM	117.0
	12046274	CHEMBL2156511	Inhibition of CLK2 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	4.3	CHEMBL4225	Homo sapiens	INH	%	4.3
	12060464	CHEMBL2154887	Binding affinity to CLK2	B	Nc1nc2c(-c3cnc4ccccc4c3)nccc2[nH]1		CHEMBL2153266	=	Kd	nM	1200.0	CHEMBL4225	Homo sapiens	Kd	nM	1200.0
Active	12140057	CHEMBL2186703	Binding affinity to CLK2	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538		Activity			CHEMBL4225	Homo sapiens	Activity		
Active	12140062	CHEMBL2186703	Binding affinity to CLK2	B	CN1C(=O)/C(=C/c2ccc3c(c2)OCO3)N=C1N		CHEMBL485053		Activity			CHEMBL4225	Homo sapiens	Activity		
	12141727	CHEMBL2186703	Binding affinity to CLK2	B	O=C1NC(Nc2ccccc2)=N/C1=C\c1ccc2c(c1)OCO2		CHEMBL1802358	=	Kd	nM	360.0	CHEMBL4225	Homo sapiens	Kd	nM	360.0
	12170827	CHEMBL2212695	Inhibition of CLK2 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL4225	Homo sapiens	Activity	%	86.0
	12172128	CHEMBL2213954	Inhibition of CLK2 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	86.0	CHEMBL4225	Homo sapiens	Activity	%	86.0
	12173685	CHEMBL2209322	Inhibition of CLK2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	55.0	CHEMBL4225	Homo sapiens	Activity	%	55.0
	12183904	CHEMBL2211480	Inhibition of CLK2	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	pIC50		5.0
	12219824	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	99.0	CHEMBL4225	Homo sapiens	Residual Activity	%	99.0
	12219825	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	27.0	CHEMBL4225	Homo sapiens	Residual Activity	%	27.0
	12219826	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	99.0	CHEMBL4225	Homo sapiens	Residual Activity	%	99.0
	12219827	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	102.0	CHEMBL4225	Homo sapiens	Residual Activity	%	102.0
	12219828	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	113.0	CHEMBL4225	Homo sapiens	Residual Activity	%	113.0
	12219829	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	103.0	CHEMBL4225	Homo sapiens	Residual Activity	%	103.0
	12219830	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	35.0	CHEMBL4225	Homo sapiens	Residual Activity	%	35.0
	12219831	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	110.0	CHEMBL4225	Homo sapiens	Residual Activity	%	110.0
	12219832	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	114.0	CHEMBL4225	Homo sapiens	Residual Activity	%	114.0
	12219833	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	106.0	CHEMBL4225	Homo sapiens	Residual Activity	%	106.0
	12219834	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	103.0	CHEMBL4225	Homo sapiens	Residual Activity	%	103.0
	12219835	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	26.0	CHEMBL4225	Homo sapiens	Residual Activity	%	26.0
	12219836	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	125.0	CHEMBL4225	Homo sapiens	Residual Activity	%	125.0
	12219837	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	94.0	CHEMBL4225	Homo sapiens	Residual Activity	%	94.0
	12219838	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	90.0	CHEMBL4225	Homo sapiens	Residual Activity	%	90.0
	12219839	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	95.0	CHEMBL4225	Homo sapiens	Residual Activity	%	95.0
	12219840	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	109.0	CHEMBL4225	Homo sapiens	Residual Activity	%	109.0
	12219841	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	120.0	CHEMBL4225	Homo sapiens	Residual Activity	%	120.0
	12219842	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	90.0	CHEMBL4225	Homo sapiens	Residual Activity	%	90.0
	12219843	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	34.0	CHEMBL4225	Homo sapiens	Residual Activity	%	34.0
	12219844	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	122.0	CHEMBL4225	Homo sapiens	Residual Activity	%	122.0
	12219845	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL4225	Homo sapiens	Residual Activity	%	100.0
	12219846	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	121.0	CHEMBL4225	Homo sapiens	Residual Activity	%	121.0
	12219847	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	120.0	CHEMBL4225	Homo sapiens	Residual Activity	%	120.0
	12219848	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	104.0	CHEMBL4225	Homo sapiens	Residual Activity	%	104.0
	12219849	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	102.0	CHEMBL4225	Homo sapiens	Residual Activity	%	102.0
	12219850	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	32.0	CHEMBL4225	Homo sapiens	Residual Activity	%	32.0
	12219851	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	80.0	CHEMBL4225	Homo sapiens	Residual Activity	%	80.0
	12219852	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	84.0	CHEMBL4225	Homo sapiens	Residual Activity	%	84.0
	12219853	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	8.0	CHEMBL4225	Homo sapiens	Residual Activity	%	8.0
	12219854	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12219855	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	114.0	CHEMBL4225	Homo sapiens	Residual Activity	%	114.0
	12219856	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12219857	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12219858	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	108.0	CHEMBL4225	Homo sapiens	Residual Activity	%	108.0
	12219859	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	110.0	CHEMBL4225	Homo sapiens	Residual Activity	%	110.0
	12219860	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	108.0	CHEMBL4225	Homo sapiens	Residual Activity	%	108.0
	12219861	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	118.0	CHEMBL4225	Homo sapiens	Residual Activity	%	118.0
	12219862	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	115.0	CHEMBL4225	Homo sapiens	Residual Activity	%	115.0
	12219863	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	106.0	CHEMBL4225	Homo sapiens	Residual Activity	%	106.0
	12219864	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	117.0	CHEMBL4225	Homo sapiens	Residual Activity	%	117.0
	12219865	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	119.0	CHEMBL4225	Homo sapiens	Residual Activity	%	119.0
	12219866	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	51.0	CHEMBL4225	Homo sapiens	Residual Activity	%	51.0
	12219867	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL4225	Homo sapiens	Residual Activity	%	1.0
	12219868	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12219869	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12219870	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12219871	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	49.0	CHEMBL4225	Homo sapiens	Residual Activity	%	49.0
	12219872	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	115.0	CHEMBL4225	Homo sapiens	Residual Activity	%	115.0
	12219873	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	118.0	CHEMBL4225	Homo sapiens	Residual Activity	%	118.0
	12219874	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	14.0	CHEMBL4225	Homo sapiens	Residual Activity	%	14.0
	12219875	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12219876	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	8.0	CHEMBL4225	Homo sapiens	Residual Activity	%	8.0
	12219877	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	113.0	CHEMBL4225	Homo sapiens	Residual Activity	%	113.0
	12219878	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	115.0	CHEMBL4225	Homo sapiens	Residual Activity	%	115.0
	12219879	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	108.0	CHEMBL4225	Homo sapiens	Residual Activity	%	108.0
	12219880	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	107.0	CHEMBL4225	Homo sapiens	Residual Activity	%	107.0
	12219881	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	115.0	CHEMBL4225	Homo sapiens	Residual Activity	%	115.0
	12219882	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	91.0	CHEMBL4225	Homo sapiens	Residual Activity	%	91.0
	12219883	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	111.0	CHEMBL4225	Homo sapiens	Residual Activity	%	111.0
	12219884	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	84.0	CHEMBL4225	Homo sapiens	Residual Activity	%	84.0
	12219885	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	17.0	CHEMBL4225	Homo sapiens	Residual Activity	%	17.0
	12219886	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	109.0	CHEMBL4225	Homo sapiens	Residual Activity	%	109.0
	12219887	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	109.0	CHEMBL4225	Homo sapiens	Residual Activity	%	109.0
	12219888	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	113.0	CHEMBL4225	Homo sapiens	Residual Activity	%	113.0
	12219889	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	86.0	CHEMBL4225	Homo sapiens	Residual Activity	%	86.0
	12219890	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	100.0	CHEMBL4225	Homo sapiens	Residual Activity	%	100.0
	12219891	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	90.0	CHEMBL4225	Homo sapiens	Residual Activity	%	90.0
	12219892	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	43.0	CHEMBL4225	Homo sapiens	Residual Activity	%	43.0
	12219893	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	108.0	CHEMBL4225	Homo sapiens	Residual Activity	%	108.0
	12219894	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	109.0	CHEMBL4225	Homo sapiens	Residual Activity	%	109.0
	12219895	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	71.0	CHEMBL4225	Homo sapiens	Residual Activity	%	71.0
	12219896	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	14.0	CHEMBL4225	Homo sapiens	Residual Activity	%	14.0
	12219897	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	117.0	CHEMBL4225	Homo sapiens	Residual Activity	%	117.0
	12219898	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	91.0	CHEMBL4225	Homo sapiens	Residual Activity	%	91.0
	12219899	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	7.0	CHEMBL4225	Homo sapiens	Residual Activity	%	7.0
	12219900	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	116.0	CHEMBL4225	Homo sapiens	Residual Activity	%	116.0
	12219901	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	9.0	CHEMBL4225	Homo sapiens	Residual Activity	%	9.0
	12219902	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	111.0	CHEMBL4225	Homo sapiens	Residual Activity	%	111.0
	12219903	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	3.0	CHEMBL4225	Homo sapiens	Residual Activity	%	3.0
	12219904	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL4225	Homo sapiens	Residual Activity	%	104.0
	12219905	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	40.0	CHEMBL4225	Homo sapiens	Residual Activity	%	40.0
	12219906	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12219907	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	97.0	CHEMBL4225	Homo sapiens	Residual Activity	%	97.0
	12219908	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	69.0	CHEMBL4225	Homo sapiens	Residual Activity	%	69.0
	12219909	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	117.0	CHEMBL4225	Homo sapiens	Residual Activity	%	117.0
	12219910	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	108.0	CHEMBL4225	Homo sapiens	Residual Activity	%	108.0
	12219911	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	114.0	CHEMBL4225	Homo sapiens	Residual Activity	%	114.0
	12219912	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	104.0	CHEMBL4225	Homo sapiens	Residual Activity	%	104.0
	12219913	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	14.0	CHEMBL4225	Homo sapiens	Residual Activity	%	14.0
	12219914	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	99.0	CHEMBL4225	Homo sapiens	Residual Activity	%	99.0
	12219915	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12219916	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	10.0	CHEMBL4225	Homo sapiens	Residual Activity	%	10.0
	12219917	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	118.0	CHEMBL4225	Homo sapiens	Residual Activity	%	118.0
	12219918	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	122.0	CHEMBL4225	Homo sapiens	Residual Activity	%	122.0
	12219919	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	104.0	CHEMBL4225	Homo sapiens	Residual Activity	%	104.0
	12219920	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12219921	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	110.0	CHEMBL4225	Homo sapiens	Residual Activity	%	110.0
	12219922	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	111.0	CHEMBL4225	Homo sapiens	Residual Activity	%	111.0
	12219923	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	114.0	CHEMBL4225	Homo sapiens	Residual Activity	%	114.0
	12219924	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	51.0	CHEMBL4225	Homo sapiens	Residual Activity	%	51.0
	12219925	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	1.0	CHEMBL4225	Homo sapiens	Residual Activity	%	1.0
	12219926	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	116.0	CHEMBL4225	Homo sapiens	Residual Activity	%	116.0
	12219927	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	100.0	CHEMBL4225	Homo sapiens	Residual Activity	%	100.0
	12219928	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	97.0	CHEMBL4225	Homo sapiens	Residual Activity	%	97.0
	12219929	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	53.0	CHEMBL4225	Homo sapiens	Residual Activity	%	53.0
	12219930	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	20.0	CHEMBL4225	Homo sapiens	Residual Activity	%	20.0
	12219931	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	114.0	CHEMBL4225	Homo sapiens	Residual Activity	%	114.0
	12219932	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	121.0	CHEMBL4225	Homo sapiens	Residual Activity	%	121.0
	12219933	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	80.0	CHEMBL4225	Homo sapiens	Residual Activity	%	80.0
	12219934	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	122.0	CHEMBL4225	Homo sapiens	Residual Activity	%	122.0
	12219935	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	114.0	CHEMBL4225	Homo sapiens	Residual Activity	%	114.0
	12219936	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	94.0	CHEMBL4225	Homo sapiens	Residual Activity	%	94.0
	12219937	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	105.0	CHEMBL4225	Homo sapiens	Residual Activity	%	105.0
	12219938	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12219939	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	106.0	CHEMBL4225	Homo sapiens	Residual Activity	%	106.0
	12219940	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	105.0	CHEMBL4225	Homo sapiens	Residual Activity	%	105.0
	12219941	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	127.0	CHEMBL4225	Homo sapiens	Residual Activity	%	127.0
	12219942	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	69.0	CHEMBL4225	Homo sapiens	Residual Activity	%	69.0
	12219943	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	115.0	CHEMBL4225	Homo sapiens	Residual Activity	%	115.0
	12219944	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	64.0	CHEMBL4225	Homo sapiens	Residual Activity	%	64.0
	12219945	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	10.0	CHEMBL4225	Homo sapiens	Residual Activity	%	10.0
	12222322	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	19.0	CHEMBL4225	Homo sapiens	Residual Activity	%	19.0
	12222323	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	12.0	CHEMBL4225	Homo sapiens	Residual Activity	%	12.0
	12222324	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	2.0	CHEMBL4225	Homo sapiens	Residual Activity	%	2.0
	12222325	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	109.0	CHEMBL4225	Homo sapiens	Residual Activity	%	109.0
	12222326	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	8.0	CHEMBL4225	Homo sapiens	Residual Activity	%	8.0
	12222327	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	118.0	CHEMBL4225	Homo sapiens	Residual Activity	%	118.0
	12222328	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	78.0	CHEMBL4225	Homo sapiens	Residual Activity	%	78.0
	12222329	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL4225	Homo sapiens	Residual Activity	%	-2.0
	12222330	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	48.0	CHEMBL4225	Homo sapiens	Residual Activity	%	48.0
	12222331	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	102.0	CHEMBL4225	Homo sapiens	Residual Activity	%	102.0
	12222332	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	36.0	CHEMBL4225	Homo sapiens	Residual Activity	%	36.0
	12222333	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	102.0	CHEMBL4225	Homo sapiens	Residual Activity	%	102.0
	12222334	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	93.0	CHEMBL4225	Homo sapiens	Residual Activity	%	93.0
	12222335	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	7.0	CHEMBL4225	Homo sapiens	Residual Activity	%	7.0
	12222336	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	84.0	CHEMBL4225	Homo sapiens	Residual Activity	%	84.0
	12222337	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	25.0	CHEMBL4225	Homo sapiens	Residual Activity	%	25.0
	12222338	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	92.0	CHEMBL4225	Homo sapiens	Residual Activity	%	92.0
	12222339	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	86.0	CHEMBL4225	Homo sapiens	Residual Activity	%	86.0
	12222340	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	97.0	CHEMBL4225	Homo sapiens	Residual Activity	%	97.0
	12222341	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	111.0	CHEMBL4225	Homo sapiens	Residual Activity	%	111.0
	12222342	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	77.0	CHEMBL4225	Homo sapiens	Residual Activity	%	77.0
	12222343	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	26.0	CHEMBL4225	Homo sapiens	Residual Activity	%	26.0
	12222344	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	108.0	CHEMBL4225	Homo sapiens	Residual Activity	%	108.0
	12222345	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	38.0	CHEMBL4225	Homo sapiens	Residual Activity	%	38.0
	12222346	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	102.0	CHEMBL4225	Homo sapiens	Residual Activity	%	102.0
	12222347	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	29.0	CHEMBL4225	Homo sapiens	Residual Activity	%	29.0
	12222348	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	109.0	CHEMBL4225	Homo sapiens	Residual Activity	%	109.0
	12222349	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222350	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	50.0	CHEMBL4225	Homo sapiens	Residual Activity	%	50.0
	12222351	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	102.0	CHEMBL4225	Homo sapiens	Residual Activity	%	102.0
	12222352	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	110.0	CHEMBL4225	Homo sapiens	Residual Activity	%	110.0
	12222353	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	52.0	CHEMBL4225	Homo sapiens	Residual Activity	%	52.0
	12222354	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	115.0	CHEMBL4225	Homo sapiens	Residual Activity	%	115.0
	12222355	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	87.0	CHEMBL4225	Homo sapiens	Residual Activity	%	87.0
	12222356	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	123.0	CHEMBL4225	Homo sapiens	Residual Activity	%	123.0
	12222357	CHEMBL2219002	Millipore: Percentage of residual kinase activity of CLK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	22.0	CHEMBL4225	Homo sapiens	Residual Activity	%	22.0
	12222358	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	103.0	CHEMBL4225	Homo sapiens	Residual Activity	%	103.0
	12222359	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	5.0	CHEMBL4225	Homo sapiens	Residual Activity	%	5.0
	12222360	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222361	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222362	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12222363	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	77.0	CHEMBL4225	Homo sapiens	Residual Activity	%	77.0
	12222364	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	14.0	CHEMBL4225	Homo sapiens	Residual Activity	%	14.0
	12222365	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	74.0	CHEMBL4225	Homo sapiens	Residual Activity	%	74.0
	12222366	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	63.0	CHEMBL4225	Homo sapiens	Residual Activity	%	63.0
	12222367	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	75.0	CHEMBL4225	Homo sapiens	Residual Activity	%	75.0
	12222368	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	88.0	CHEMBL4225	Homo sapiens	Residual Activity	%	88.0
	12222369	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	24.0	CHEMBL4225	Homo sapiens	Residual Activity	%	24.0
	12222370	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	105.0	CHEMBL4225	Homo sapiens	Residual Activity	%	105.0
	12222371	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	42.0	CHEMBL4225	Homo sapiens	Residual Activity	%	42.0
	12222372	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	43.0	CHEMBL4225	Homo sapiens	Residual Activity	%	43.0
	12222373	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	95.0	CHEMBL4225	Homo sapiens	Residual Activity	%	95.0
	12222374	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	108.0	CHEMBL4225	Homo sapiens	Residual Activity	%	108.0
	12222375	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	93.0	CHEMBL4225	Homo sapiens	Residual Activity	%	93.0
	12222376	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	82.0	CHEMBL4225	Homo sapiens	Residual Activity	%	82.0
	12222377	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	50.0	CHEMBL4225	Homo sapiens	Residual Activity	%	50.0
	12222378	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222379	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	40.0	CHEMBL4225	Homo sapiens	Residual Activity	%	40.0
	12222380	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222381	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	99.0	CHEMBL4225	Homo sapiens	Residual Activity	%	99.0
	12222382	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	69.0	CHEMBL4225	Homo sapiens	Residual Activity	%	69.0
	12222383	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	68.0	CHEMBL4225	Homo sapiens	Residual Activity	%	68.0
	12222384	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	5.0	CHEMBL4225	Homo sapiens	Residual Activity	%	5.0
	12222385	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	30.0	CHEMBL4225	Homo sapiens	Residual Activity	%	30.0
	12222386	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	55.0	CHEMBL4225	Homo sapiens	Residual Activity	%	55.0
	12222387	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	2.0	CHEMBL4225	Homo sapiens	Residual Activity	%	2.0
	12222388	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	86.0	CHEMBL4225	Homo sapiens	Residual Activity	%	86.0
	12222389	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	99.0	CHEMBL4225	Homo sapiens	Residual Activity	%	99.0
	12222390	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	76.0	CHEMBL4225	Homo sapiens	Residual Activity	%	76.0
	12222391	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	45.0	CHEMBL4225	Homo sapiens	Residual Activity	%	45.0
	12222392	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	100.0	CHEMBL4225	Homo sapiens	Residual Activity	%	100.0
	12222393	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	116.0	CHEMBL4225	Homo sapiens	Residual Activity	%	116.0
	12222394	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	68.0	CHEMBL4225	Homo sapiens	Residual Activity	%	68.0
	12222395	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	137.0	CHEMBL4225	Homo sapiens	Residual Activity	%	137.0
	12222396	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	91.0	CHEMBL4225	Homo sapiens	Residual Activity	%	91.0
	12222397	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222398	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	127.0	CHEMBL4225	Homo sapiens	Residual Activity	%	127.0
	12222399	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222400	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	29.0	CHEMBL4225	Homo sapiens	Residual Activity	%	29.0
	12222401	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL4225	Homo sapiens	Residual Activity	%	1.0
	12222402	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	88.0	CHEMBL4225	Homo sapiens	Residual Activity	%	88.0
	12222403	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL4225	Homo sapiens	Residual Activity	%	85.0
	12222404	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	94.0	CHEMBL4225	Homo sapiens	Residual Activity	%	94.0
	12222405	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	37.0	CHEMBL4225	Homo sapiens	Residual Activity	%	37.0
	12222406	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	107.0	CHEMBL4225	Homo sapiens	Residual Activity	%	107.0
	12222407	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	89.0	CHEMBL4225	Homo sapiens	Residual Activity	%	89.0
	12222408	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	2.0	CHEMBL4225	Homo sapiens	Residual Activity	%	2.0
	12222409	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	88.0	CHEMBL4225	Homo sapiens	Residual Activity	%	88.0
	12222410	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	3.0	CHEMBL4225	Homo sapiens	Residual Activity	%	3.0
	12222411	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	50.0	CHEMBL4225	Homo sapiens	Residual Activity	%	50.0
	12222412	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	80.0	CHEMBL4225	Homo sapiens	Residual Activity	%	80.0
	12222413	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	95.0	CHEMBL4225	Homo sapiens	Residual Activity	%	95.0
	12222414	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	82.0	CHEMBL4225	Homo sapiens	Residual Activity	%	82.0
	12222415	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	94.0	CHEMBL4225	Homo sapiens	Residual Activity	%	94.0
	12222416	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	80.0	CHEMBL4225	Homo sapiens	Residual Activity	%	80.0
	12222417	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	87.0	CHEMBL4225	Homo sapiens	Residual Activity	%	87.0
	12222418	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	45.0	CHEMBL4225	Homo sapiens	Residual Activity	%	45.0
	12222419	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	9.0	CHEMBL4225	Homo sapiens	Residual Activity	%	9.0
	12222420	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	81.0	CHEMBL4225	Homo sapiens	Residual Activity	%	81.0
	12222421	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222422	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222423	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	48.0	CHEMBL4225	Homo sapiens	Residual Activity	%	48.0
	12222424	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	110.0	CHEMBL4225	Homo sapiens	Residual Activity	%	110.0
	12222425	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	93.0	CHEMBL4225	Homo sapiens	Residual Activity	%	93.0
	12222426	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	6.0	CHEMBL4225	Homo sapiens	Residual Activity	%	6.0
	12222427	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	106.0	CHEMBL4225	Homo sapiens	Residual Activity	%	106.0
	12222428	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12222429	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	82.0	CHEMBL4225	Homo sapiens	Residual Activity	%	82.0
	12222430	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	2.0	CHEMBL4225	Homo sapiens	Residual Activity	%	2.0
	12222431	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	93.0	CHEMBL4225	Homo sapiens	Residual Activity	%	93.0
	12222432	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	30.0	CHEMBL4225	Homo sapiens	Residual Activity	%	30.0
	12222433	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	2.0	CHEMBL4225	Homo sapiens	Residual Activity	%	2.0
	12222434	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	75.0	CHEMBL4225	Homo sapiens	Residual Activity	%	75.0
	12222435	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	1.0	CHEMBL4225	Homo sapiens	Residual Activity	%	1.0
	12222436	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	94.0	CHEMBL4225	Homo sapiens	Residual Activity	%	94.0
	12222437	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4225	Homo sapiens	Residual Activity	%	0.0
	12222438	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12222439	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	9.0	CHEMBL4225	Homo sapiens	Residual Activity	%	9.0
	12222440	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	87.0	CHEMBL4225	Homo sapiens	Residual Activity	%	87.0
	12222441	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	66.0	CHEMBL4225	Homo sapiens	Residual Activity	%	66.0
	12222442	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	71.0	CHEMBL4225	Homo sapiens	Residual Activity	%	71.0
	12222443	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12222444	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	89.0	CHEMBL4225	Homo sapiens	Residual Activity	%	89.0
	12222445	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	94.0	CHEMBL4225	Homo sapiens	Residual Activity	%	94.0
	12222446	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	92.0	CHEMBL4225	Homo sapiens	Residual Activity	%	92.0
	12222447	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	4.0	CHEMBL4225	Homo sapiens	Residual Activity	%	4.0
	12222448	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	74.0	CHEMBL4225	Homo sapiens	Residual Activity	%	74.0
	12222449	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	84.0	CHEMBL4225	Homo sapiens	Residual Activity	%	84.0
	12222450	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	8.0	CHEMBL4225	Homo sapiens	Residual Activity	%	8.0
	12222451	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	114.0	CHEMBL4225	Homo sapiens	Residual Activity	%	114.0
	12222452	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222453	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	79.0	CHEMBL4225	Homo sapiens	Residual Activity	%	79.0
	12222454	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	90.0	CHEMBL4225	Homo sapiens	Residual Activity	%	90.0
	12222455	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	112.0	CHEMBL4225	Homo sapiens	Residual Activity	%	112.0
	12222456	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	109.0	CHEMBL4225	Homo sapiens	Residual Activity	%	109.0
	12222457	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	118.0	CHEMBL4225	Homo sapiens	Residual Activity	%	118.0
	12222458	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	46.0	CHEMBL4225	Homo sapiens	Residual Activity	%	46.0
	12222459	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	4.0	CHEMBL4225	Homo sapiens	Residual Activity	%	4.0
	12222460	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	105.0	CHEMBL4225	Homo sapiens	Residual Activity	%	105.0
	12222461	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	92.0	CHEMBL4225	Homo sapiens	Residual Activity	%	92.0
	12222462	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	98.0	CHEMBL4225	Homo sapiens	Residual Activity	%	98.0
	12222463	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	14.0	CHEMBL4225	Homo sapiens	Residual Activity	%	14.0
	12222464	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	6.0	CHEMBL4225	Homo sapiens	Residual Activity	%	6.0
	12222465	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	103.0	CHEMBL4225	Homo sapiens	Residual Activity	%	103.0
	12222466	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	107.0	CHEMBL4225	Homo sapiens	Residual Activity	%	107.0
	12222467	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	56.0	CHEMBL4225	Homo sapiens	Residual Activity	%	56.0
	12222468	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	107.0	CHEMBL4225	Homo sapiens	Residual Activity	%	107.0
	12222469	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	96.0	CHEMBL4225	Homo sapiens	Residual Activity	%	96.0
	12222470	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	59.0	CHEMBL4225	Homo sapiens	Residual Activity	%	59.0
	12222471	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	59.0	CHEMBL4225	Homo sapiens	Residual Activity	%	59.0
	12222472	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	104.0	CHEMBL4225	Homo sapiens	Residual Activity	%	104.0
	12222473	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222474	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	46.0	CHEMBL4225	Homo sapiens	Residual Activity	%	46.0
	12222475	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	102.0	CHEMBL4225	Homo sapiens	Residual Activity	%	102.0
	12222476	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	30.0	CHEMBL4225	Homo sapiens	Residual Activity	%	30.0
	12222477	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	100.0	CHEMBL4225	Homo sapiens	Residual Activity	%	100.0
	12222478	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	47.0	CHEMBL4225	Homo sapiens	Residual Activity	%	47.0
	12222479	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	4.0	CHEMBL4225	Homo sapiens	Residual Activity	%	4.0
	12222480	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	6.0	CHEMBL4225	Homo sapiens	Residual Activity	%	6.0
	12222481	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	13.0	CHEMBL4225	Homo sapiens	Residual Activity	%	13.0
	12222482	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	4.0	CHEMBL4225	Homo sapiens	Residual Activity	%	4.0
	12222483	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	96.0	CHEMBL4225	Homo sapiens	Residual Activity	%	96.0
	12222484	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	1.0	CHEMBL4225	Homo sapiens	Residual Activity	%	1.0
	12222485	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	101.0	CHEMBL4225	Homo sapiens	Residual Activity	%	101.0
	12222486	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	93.0	CHEMBL4225	Homo sapiens	Residual Activity	%	93.0
	12222487	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	2.0	CHEMBL4225	Homo sapiens	Residual Activity	%	2.0
	12222488	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	18.0	CHEMBL4225	Homo sapiens	Residual Activity	%	18.0
	12222489	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	105.0	CHEMBL4225	Homo sapiens	Residual Activity	%	105.0
	12222490	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	21.0	CHEMBL4225	Homo sapiens	Residual Activity	%	21.0
	12222491	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	80.0	CHEMBL4225	Homo sapiens	Residual Activity	%	80.0
	12222492	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	50.0	CHEMBL4225	Homo sapiens	Residual Activity	%	50.0
	12222493	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	1.0	CHEMBL4225	Homo sapiens	Residual Activity	%	1.0
	12222494	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	52.0	CHEMBL4225	Homo sapiens	Residual Activity	%	52.0
	12222495	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	6.0	CHEMBL4225	Homo sapiens	Residual Activity	%	6.0
	12222496	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	74.0	CHEMBL4225	Homo sapiens	Residual Activity	%	74.0
	12222497	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	83.0	CHEMBL4225	Homo sapiens	Residual Activity	%	83.0
	12222498	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	94.0	CHEMBL4225	Homo sapiens	Residual Activity	%	94.0
	12222499	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	68.0	CHEMBL4225	Homo sapiens	Residual Activity	%	68.0
	12222500	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	27.0	CHEMBL4225	Homo sapiens	Residual Activity	%	27.0
	12222501	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	3.0	CHEMBL4225	Homo sapiens	Residual Activity	%	3.0
	12222502	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	87.0	CHEMBL4225	Homo sapiens	Residual Activity	%	87.0
	12222503	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	48.0	CHEMBL4225	Homo sapiens	Residual Activity	%	48.0
	12222504	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	65.0	CHEMBL4225	Homo sapiens	Residual Activity	%	65.0
	12222505	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	13.0	CHEMBL4225	Homo sapiens	Residual Activity	%	13.0
	12222506	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	68.0	CHEMBL4225	Homo sapiens	Residual Activity	%	68.0
	12222507	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	74.0	CHEMBL4225	Homo sapiens	Residual Activity	%	74.0
	12222508	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	10.0	CHEMBL4225	Homo sapiens	Residual Activity	%	10.0
	12222509	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	49.0	CHEMBL4225	Homo sapiens	Residual Activity	%	49.0
	12222510	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	93.0	CHEMBL4225	Homo sapiens	Residual Activity	%	93.0
	12222511	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	36.0	CHEMBL4225	Homo sapiens	Residual Activity	%	36.0
	12222512	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	99.0	CHEMBL4225	Homo sapiens	Residual Activity	%	99.0
	12222513	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	69.0	CHEMBL4225	Homo sapiens	Residual Activity	%	69.0
	12222514	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	104.0	CHEMBL4225	Homo sapiens	Residual Activity	%	104.0
	12222515	CHEMBL2219003	Millipore: Percentage of residual kinase activity of CLK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	16.0	CHEMBL4225	Homo sapiens	Residual Activity	%	16.0
	12673075	CHEMBL2345623	Inhibition of recombinant CLK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336379	=	Activity	%	4.0	CHEMBL4225	Homo sapiens	Activity	%	4.0
	12673076	CHEMBL2345623	Inhibition of recombinant CLK2 (unknown origin) assessed as residual activity using [gamma-33P]ATP as substrate at 1 uM	B	CC[C@H](CO)Nc1nc(NC(=N)N)c2ncn(C(C)C)c2n1		CHEMBL2336377	=	Activity	%	4.0	CHEMBL4225	Homo sapiens	Activity	%	4.0
	12693243	CHEMBL2343928	Inhibition of CLK2 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	nM	10000.0
	12728868	CHEMBL2353151	Inhibition of CLK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	79.0	CHEMBL4225	Homo sapiens	Activity	%	79.0
	12730010	CHEMBL2353655	Inhibition of CLK2 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL4225	Homo sapiens	Activity	%	96.0
	12730258	CHEMBL2353151	Inhibition of CLK2 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	96.0	CHEMBL4225	Homo sapiens	Activity	%	96.0
	12730889	CHEMBL2349817	Inhibition of CLK2 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	68.0	CHEMBL4225	Homo sapiens	Activity	%	68.0
	13279233	CHEMBL2380169	Inhibition of human CLK2 at 0.1 uM incubated for 15 mins prior to substrate addition measured after 90 mins by P33-radiolabeled assay relative to control	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)sc1C(=O)c1ccccc1[N+](=O)[O-]		CHEMBL2377825	=	Inhibition	%	60.0	CHEMBL4225	Homo sapiens	INH	%	60.0
Active	13301908	CHEMBL2383370	Inhibition of human CLK2 at 1 uM	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	13341507	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	COc1cccc(-c2ccnc(NCc3ccc(Cl)c(Cl)c3)n2)c1		CHEMBL2392362	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	nM	10000.0
	13341508	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	COc1cccc(-c2ccnc(NCc3ccc(Cl)cc3)n2)c1		CHEMBL2392361	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	nM	10000.0
	13341521	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	c1cncc(CNc2ncncc2-c2ccc3c(c2)OCO3)c1		CHEMBL1331525	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	nM	10000.0
	13341522	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(Nc2nccc(-c3ccc4c(c3)OCO4)n2)cc1		CHEMBL1899640	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	nM	10000.0
	13341527	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(CNc2ncncc2-c2ccc3c(c2)OCO3)cc1		CHEMBL1882945	=	IC50	nM	8791.0	CHEMBL4225	Homo sapiens	IC50	nM	8791.0
	13341561	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	c1cncc(CNc2ccnc(-c3ccc4cn[nH]c4c3)n2)c1		CHEMBL1872011	=	IC50	nM	1903.0	CHEMBL4225	Homo sapiens	IC50	nM	1903.0
	13341566	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(CNc2ncncc2-c2ccc3c(c2)OCO3)cc1Cl		CHEMBL2392228	=	IC50	nM	1557.0	CHEMBL4225	Homo sapiens	IC50	nM	1557.0
	13341575	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	COc1ccc(-c2ccnc(NCc3ccc(Cl)cc3)n2)cc1		CHEMBL2392359	=	IC50	nM	1092.0	CHEMBL4225	Homo sapiens	IC50	nM	1092.0
	13341581	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	c1cncc(CNc2ccnc(-c3ccc4[nH]ncc4c3)n2)c1		CHEMBL1884711	=	IC50	nM	665.0	CHEMBL4225	Homo sapiens	IC50	nM	665.0
	13341593	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	c1cncc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)c1		CHEMBL1902528	=	IC50	nM	462.0	CHEMBL4225	Homo sapiens	IC50	nM	462.0
	13341594	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(CNc2nccc(-c3ccc4cn[nH]c4c3)n2)cc1Cl		CHEMBL2392367	=	IC50	nM	429.0	CHEMBL4225	Homo sapiens	IC50	nM	429.0
	13341596	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	COc1ccc(-c2ccnc(NCc3ccc(Cl)c(Cl)c3)n2)cc1		CHEMBL2392360	=	IC50	nM	409.0	CHEMBL4225	Homo sapiens	IC50	nM	409.0
	13341599	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	FC(F)(F)c1cc(Br)cc(Nc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL2392368	=	IC50	nM	345.0	CHEMBL4225	Homo sapiens	IC50	nM	345.0
	13341609	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	c1cc(-c2ccc3c(c2)OCO3)nc(Nc2ccc3c(c2)OCO3)n1		CHEMBL1885536	=	IC50	nM	259.0	CHEMBL4225	Homo sapiens	IC50	nM	259.0
	13341611	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(CNc2ccnc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1898211	=	IC50	nM	238.0	CHEMBL4225	Homo sapiens	IC50	nM	238.0
	13341612	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1cc(Cl)cc(CNc2ncncc2-c2ccc3c(c2)OCO3)c1		CHEMBL1885748	=	IC50	nM	231.0	CHEMBL4225	Homo sapiens	IC50	nM	231.0
	13342211	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	=	IC50	nM	190.0	CHEMBL4225	Homo sapiens	IC50	nM	190.0
	13342256	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	c1cncc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL1877990	=	IC50	nM	60.0	CHEMBL4225	Homo sapiens	IC50	nM	60.0
	13342260	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	FC(F)(F)c1cccc(Nc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL1868723	=	IC50	nM	52.0	CHEMBL4225	Homo sapiens	IC50	nM	52.0
	13342279	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Brc1cc(Br)cc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL2392365	=	IC50	nM	41.0	CHEMBL4225	Homo sapiens	IC50	nM	41.0
	13342284	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(CNc2nccc(-c3ccc4c(c3)OCCO4)n2)cc1Cl		CHEMBL1904905	=	IC50	nM	39.0	CHEMBL4225	Homo sapiens	IC50	nM	39.0
	13342334	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Brc1ccc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)cc1Br		CHEMBL1899256	=	IC50	nM	30.0	CHEMBL4225	Homo sapiens	IC50	nM	30.0
	13342371	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1cc(Cl)cc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)c1		CHEMBL2392364	=	IC50	nM	23.0	CHEMBL4225	Homo sapiens	IC50	nM	23.0
	13342379	CHEMBL2394345	Inhibition of CLK2 (unknown origin)	B	Clc1ccc(CNc2nccc(-c3ccc4c(c3)OCO4)n2)cc1Cl		CHEMBL1898197	=	IC50	nM	20.0	CHEMBL4225	Homo sapiens	IC50	nM	20.0
	13342428	CHEMBL2394337	Competitive binding affinity to CLK2 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1cc(Cl)cc(CNc2ncncc2-c2ccc3c(c2)OCO3)c1		CHEMBL1885748	<	Activity	%	10.0	CHEMBL4225	Homo sapiens	Activity	%	10.0
	13342432	CHEMBL2394337	Competitive binding affinity to CLK2 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2ccnc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1898211	<	Activity	%	10.0	CHEMBL4225	Homo sapiens	Activity	%	10.0
	13342450	CHEMBL2394337	Competitive binding affinity to CLK2 (unknown origin) assessed as enzyme remaining bound to anchored active-site ligand at 10 uM relative to control	B	Clc1ccc(CNc2nccc(-c3ccc4[nH]ncc4c3)n2)cc1Cl		CHEMBL1892019	<	Activity	%	10.0	CHEMBL4225	Homo sapiens	Activity	%	10.0
	13375911	CHEMBL2405320	Inhibition of CLK2 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-7.0	CHEMBL4225	Homo sapiens	INH	%	-7.0
	13438140	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(Cc2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420551	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438141	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccc(F)cc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420555	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438142	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CCC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420573	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438143	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(NC1(c2ccccc2)CC1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420572	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438144	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC(C)(NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420570	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438145	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CCC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420565	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438146	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(N[C@H](CO)c1ccccc1)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420564	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438147	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	CC[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420562	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438148	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420560	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438149	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	C[C@@H](NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1)c1ccccc1		CHEMBL2420556	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438150	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	NC(=O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420587	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13438151	CHEMBL2422445	Inhibition of CLK2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis	B	O=C(O)c1ccc2nc(N[C@H]3CC[C@H](O)CC3)c3nccn3c2c1		CHEMBL2420585	<	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	13442385	CHEMBL2428007	Competitive binding affinity to CLK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	97.0	CHEMBL4225	Homo sapiens	INH	%	97.0
	13445520	CHEMBL2428007	Competitive binding affinity to CLK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	95.0	CHEMBL4225	Homo sapiens	INH	%	95.0
	13448575	CHEMBL2428007	Competitive binding affinity to CLK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	99.0	CHEMBL4225	Homo sapiens	INH	%	99.0
	13448711	CHEMBL2428007	Competitive binding affinity to CLK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	=	Inhibition	%	94.0	CHEMBL4225	Homo sapiens	INH	%	94.0
	13451506	CHEMBL2428007	Competitive binding affinity to CLK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	=	Inhibition	%	100.0	CHEMBL4225	Homo sapiens	INH	%	100.0
	13454691	CHEMBL2428007	Competitive binding affinity to CLK2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	99.0	CHEMBL4225	Homo sapiens	INH	%	99.0
	13476413	CHEMBL2439137	Inhibition of human wild type CLK2 at 1 uM by qPCR analysis relative to control	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	>	Inhibition	%	90.0	CHEMBL4225	Homo sapiens	INH	%	90.0
	13872177	CHEMBL3101929	Inhibition of human CLK2 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	81.0	CHEMBL4225	Homo sapiens	Activity	%	81.0
	14582469	CHEMBL3240429	Inhibition of human CLK2 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	110.0	CHEMBL4225	Homo sapiens	Activity	%	110.0
	14663244	CHEMBL3270856	Inhibition of CLK2 (unknown origin) at 1 uM relative to control	B	CCOC(=O)c1sc(-c2ccncc2)nc1O		CHEMBL3261228	=	Inhibition	%	86.0	CHEMBL4225	Homo sapiens	INH	%	86.0
	14663245	CHEMBL3270856	Inhibition of CLK2 (unknown origin) at 1 uM relative to control	B	NC(=O)c1sc(-c2ccnc(N)n2)nc1-c1ccc(Cl)cc1Cl		CHEMBL3261514	=	Inhibition	%	7.9	CHEMBL4225	Homo sapiens	INH	%	7.9
	14663246	CHEMBL3270856	Inhibition of CLK2 (unknown origin) at 1 uM relative to control	B	COc1ccc(-c2nc(-c3ccnc(N)n3)sc2C(N)=O)c(Cl)c1		CHEMBL3261517	=	Inhibition	%	10.0	CHEMBL4225	Homo sapiens	INH	%	10.0
	14750917	CHEMBL3299309	Inhibition of CLK2 (unknown origin)	B	COc1c(O)ccc2c(=O)c3c(O)cc4c(c3[nH]c12)C=CC(C)(C)O4		CHEMBL3297832	=	IC50	nM	680.0	CHEMBL4225	Homo sapiens	IC50	uM	0.68
	15001744	CHEMBL3380555	Inhibition of CLK2 (unknown origin) at 0.1 uM	B	CN(C)CC[C@@H](c1ccccc1)n1cc(NC(=O)c2n[nH]c3c2CCC(C)(C)C3)cn1		CHEMBL3298371	=	Inhibition	%	93.0	CHEMBL4225	Homo sapiens	INH	%	93.0
	15018568	CHEMBL3361882	Inhibition of CLK2 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	9.4	CHEMBL4225	Homo sapiens	INH	%	9.4
	15055358	CHEMBL3380490	Inhibition of CLK2 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	12.0	CHEMBL4225	Homo sapiens	Activity	%	12.0
	15063571	CHEMBL3374511	Inhibition of human CLK2 at 0.1 uM	B	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1cc(C(F)(F)F)ccc1Cl		CHEMBL3330125	=	Inhibition	%	1.0	CHEMBL4225	Homo sapiens	INH	%	1.0
	15072413	CHEMBL3388080	Inhibition of CLK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	83.0	CHEMBL4225	Homo sapiens	Activity	%	83.0
Active	15105941	CHEMBL3387825	Inhibition of CLK2 (unknown origin)	B	C[C@@H]1CN(C)CC[C@@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355124		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	15105942	CHEMBL3387825	Inhibition of CLK2 (unknown origin)	B	C[C@H]1CN(C)CC[C@H]1c1cc2c(cc1-c1ccccc1F)OCC1=NNC(=O)[C@@H](C)N12		CHEMBL3355127		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	15105943	CHEMBL3387825	Inhibition of CLK2 (unknown origin)	B	Cc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1		CHEMBL3355137		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	15105944	CHEMBL3387825	Inhibition of CLK2 (unknown origin)	B	COc1ccc(-c2cc3c(cc2[C@@H]2CCN(C)C[C@@H]2C)N2C(=NNC(=O)[C@H]2C)CO3)c(F)c1		CHEMBL3355138		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	15109390	CHEMBL3373400	Inhibition of CLK2 (unknown origin) assessed as residual enzyme activity at 10 uM	B	COc1cccc(C(=O)Nc2nc3cc4c(cc3[nH]2)OC(F)(F)O4)c1		CHEMBL3337846	=	Activity	%	5.7	CHEMBL4225	Homo sapiens	Activity	%	5.7
	15144922	CHEMBL3396431	Competitive binding affinity at CLK2 (unknown origin) at 1 uM relative to control	B	Fc1cccc(F)c1-c1ccc2[nH]nc(-c3cncc(O[C@H]4CNCCC45CC5)n3)c2c1		CHEMBL3393706	=	Activity	%	22.0	CHEMBL4225	Homo sapiens	Activity	%	22.0
Active	15189802	CHEMBL3411531	Inhibition of human CLK2 at 1 uM	B	O=C(NC1CC1)c1ccc(-c2cnc3c(NCC4CCOCC4)cc(Oc4ccccc4O)nn23)cc1		CHEMBL3410078		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	15189804	CHEMBL3411533	Inhibition of human CLK2 at 0.2 uM	B	O=C(NC1CC1)c1ccc(-c2cnc3c(NCC4CCOCC4)cc(Oc4ccccc4O)nn23)cc1		CHEMBL3410078	>	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	15189859	CHEMBL3411531	Inhibition of human CLK2 at 1 uM	B	CC(C)(Nc1cc(NCC2CCOCC2)c2ncc(-c3ccc(C(=O)NC4CC4)cc3)n2n1)C(F)(F)F		CHEMBL3410084	>	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	15250383	CHEMBL3430287	Binding affinity to human CLK2 at 10 uM relative to control	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	<	Activity	%	10.0	CHEMBL4225	Homo sapiens	Activity	%	10.0
	15250390	CHEMBL3430294	Binding affinity to human CLK2	B	COc1cc(-c2cnc3c(N4CCOCC4)snc3c2)cc(OC)c1OC		CHEMBL3425865	=	Kd	nM	710.0	CHEMBL4225	Homo sapiens	Kd	nM	710.0
	15258344	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	5.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.8
	15258404	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.3
	15258464	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	4.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.1
	15258524	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	2.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.8
	15258584	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	0.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.4
	15258644	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	-0.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.4
	15258704	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	4.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.3
	15258764	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	0.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.5
	15258824	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	2.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.7
	15258884	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	4.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.1
	15258944	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	0.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.7
	15259004	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	4.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.4
	15259064	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	1.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.4
	15259124	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	7.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	7.8
	15259184	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	8.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	8.9
	15259244	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	3.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.6
	15259304	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	2.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.4
	15259364	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.2
	15259424	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	0.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.8
	15259484	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15259544	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	0.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.3
	15259604	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.8
	15259664	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	4.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.2
	15259724	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	5.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.9
	15259784	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	-0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259844	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	0.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.0
	15259904	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259964	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	1.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.6
	15260024	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	5.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.9
	15260084	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	0.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.5
	15260144	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	1.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.1
	15260204	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	3.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.8
	15260264	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	0.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.9
	15260324	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	4.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.3
	15260384	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	1.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.3
	15260444	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-1.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-1.0
	15260504	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	7.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	7.9
	15260564	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.6
	15260624	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	4.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.9
	15260684	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	4.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.5
	15260744	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.6
	15260804	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	6.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	6.2
	15260864	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	6.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	6.5
	15260924	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15260984	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	-0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.6
	15261044	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	4.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.2
	15261104	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	0.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.0
	15261187	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15261247	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	2.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.4
	15261307	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	1.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.6
	15261367	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	1.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.0
	15261422	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	3.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.7
	15261482	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	-0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261542	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	4.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.2
	15261602	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261675	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.7
	15261735	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.2
	15261795	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	2.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.8
	15261855	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	0.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.5
	15261911	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15261971	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	1.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.3
	15262031	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	0.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.7
	15262091	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	1.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.5
	15262164	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	0.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.8
	15262224	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	1.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.4
	15262284	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	5.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.6
	15262344	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	-0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262404	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	1.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.6
	15262464	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.5
	15262524	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	1.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.2
	15262584	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	2.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.2
	15262644	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.9
	15262704	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	1.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.6
	15262764	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15262824	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	1.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.2
	15262884	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	1.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.9
	15262944	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	1.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.7
	15263004	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15263064	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	0.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.7
	15263124	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15263184	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.7
	15263244	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	0.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.9
	15263304	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.2
	15263364	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	0.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.5
	15263400	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	1.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.9
	15263460	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.2
	15263515	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	3.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.0
	15263575	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	0.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.9
	15263635	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	2.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.8
	15263695	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	3.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.3
	15263769	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	1.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.8
	15263829	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.6
	15263889	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	1.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.7
	15263949	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	1.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.4
	15264003	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	3.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.5
	15264063	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-0.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264123	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	-0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264183	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	1.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.0
	15264256	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	2.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.5
	15264316	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.6
	15264376	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	2.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.6
	15264436	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	5.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.6
	15264492	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	1.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.5
	15264552	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	4.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.8
	15264612	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	-0.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.3
	15264672	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	0.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.3
	15264744	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-0.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.8
	15264804	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	0.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.4
	15264864	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	3.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.6
	15264924	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	5.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.8
	15264980	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15265040	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	-2.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-2.5
	15265100	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	-0.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.9
	15265160	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	4.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.6
	15265233	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	4.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.5
	15265293	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15265353	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	1.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.0
	15265413	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	2.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.4
	15265469	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	0.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.7
	15265529	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.2
	15265589	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.0
	15265649	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15265709	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	4.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.8
	15265721	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.8	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.8
	15265781	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	2.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.3
	15265841	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.6
	15265901	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	0.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.0
	15266018	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.6
	15266078	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	0.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.0
	15266138	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	2.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.9
	15266198	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	3.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.7
	15266210	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	1.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.3
	15266270	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-1.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-1.3
	15266330	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	1.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.7
	15266390	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	2.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.1
	15266450	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	4.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.9
	15266505	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	2.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.3
	15266565	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	4.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	4.1
	15266625	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	5.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.6
	15266685	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	2.5	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	2.5
	15266758	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	0.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.3
	15266818	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	3.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	3.2
	15266878	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.3
	15266938	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	1.4	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.4
	15266993	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	5.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	5.1
	15267053	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	1.0	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.0
	15267113	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	1.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.1
	15267173	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	6.9	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	6.9
	15267246	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	1.7	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.7
	15267306	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	1.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	1.3
	15267366	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	0.1	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.1
	15267426	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.2
	15267481	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	-0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.2
	15267541	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	0.6	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	0.6
	15267601	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-0.2	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.2
	15267661	CHEMBL3430803	Delta TM value showing the stabilisation of CLK2 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.3	CHEMBL4225	Homo sapiens	Thermal melting change	degrees C	-0.3
	15650182	CHEMBL3595502	Inhibition of human CLK2 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	-7.0	CHEMBL4225	Homo sapiens	INH	%	-7.0
Active	15666678	CHEMBL3603423	Inhibition of CLK2 (unknown origin)	B	Cc1cc(Nc2cc(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)c(-c3nc4ccccc4s3)cn2)cc(C)n1		CHEMBL3601196		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	15666679	CHEMBL3603423	Inhibition of CLK2 (unknown origin)	B	Cc1cc(Nc2ncc(-c3ccc4ccccc4n3)c(N[C@@H]3C[C@H](CO)[C@@H](O)[C@H]3O)n2)cc(C)n1		CHEMBL3601192		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	15756050	CHEMBL3632423	Inhibition of CLK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	24.47	CHEMBL4225	Homo sapiens	INH	%	24.47
	15757005	CHEMBL3632423	Inhibition of CLK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	28.77	CHEMBL4225	Homo sapiens	INH	%	28.77
	15758672	CHEMBL3632423	Inhibition of CLK2 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	7.06	CHEMBL4225	Homo sapiens	INH	%	7.06
	16413431	CHEMBL3743713	Inhibition of CLK2 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	uM	10.0
	16426119	CHEMBL3750446	Inhibition of CLK2 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-7.0	CHEMBL4225	Homo sapiens	INH	%	-7.0
	16431789	CHEMBL3748993	Inhibition of human CLK2 using MBP as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	uM	10.0
	16450796	CHEMBL3762314	Inhibition of CLK2 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-3.6	CHEMBL4225	Homo sapiens	INH	%	-3.6
	16472952	CHEMBL3768603	Inhibition of human CLK2	B	COCCOc1cc2c(-n3nc(-c4ccccn4)nc3N)ncnc2cc1OC		CHEMBL3763358	>	Inhibition	%	95.0	CHEMBL4225	Homo sapiens	INH	%	95.0
	16495376	CHEMBL3778356	Inhibition of N-terminal His6-tagged recombinant human CLK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-16.0	CHEMBL4225	Homo sapiens	Activity	%	-16.0
	16506477	CHEMBL3778443	Inhibition of recombinant human GST-tagged CLK2 expressed in baculovirus expression system at 5 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncsc2c1		CHEMBL3775393	=	Inhibition	%	65.0	CHEMBL4225	Homo sapiens	INH	%	65.0
	16506478	CHEMBL3778444	Inhibition of recombinant human GST-tagged CLK2 expressed in baculovirus expression system at 1 uM by lantha screen kinase binding assay relative to control	B	O=C1NC(=S)S/C1=C\c1ccc2ncccc2c1		CHEMBL3774448	=	Inhibition	%	80.0	CHEMBL4225	Homo sapiens	INH	%	80.0
	16508145	CHEMBL3778356	Inhibition of N-terminal His6-tagged recombinant human CLK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	14.0	CHEMBL4225	Homo sapiens	Activity	%	14.0
	16509122	CHEMBL3778356	Inhibition of N-terminal His6-tagged recombinant human CLK2 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-13.0	CHEMBL4225	Homo sapiens	Activity	%	-13.0
	16578334	CHEMBL3804388	Inhibition of partial length wild type human CLK2 expressed in bacterial system assessed as enzyme activity at 1 uM relative to control	B	CN(C)S(=O)(=O)Nc1ccc(F)c(Nc2ncccc2-c2ncnc3[nH]cnc23)c1F		CHEMBL3798256	=	Activity	%	79.0	CHEMBL4225	Homo sapiens	Activity	%	79.0
	16596817	CHEMBL3812022	Inhibition of human CLK2 assessed as remaining enzyme activity at 1 uM by KINOMEscan assay	B	Cc1nc2cccc3c2nc1N[C@H](C)/C=C\C[C@H]1CNC(=O)c2cc-3[nH]c21		CHEMBL3809691	<	Activity	%	10.0	CHEMBL4225	Homo sapiens	Activity	%	10.0
	16611882	CHEMBL3816739	Inhibition of human CLK2 (138 to 499 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-98.0	CHEMBL4225	Homo sapiens	Activity	%	-98.0
	16614436	CHEMBL3817302	Inhibition of human CLK2 at 1 uM using MBP as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1	Outside typical range	CHEMBL3815093	=	Inhibition	%	-23.0	CHEMBL4225	Homo sapiens	INH	%	-23.0
	16618254	CHEMBL3817070	Inhibition of recombinant human GST-tagged CLK2 catalytic domain expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	16654107	CHEMBL3829307	Inhibition of human CLK2 (138 to 499 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	45.0	CHEMBL4225	Homo sapiens	Activity	%	45.0
	16836254	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#C/C(=C\c1cccnc1)c1c[nH]c2ncccc12		CHEMBL3753668	=	IC50	nM	4600.0	CHEMBL4225	Homo sapiens	IC50	uM	4.6
	16836255	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(/C(C#N)=C/c3cccnc3)c[nH]c2n1		CHEMBL3884570	=	IC50	nM	2300.0	CHEMBL4225	Homo sapiens	IC50	uM	2.3
	16836256	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#Cc1cc2ccncc2c2[nH]c3ccccc3c12		CHEMBL3883820	=	IC50	nM	1100.0	CHEMBL4225	Homo sapiens	IC50	uM	1.1
	16836257	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1cccc2[nH]c3c4ccncc4cc(C#N)c3c12		CHEMBL3884250	=	IC50	nM	4000.0	CHEMBL4225	Homo sapiens	IC50	uM	4.0
	16836258	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]c3c4ccncc4cc(C#N)c3c2c1		CHEMBL3883639	=	IC50	nM	110.0	CHEMBL4225	Homo sapiens	IC50	uM	0.11
	16836259	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(C#N)c21		CHEMBL3883660	=	IC50	nM	80.0	CHEMBL4225	Homo sapiens	IC50	uM	0.08
	16836260	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1cccc2c1[nH]c1c3ccncc3cc(C#N)c21		CHEMBL3885431	=	IC50	nM	44.0	CHEMBL4225	Homo sapiens	IC50	uM	0.044
	16836261	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#Cc1cc2cnccc2c2[nH]c3ncccc3c12		CHEMBL3884015	=	IC50	nM	400.0	CHEMBL4225	Homo sapiens	IC50	uM	0.4
	16836262	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	N#Cc1cc2cnccc2c2[nH]c3ccc(F)cc3c12		CHEMBL3883414	=	IC50	nM	610.0	CHEMBL4225	Homo sapiens	IC50	uM	0.61
Not Determined	16836263	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]c3c4c(OC)cncc4cc(C#N)c3c2c1		CHEMBL3884932		IC50			CHEMBL4225	Homo sapiens	IC50		
	16836264	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(n1)[nH]c1c3ccncc3cc(C#N)c21		CHEMBL3885316	=	IC50	nM	4600.0	CHEMBL4225	Homo sapiens	IC50	uM	4.6
	16836265	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3c(OC)cncc3cc(C#N)c21		CHEMBL3884821	=	IC50	nM	150.0	CHEMBL4225	Homo sapiens	IC50	uM	0.15
	16836266	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1cccc2c1[nH]c1c3ccncc3cc(C(N)=O)c21		CHEMBL3884627	=	IC50	nM	3500.0	CHEMBL4225	Homo sapiens	IC50	uM	3.5
	16836267	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(CN)c21		CHEMBL3885328	=	IC50	nM	1600.0	CHEMBL4225	Homo sapiens	IC50	uM	1.6
	16836268	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(CNC(C)=O)c21		CHEMBL3885360	=	IC50	nM	2800.0	CHEMBL4225	Homo sapiens	IC50	uM	2.8
Not Determined	16836269	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(c1)[nH]c1c3ccncc3cc(CN(C)C)c21		CHEMBL3884845		IC50			CHEMBL4225	Homo sapiens	IC50		
	16836270	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]c3c(=O)[nH]c(-c4cccnc4)c(C#N)c3c2c1		CHEMBL3885036	=	IC50	nM	610.0	CHEMBL4225	Homo sapiens	IC50	uM	0.61
	16836271	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2[nH]cc(-c3cc4cnccc4cc3NC(C)=O)c2c1		CHEMBL3885335	=	IC50	nM	1100.0	CHEMBL4225	Homo sapiens	IC50	uM	1.1
	16836272	CHEMBL3875859	Inhibition of GST-tagged human recombinant CLK2 expressed in Escherichia coli using RS peptide as substrate incubated for 30 mins in presence of [gamma-33 P] ATP by liquid scintillation counting analysis	B	COc1ccc2c(-c3ccncc3)c[nH]c2n1		CHEMBL3883448	=	IC50	nM	3500.0	CHEMBL4225	Homo sapiens	IC50	uM	3.5
	16837397	CHEMBL3876055	Inhibition of human recombinant GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system	B	CC1(C)C(=O)N([C@H]2CCc3c(O)cccc32)c2nc(Nc3ccccc3)ncc21		CHEMBL3884319	=	IC50	nM	1012.0	CHEMBL4225	Homo sapiens	IC50	nM	1012.0
Inactive	17892477	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892478	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892479	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892480	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892481	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892482	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892483	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892484	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892485	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892486	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892487	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892488	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892489	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892490	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892491	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892492	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892493	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892494	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892495	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892496	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892497	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892498	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892499	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892500	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892501	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892502	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892503	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892504	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892505	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892506	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892507	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	=	Kd	nM	18.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	18.0
Inactive	17892508	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892509	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Kd	nM	3844.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	3844.0
Inactive	17892510	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892511	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892512	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892513	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892514	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892515	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892516	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892517	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892518	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892519	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892520	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892521	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892522	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892523	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892524	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892525	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892526	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	3809.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	3809.0
Inactive	17892527	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892528	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892529	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892530	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892531	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892532	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892533	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892534	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892535	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892536	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892537	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892538	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892539	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892540	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892541	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892542	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892543	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892544	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892545	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892546	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892547	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892548	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892549	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892550	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892551	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892552	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892553	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892554	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892555	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892556	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892557	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892558	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892559	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892560	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892561	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892562	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892563	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892564	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892565	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892566	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892567	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892568	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892569	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892570	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892571	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892572	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892573	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892574	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892575	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892576	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892577	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892578	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892579	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892580	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892581	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892582	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892583	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892584	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892585	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892586	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892587	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	=	Kd	nM	2320.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	2320.0
Inactive	17892588	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892589	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17892590	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	375.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	375.0
Inactive	17892591	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892592	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892593	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17892594	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	121.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	121.0
Inactive	17892595	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892596	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892597	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892598	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892599	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892600	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892601	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892602	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892603	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892604	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892605	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892606	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892607	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892608	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892609	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892610	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892611	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892612	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892613	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892614	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892615	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	2879.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	2879.0
Inactive	17892616	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892617	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892618	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892619	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892620	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892621	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892622	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892623	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	=	Kd	nM	0.4	CHEMBL4225	Homo sapiens	Kd apparent	nM	0.4
Inactive	17892624	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892625	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892626	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892627	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892628	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892629	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892630	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892631	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892632	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892633	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892634	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892635	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892636	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892637	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892638	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17892639	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	=	Kd	nM	7.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	7.0
Inactive	17892640	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892641	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892642	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892643	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892644	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892645	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892646	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892647	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	922.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	922.0
Inactive	17892648	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892649	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892650	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892651	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892652	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892653	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892654	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892655	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892656	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892657	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892658	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892659	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Active	17892660	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	=	Kd	nM	3218.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	3218.0
Inactive	17892661	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892662	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892663	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892664	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892665	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892666	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892667	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892668	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892669	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17892670	CHEMBL3991669	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4225	Homo sapiens	Kd apparent	nM	30000.0
	18006654	CHEMBL4003363	Binding affinity to recombinant human CLK2 (D144 to R498 residues) expressed in bacterial expression system by KinomeScan assay	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	1700.0	CHEMBL4225	Homo sapiens	Kd	nM	1700.0
	18006655	CHEMBL4003363	Binding affinity to recombinant human CLK2 (D144 to R498 residues) expressed in bacterial expression system by KinomeScan assay	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	460.0	CHEMBL4225	Homo sapiens	Kd	nM	460.0
	18006656	CHEMBL4003363	Binding affinity to recombinant human CLK2 (D144 to R498 residues) expressed in bacterial expression system by KinomeScan assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	20.0	CHEMBL4225	Homo sapiens	Kd	nM	20.0
	18008539	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@H]3N)nc21		CHEMBL4073318	=	IC50	nM	26.0	CHEMBL4225	Homo sapiens	IC50	nM	26.0
	18008540	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4066861	=	IC50	nM	11.0	CHEMBL4225	Homo sapiens	IC50	nM	11.0
	18008541	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4088144	=	IC50	nM	16.0	CHEMBL4225	Homo sapiens	IC50	nM	16.0
	18008542	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21		CHEMBL4104505	=	IC50	nM	120.0	CHEMBL4225	Homo sapiens	IC50	nM	120.0
	18008543	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4080283	=	IC50	nM	190.0	CHEMBL4225	Homo sapiens	IC50	nM	190.0
	18008544	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21		CHEMBL1532768	=	IC50	nM	498.0	CHEMBL4225	Homo sapiens	IC50	nM	498.0
	18008545	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	IC50	nM	111.0	CHEMBL4225	Homo sapiens	IC50	nM	111.0
	18008610	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCNC3)nc21		CHEMBL4084116	=	IC50	nM	92.0	CHEMBL4225	Homo sapiens	IC50	nM	92.0
	18008611	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCNC3)nc21		CHEMBL4102101	=	IC50	nM	28.0	CHEMBL4225	Homo sapiens	IC50	nM	28.0
	18008612	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCNC3)nc21		CHEMBL4091876	=	IC50	nM	34.0	CHEMBL4225	Homo sapiens	IC50	nM	34.0
	18008613	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCCNC3)nc21		CHEMBL4064123	=	IC50	nM	26.0	CHEMBL4225	Homo sapiens	IC50	nM	26.0
	18008614	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@H]3N)nc21		CHEMBL4100324	=	IC50	nM	163.0	CHEMBL4225	Homo sapiens	IC50	nM	163.0
	18008615	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCCC[C@@H]3N)nc21		CHEMBL4082309	=	IC50	nM	14.0	CHEMBL4225	Homo sapiens	IC50	nM	14.0
	18008616	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(=O)Nc1cc(Cl)cc(Nc2nc(N[C@H]3CCCC[C@H]3N)nc3c2ncn3C(C)C)c1		CHEMBL4067013	=	IC50	nM	17.0	CHEMBL4225	Homo sapiens	IC50	nM	17.0
	18008617	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(=O)Nc1cc(Cl)cc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)nc3c2ncn3C(C)C)c1		CHEMBL4094492	=	IC50	nM	7.0	CHEMBL4225	Homo sapiens	IC50	nM	7.0
	18008618	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@H]3CCCC[C@H]3N)nc21		CHEMBL4104657	=	IC50	nM	26.0	CHEMBL4225	Homo sapiens	IC50	nM	26.0
	18008619	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	=	IC50	nM	6.0	CHEMBL4225	Homo sapiens	IC50	nM	6.0
	18008620	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(=O)Nc1cc(Cl)cc(Nc2nc(N[C@@H]3CCCC[C@@H]3N)nc3c2ncn3C(C)C)c1		CHEMBL4094492	=	IC50	nM	13.0	CHEMBL4225	Homo sapiens	IC50	nM	13.0
	18008621	CHEMBL4003769	Inhibition of human CLK2 using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate in presence of [gamma-33P]ATP after 40 mins by scintillation counter method	B	CC(C)n1cnc2c(Nc3cc(N)cc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL4078898	=	IC50	nM	16.0	CHEMBL4225	Homo sapiens	IC50	nM	16.0
	18031661	CHEMBL4007698	Inhibition of CLK2 (unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	211.0	CHEMBL4225	Homo sapiens	IC50	uM	0.211
	18031662	CHEMBL4007698	Inhibition of CLK2 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	uM	10.0
	18031663	CHEMBL4007698	Inhibition of CLK2 (unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	=	IC50	nM	6440.0	CHEMBL4225	Homo sapiens	IC50	uM	6.44
	18031664	CHEMBL4007698	Inhibition of CLK2 (unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	uM	10.0
	18031665	CHEMBL4007698	Inhibition of CLK2 (unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	uM	10.0
	18052936	CHEMBL4011949	Inhibition of CLK2 (unknown origin) pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	IC50	nM	5.3	CHEMBL4225	Homo sapiens	IC50	nM	5.3
	18053070	CHEMBL4011917	Inhibition of CLK2 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	96.9	CHEMBL4225	Homo sapiens	INH	%	96.9
	18064945	CHEMBL4014114	Inhibition of recombinant human CLK2 (144 to 498 residues) expressed in insect cells using S6 kinase/Rsk2 substrate peptide 2 in presence of [gamma-32P]ATP	B	C[C@@H](c1ccc(F)cc1)n1nnc2cnc3ccc(-c4ccc5ocnc5c4)cc3c21		CHEMBL4083249	=	IC50	nM	31.0	CHEMBL4225	Homo sapiens	IC50	nM	31.0
	18114426	CHEMBL4025068	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	100.0	CHEMBL4225	Homo sapiens	Activity	%	100.0
Active	18122273	CHEMBL4027004	Inhibition of recombinant full length N-terminal GST-tagged human CLK2 (138 end residues) expressed in baculovirus infected Sf21 insect cells at 0.1 uM	B	c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1		CHEMBL4064608		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	18122282	CHEMBL4027014	Inhibition of recombinant N-terminal GST-tagged human CLK2 (138 end residues) expressed in baculovirus infected Sf21 cells	B	c1nc(N[C@H]2CC[C@H](N3CCOCC3)CC2)c2c(C3CCOCC3)c[nH]c2n1		CHEMBL4064608	=	IC50	nM	5.0	CHEMBL4225	Homo sapiens	IC50	uM	0.005
	18143368	CHEMBL4031772	Inhibition of CLK2 in human CAL51 cells assessed as reduction in phosphorylation of SRp75 after 1 hr by Western blot analysis	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	=	IC50	nM	549.0	CHEMBL4225	Homo sapiens	IC50	uM	0.549
	18143374	CHEMBL4031765	Inhibition of CLK2 in human HCT116 cell lysate after 1 hr by LC-MS/MS analysis relative to control	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	=	IC50	nM	15.0	CHEMBL4225	Homo sapiens	IC50	uM	0.015
	18143377	CHEMBL4031762	Binding affinity to CLK2 in human HCT116 cell lysate at 3 uM after 1 hr by LC-MS/MS analysis	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	>=	Activity	%	75.0	CHEMBL4225	Homo sapiens	Activity	%	75.0
	18143383	CHEMBL4031756	Inhibition of human GST-tagged CLK2 expressed in baculovirus by Z'-LYTE assay	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	=	IC50	nM	6.0	CHEMBL4225	Homo sapiens	IC50	uM	0.006
	18143390	CHEMBL4031749	Inhibition of human GST-tagged CLK2 expressed in baculovirus at 3 uM by Z'-LYTE assay relative to control	B	CNC(=O)c1ccc(Nc2nc(OC3CCCC3)c3c(-c4ccc5nc(C)oc5c4)c[nH]c3n2)c(OC)c1		CHEMBL4062218	>	Inhibition	%	80.0	CHEMBL4225	Homo sapiens	INH	%	80.0
	18147994	CHEMBL4032835	Inhibition of CLK2 (unknown origin) at 10 uM after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting	B	N#Cc1ccc2c(c1)[nH]c(=O)n2[C@H]1C[C@H](c2nnc(-c3ccncn3)n2-c2ccccc2Cl)C1		CHEMBL4095003	=	Inhibition	%	73.0	CHEMBL4225	Homo sapiens	INH	%	73.0
	18203592	CHEMBL4043879	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4225	Homo sapiens	Activity	%	100.0
	18232209	CHEMBL4050297	Inhibition of human CLK2 assessed as residual activity at 1 uM in presence of 33P-ATP by filter-binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	19.0	CHEMBL4225	Homo sapiens	Activity	%	19.0
	18253401	CHEMBL4054984	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	69.0	CHEMBL4225	Homo sapiens	Activity	%	69.0
	18253402	CHEMBL4054984	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	71.0	CHEMBL4225	Homo sapiens	Activity	%	71.0
	18265774	CHEMBL4057224	Inhibition of CLK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	9.0	CHEMBL4225	Homo sapiens	INH	%	9.0
	18266022	CHEMBL4057472	Inhibition of CLK2 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-0.7	CHEMBL4225	Homo sapiens	INH	%	-0.7
	18282016	CHEMBL4119971	Inhibition of recombinant GST-tagged human CLK2 catalytic domain(137 to 498 residues)expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	17.6	CHEMBL4225	Homo sapiens	INH	%	17.6
	18282335	CHEMBL4119971	Inhibition of recombinant GST-tagged human CLK2 catalytic domain(137 to 498 residues)expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	0.3	CHEMBL4225	Homo sapiens	INH	%	0.3
	18282837	CHEMBL4120422	Inhibition of CLK2 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	9.0	CHEMBL4225	Homo sapiens	INH	%	9.0
	18283057	CHEMBL4120642	Inhibition of CLK2 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-0.3	CHEMBL4225	Homo sapiens	INH	%	-0.3
	18283277	CHEMBL4120862	Inhibition of CLK2 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	0.7	CHEMBL4225	Homo sapiens	INH	%	0.7
	18286294	CHEMBL4121529	Inhibition of recombinant GST-tagged human CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system at 10 uM in presence of ATP relative to control	B	CC(C)(C)NS(=O)(=O)c1ccc(-c2sc(C(=O)N[C@H]3C[C@H](C(=O)O)C3)nc2CC2CCCCC2)c2ccccc12		CHEMBL4128926	=	Inhibition	%	-1.0	CHEMBL4225	Homo sapiens	INH	%	-1.0
	18407893	CHEMBL4151449	Inhibition of human CLK2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	5.5	CHEMBL4225	Homo sapiens	Activity	%	5.5
	18407934	CHEMBL4151449	Inhibition of human CLK2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nc(CO)cc12		CHEMBL4173266	=	Activity	%	1.8	CHEMBL4225	Homo sapiens	Activity	%	1.8
	18407979	CHEMBL4151449	Inhibition of human CLK2 expressed in bacterial expression system assessed as remaining enzyme activity at 10 uM by kinome scan assay	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	2.4	CHEMBL4225	Homo sapiens	Activity	%	2.4
Active	18410242	CHEMBL4151862	Inhibition of human CLK2 expressed in bacterial expression system at 10 uM	B	COc1ccc(N)cc1-c1cnc(N)c(C(=O)c2cccnc2)n1		CHEMBL4167484		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	18410243	CHEMBL4151862	Inhibition of human CLK2 expressed in bacterial expression system at 10 uM	B	O=C(NCCN1CCOCC1)Nc1cccc(-c2ccc3nc(NC(=O)C4CC4)sc3n2)c1		CHEMBL4171209		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	18410244	CHEMBL4151862	Inhibition of human CLK2 expressed in bacterial expression system at 10 uM	B	C=CC(=O)Nc1ccc(C(=O)c2sc(Nc3ccc(N4CCN(C)CC4)cc3OC)nc2N)cc1		CHEMBL4168671		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	18410245	CHEMBL4151862	Inhibition of human CLK2 expressed in bacterial expression system at 10 uM	B	C=CC(=O)Nc1cccc(C(=O)c2sc(Nc3ccc(N4CCN(C)CC4)cc3)nc2N)c1		CHEMBL4172746		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	18440134	CHEMBL4156958	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	74.0	CHEMBL4225	Homo sapiens	Activity	%	74.0
	18449932	CHEMBL4178166	Inhibition of human CLK2 (138 to 499 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	76.0	CHEMBL4225	Homo sapiens	Activity	%	76.0
	18484574	CHEMBL4185737	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	88.0	CHEMBL4225	Homo sapiens	Activity	%	88.0
	18485047	CHEMBL4185737	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	99.0	CHEMBL4225	Homo sapiens	Activity	%	99.0
	18507834	CHEMBL4190928	Inhibition of recombinant human CLK2 (138 to end residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	13.0	CHEMBL4225	Homo sapiens	INH	%	13.0
	18590828	CHEMBL4224407	Inhibition of CLK2 (unknown origin)	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	IC50	nM	3.8	CHEMBL4225	Homo sapiens	IC50	nM	3.8
	18653695	CHEMBL4230056	Inhibition of CLK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	5.0	CHEMBL4225	Homo sapiens	INH	%	5.0
	18653696	CHEMBL4230056	Inhibition of CLK2 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	-1.0	CHEMBL4225	Homo sapiens	INH	%	-1.0
	18655598	CHEMBL4230637	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	73.0	CHEMBL4225	Homo sapiens	Activity	%	73.0
	18750325	CHEMBL4263636	Inhibition of recombinant human Clk2 expressed in Baculovirus expression system at 2 uM by Z'-LYTE assay	B	O=C(Cc1ccc(F)cc1)Nc1cncc(-c2cc(-c3cccnc3)cs2)c1		CHEMBL4290247	=	Inhibition	%	19.0	CHEMBL4225	Homo sapiens	INH	%	19.0
	18751142	CHEMBL4263772	Inhibition of CLK2 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	8.0	CHEMBL4225	Homo sapiens	INH	%	8.0
	18751677	CHEMBL4264226	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	38.0	CHEMBL4225	Homo sapiens	Activity	%	38.0
	18761720	CHEMBL4266500	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system in presence of 25 uM ATP	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	IC50	nM	175.0	CHEMBL4225	Homo sapiens	IC50	uM	0.175
	18761883	CHEMBL4266500	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system in presence of 25 uM ATP	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	IC50	nM	39.0	CHEMBL4225	Homo sapiens	IC50	uM	0.039
	18762114	CHEMBL4266658	Inhibition of CLK2 (unknown origin)	B	CN1C(=O)/C(=C\c2ccc3c(c2)OCO3)N=C1N		CHEMBL4291088	=	IC50	nM	910.0	CHEMBL4225	Homo sapiens	IC50	uM	0.91
	18811055	CHEMBL4275972	Inhibition of human GST-tagged CLK2 expressed in baculovirus expression system at 1.25 uM in presence of 100 uM ATP relative to control	B	O=C(Nc1cncc(-c2cc(-c3cccnc3)cs2)c1)C1CC1		CHEMBL4283503	=	Inhibition	%	21.0	CHEMBL4225	Homo sapiens	INH	%	21.0
	18857895	CHEMBL4307741	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	90.0	CHEMBL4225	Homo sapiens	Activity	%	90.0
	18892588	CHEMBL4314763	Inhibition of recombinant human CLK2 (138 to end residues) assessed as residual activity at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	131.5	CHEMBL4225	Homo sapiens	Activity	%	131.5
	18919451	CHEMBL4322808	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CLK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	318.0	CHEMBL4225	Homo sapiens	Kd	nM	318.0
	18919639	CHEMBL4322808	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged CLK2 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	396.0	CHEMBL4225	Homo sapiens	Kd	nM	396.0
	18921851	CHEMBL4323541	Inhibition of human recombinant CLK2 expressed in Baculovirus system	B	COC(=O)N1CCN([C@H]2CC[C@H](Nc3nc(Nc4cnn(C)c4)nc4ccc(CC#N)nc34)CC2)CC1		CHEMBL4582624	=	IC50	nM	1400.0	CHEMBL4225	Homo sapiens	IC50	uM	1.4
	18921852	CHEMBL4323541	Inhibition of human recombinant CLK2 expressed in Baculovirus system	B	COC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnc4ccc(C#N)cc34)CC2)CC1		CHEMBL4455718	=	IC50	nM	360.0	CHEMBL4225	Homo sapiens	IC50	uM	0.36
Not Determined	18929790	CHEMBL4325342	Inhibition of GST-tagged human recombinant CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133		IC50			CHEMBL4225	Homo sapiens	IC50		
	18929805	CHEMBL4325357	Inhibition of GST-tagged human recombinant CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system at 1000 nM by Z'-LYTE assay relative to control	B	Cc1n[nH]cc1-c1cc2nc([C@@H]3CCCCN3)[nH]c(=O)c2s1.Cl.Cl		CHEMBL4439133	=	Inhibition	%	88.0	CHEMBL4225	Homo sapiens	INH	%	88.0
	18937839	CHEMBL4327650	Inhibition of human CLK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	93.86	CHEMBL4225	Homo sapiens	Activity	%	93.86
	18937840	CHEMBL4327650	Inhibition of human CLK2 assessed as residual activity at 1 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	102.16	CHEMBL4225	Homo sapiens	Activity	%	102.16
	18938490	CHEMBL4328010	Inhibition of human CLK2 assessed as residual activity at 100 uM using MBP as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4225	Homo sapiens	Activity	%	65.0
	18938866	CHEMBL4328374	Inhibition of human CLK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.52	CHEMBL4225	Homo sapiens	IC50	10'-9M	5.52
	18958813	CHEMBL4333332	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	60.0	CHEMBL4225	Homo sapiens	Activity	%	60.0
	18964195	CHEMBL4335034	Inhibition of recombinant human CLK2 (138 to end residues) assessed as residual activity at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	39.0	CHEMBL4225	Homo sapiens	Activity	%	39.0
	18964196	CHEMBL4335034	Inhibition of recombinant human CLK2 (138 to end residues) assessed as residual activity at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	38.0	CHEMBL4225	Homo sapiens	Activity	%	38.0
	18971852	CHEMBL4336862	Inhibition of recombinant human CLK2 (138 to end residues) assessed as residual activity at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	30.0	CHEMBL4225	Homo sapiens	Activity	%	30.0
	19005786	CHEMBL4344393	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c3ccnc(C)c3n(CCCC(N)=O)c2c1		CHEMBL4474836	=	Activity	%	3.2	CHEMBL4225	Homo sapiens	Activity	%	3.2
	19005787	CHEMBL4344393	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	2.4	CHEMBL4225	Homo sapiens	Activity	%	2.4
	19005788	CHEMBL4344393	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual bound protein level at 10 uM by Kinomescan method relative to control	B	COc1ccc2c(c1)[nH]c1c(CO)nccc12		CHEMBL4066450	=	Activity	%	5.5	CHEMBL4225	Homo sapiens	Activity	%	5.5
	19029876	CHEMBL4349111	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system by Z'-LYTE assay	B	C[C@@H](Oc1cc(C(=O)N(C)C)ccc1Nc1nc(O[C@H]2CC[C@@](C)(O)CC2)c2c(Cl)c[nH]c2n1)C(F)(F)F		CHEMBL4546504	=	IC50	nM	0.261	CHEMBL4225	Homo sapiens	IC50	nM	0.261
	19029877	CHEMBL4349112	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system at 3 uM by Z'-LYTE assay relative to control	B	C[C@@H](Oc1cc(C(=O)N(C)C)ccc1Nc1nc(O[C@H]2CC[C@@](C)(O)CC2)c2c(Cl)c[nH]c2n1)C(F)(F)F		CHEMBL4546504	>	Inhibition	%	80.0	CHEMBL4225	Homo sapiens	INH	%	80.0
Not Active	19039829	CHEMBL4351813	Inhibition of recombinant human CLK2 (138 to end residues) at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
Active	19041068	CHEMBL4352329	Inhibition of human CLK2 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	19059514	CHEMBL4357815	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL4225	Homo sapiens	Activity	%	100.0
	19090085	CHEMBL4365659	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	65.0	CHEMBL4225	Homo sapiens	Activity	%	65.0
	19091883	CHEMBL4366357	Inhibition of human CLK2 at 100 nM using MBP as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	10.25	CHEMBL4225	Homo sapiens	INH	%	10.25
	19144713	CHEMBL4377729	Inhibition of recombinant human CLK2 (138 to end residues) at 1 uM using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	12.0	CHEMBL4225	Homo sapiens	INH	%	12.0
	19147804	CHEMBL4379200	Inhibition of recombinant human CLK2 (138 to end residues) using YRRAAVPPSPSLSR as substrate incubated 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4225	Homo sapiens	IC50	uM	10.0
	19159342	CHEMBL4382446	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	1.7	CHEMBL4225	Homo sapiens	Activity	%	1.7
	19180999	CHEMBL4387210	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in Baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	92.5	CHEMBL4225	Homo sapiens	INH	%	92.5
	19181225	CHEMBL4387210	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in Baculovirus expression system at 0.1 uM using serine/threonine-6 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	98.0	CHEMBL4225	Homo sapiens	INH	%	98.0
	19191665	CHEMBL4389165	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	53.0	CHEMBL4225	Homo sapiens	INH	%	53.0
	19191828	CHEMBL4389642	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	86.0	CHEMBL4225	Homo sapiens	INH	%	86.0
	19199954	CHEMBL4391268	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	24.0	CHEMBL4225	Homo sapiens	Activity	%	24.0
	19251833	CHEMBL4401823	Inhibition of recombinant human GST-tagged CLK2 expressed in baculovirus expression system at 1 uM by kinomescan assay relative to control	B	Clc1cc(NCC2CC2)c2ncc(-c3ccc4[nH]ncc4c3)n2n1		CHEMBL4525939	>	Inhibition	%	90.0	CHEMBL4225	Homo sapiens	INH	%	90.0
	19251834	CHEMBL4401823	Inhibition of recombinant human GST-tagged CLK2 expressed in baculovirus expression system at 1 uM by kinomescan assay relative to control	B	O=C(CN1CCOCC1)N[C@H]1CC[C@H](Nc2cc(Cl)nn3c(-c4ccc5[nH]ncc5c4)cnc23)CC1		CHEMBL4565193	>	Inhibition	%	90.0	CHEMBL4225	Homo sapiens	INH	%	90.0
	19266379	CHEMBL4405329	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	19303723	CHEMBL4414195	Inhibition of N-terminal GST-tagged human CLK2 (138 to end residues) using SR-rich substrate and [gamma-33P]ATP incubated for 40 mins by scintillation counting method	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	IC50	nM	4.0	CHEMBL4225	Homo sapiens	IC50	nM	4.0
	19303738	CHEMBL4414169	Inhibition of recombinant human GST-tagged catalytic CLK2 expressed in baculovirus expression system assessed as reduction in enzyme activity at 5 uM in presence of ATP relative to control	B	O=C(O)c1ccc(Nc2nc(-c3ccc4ccccc4c3)cs2)cc1O		CHEMBL4520531	=	Inhibition	%	20.0	CHEMBL4225	Homo sapiens	INH	%	20.0
	19303855	CHEMBL4414288	Inhibition of CLK2 (unknown origin) assessed as residual activity at 50 uM relative to control	B	O=C(O)c1ccc(Nc2nc(-c3cccc(Br)c3)cs2)cc1		CHEMBL4458300	=	Activity	%	67.0	CHEMBL4225	Homo sapiens	Activity	%	67.0
	19303871	CHEMBL4414274	Inhibition of recombinant human CLK2 in presence of ATP by radiometric filter-binding assay	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	IC50	nM	4.0	CHEMBL4225	Homo sapiens	IC50	nM	4.0
Active	19368550	CHEMBL4424372	Inhibition of CLK2 (unknown origin) at 5 uM relative to control	B	CC(C1CC1)n1cnc2c(NCc3cccc(C(F)(F)F)c3)nc(NCCN(C)C)nc21		CHEMBL4462126		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	19411477	CHEMBL4427688	Inhibition of CLK2 (unknown origin)	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL4225	Homo sapiens	IC50	uM	5.0
	19411533	CHEMBL4427632	Inhibition of CLK2 (unknown origin) at 1 uM relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL4225	Homo sapiens	INH	%	16.0
	19476561	CHEMBL4479709	Inhibition of recombinant human GST-tagged CLK2 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	<	IC50	nM	10.0	CHEMBL4225	Homo sapiens	IC50	nM	10.0
	19476661	CHEMBL4479709	Inhibition of recombinant human GST-tagged CLK2 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	<	IC50	nM	10.0	CHEMBL4225	Homo sapiens	IC50	nM	10.0
	19476761	CHEMBL4479709	Inhibition of recombinant human GST-tagged CLK2 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	14.0	CHEMBL4225	Homo sapiens	IC50	nM	14.0
	19476861	CHEMBL4479709	Inhibition of recombinant human GST-tagged CLK2 catalytic domain expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	110.0	CHEMBL4225	Homo sapiens	IC50	nM	110.0
	20600490	CHEMBL4603442	Inhibition of recombinant human GST-tagged CLK2 catalytic domain (137 to 498 residues) expressed in baculovirus expression system using serine/threonine-6 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4225	Homo sapiens	IC50	uM	100.0
	20606250	CHEMBL4604989	Inhibition of CLK2 (unknown origin) at 2 uM caliper microfluidic kinase assay relative to control	B	CCN1CCN(C(=O)Nc2cc(-c3cn(C4CCOCC4)c4cnccc34)ccn2)CC1		CHEMBL4636064	>	Inhibition	%	95.0	CHEMBL4225	Homo sapiens	INH	%	95.0
	20680065	CHEMBL4622613	Inhibition of recombinant human partial length CLK2 (144 to 484 residues) expressed in bacterial expression system at 1 uM by DiscoverX competition binding assay relative to control	B	Cc1cccc(N(C)c2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL4637319	=	Inhibition	%	59.0	CHEMBL4225	Homo sapiens	INH	%	59.0
	22392026	CHEMBL4667121	Inhibition of recombinant human GST-tagged CLK2 (137 to 498 residues) expressed in baculovirus expression system using Ser/Thr 06 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	24.0	CHEMBL4225	Homo sapiens	INH	%	24.0
	22419430	CHEMBL4673026	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	Cc1cc(-c2nc(C(=O)Nc3cc4oc(N5CCOCC5)nc4nc3N3CC[C@@H](O)C3)co2)ccn1		CHEMBL4783351	>=	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	22423705	CHEMBL4674428	Inhibition of human CLK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	82.31	CHEMBL4225	Homo sapiens	Activity	%	82.31
	22423706	CHEMBL4674428	Inhibition of human CLK2 using MBP as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	73.6	CHEMBL4225	Homo sapiens	Activity	%	73.6
Active	22424846	CHEMBL4674743	Inhibition of CLK2 (unknown origin) at 0.5 uM	B	COc1ccc2c(c1)CC(C)(C)c1c(N)ncnc1-2		CHEMBL4741586		Inhibition	%		CHEMBL4225	Homo sapiens	INH		
	22488124	CHEMBL4689200	Inhibition of recombinant human CLK2 (138 to end residues) using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate incubated for 40 mins in presence of [gamma33P-ATP] by scintillation counting analysis	B	Cc1ccc(-n2cc(COc3cccc4cnc(Nc5cccc(Cl)c5)nc34)nn2)c([N+](=O)[O-])c1		CHEMBL4783398	=	IC50	nM	27.0	CHEMBL4225	Homo sapiens	IC50	nM	27.0
	22840052	CHEMBL4719517	Inhibition of CLK2 (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	IC50	nM	32.5	CHEMBL4225	Homo sapiens	IC50	nM	32.5
	22840053	CHEMBL4719517	Inhibition of CLK2 (unknown origin)	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(Cl)cc4Cl)c3c2s1		CHEMBL2386747	=	IC50	nM	88.8	CHEMBL4225	Homo sapiens	IC50	nM	88.8
	22843437	CHEMBL4720434	Inhibition of human CLK2 assessed as residual activity using MBP as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	104.05	CHEMBL4225	Homo sapiens	Activity	%	104.05
	22843787	CHEMBL4720773	Inhibition of human CLK2 using MBP as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	2.86	CHEMBL4225	Homo sapiens	IC50	10^-9M	2.86
	22844673	CHEMBL4721348	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	28.29	CHEMBL4225	Homo sapiens	Activity	%	28.29
	22886546	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	>=	Delta Tm	degrees C	4.0	CHEMBL4225	Homo sapiens	deltaTm	degrees C	4.0
	22886547	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Delta Tm	degrees C	8.4	CHEMBL4225	Homo sapiens	deltaTm	degrees C	8.4
	22886548	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	O=C1NCc2ccc3c(-c4cccc(Cl)c4)c[nH]c3c21		CHEMBL4796016	=	Delta Tm	degrees C	4.9	CHEMBL4225	Homo sapiens	deltaTm	degrees C	4.9
	22886549	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	=	Delta Tm	degrees C	7.0	CHEMBL4225	Homo sapiens	deltaTm	degrees C	7.0
	22886550	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	Cn1cc(-c2ccc3occ(-c4cccc(Oc5ccccc5)c4)c3n2)cn1		CHEMBL4751637	=	Delta Tm	degrees C	8.3	CHEMBL4225	Homo sapiens	deltaTm	degrees C	8.3
	22886551	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Delta Tm	degrees C	12.0	CHEMBL4225	Homo sapiens	deltaTm	degrees C	12.0
	22886552	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	CC(=O)c1cccc(-c2cnc3ccc(NCC4CC4)nn23)c1		CHEMBL200528	>	Delta Tm	degrees C	4.0	CHEMBL4225	Homo sapiens	deltaTm	degrees C	4.0
	22886553	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	Nc1nccc(-c2ccc3noc(-c4ccc(Cl)cc4)c3c2)n1		CHEMBL409038	>	Delta Tm	degrees C	6.0	CHEMBL4225	Homo sapiens	deltaTm	degrees C	6.0
	22886554	CHEMBL4728260	Binding affinity to CLK2 (unknown origin) assessed as change in melting temperature at 10 uM incubated for 10 mins using SYPRO orange dye by RT-PCR-based fluorescence assay	B	Cn1c2c(c3ccc(Cl)c(Cl)c31)C(C#N)C1(CCNCC1)NC2=O		CHEMBL1945559	=	Delta Tm	degrees C	3.5	CHEMBL4225	Homo sapiens	deltaTm	degrees C	3.5
	22886577	CHEMBL4728280	Binding affinity to CLK2 (unknown origin)	B	CCN1/C(=C\C(C)=O)Sc2ccc(OC)cc21		CHEMBL1349996	<	Kd	nM	100.0	CHEMBL4225	Homo sapiens	Kd	nM	100.0
	22886591	CHEMBL4728294	Inhibition of human CLK2 assessed as residual activity at 1 uM relative to control	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	<	Activity	%	25.0	CHEMBL4225	Homo sapiens	Activity	%	25.0
	22886600	CHEMBL4728303	Inhibition of human CLK2 by radiometric assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	=	IC50	nM	20.0	CHEMBL4225	Homo sapiens	IC50	nM	20.0
	22932946	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5ccncc5)c4)c3n2)cn1		CHEMBL4754195	=	IC50	nM	20.0	CHEMBL4225	Homo sapiens	IC50	nM	20.0
	22932947	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(C5CCNCC5)c4)c3n2)cn1		CHEMBL4791451	=	IC50	nM	90.0	CHEMBL4225	Homo sapiens	IC50	nM	90.0
	22932948	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CN1CCC(c2cccc(-c3coc4ccc(-c5cnn(C)c5)nc34)c2)CC1		CHEMBL4741919	=	IC50	nM	667.0	CHEMBL4225	Homo sapiens	IC50	nM	667.0
	22932949	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5cn[nH]c5)c4)c3n2)cn1		CHEMBL4789951	=	IC50	nM	37.0	CHEMBL4225	Homo sapiens	IC50	nM	37.0
	22932950	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2cccc(-c3coc4ccc(-c5cnn(C)c5)nc34)c2)cn1		CHEMBL4797457	=	IC50	nM	16.0	CHEMBL4225	Homo sapiens	IC50	nM	16.0
	22932951	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4cccc(-c5cc[nH]n5)c4)c3n2)cn1		CHEMBL4762964	=	IC50	nM	16.0	CHEMBL4225	Homo sapiens	IC50	nM	16.0
	22932952	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4790030	=	IC50	nM	72.0	CHEMBL4225	Homo sapiens	IC50	nM	72.0
	22932953	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	c1ccc2cc(-c3coc4ccc(-c5cn[nH]c5)nc34)ccc2c1		CHEMBL4750420	=	IC50	nM	25.0	CHEMBL4225	Homo sapiens	IC50	nM	25.0
	22932954	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	COc1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4743939	=	IC50	nM	39.0	CHEMBL4225	Homo sapiens	IC50	nM	39.0
	22932955	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2coc3ccc(-c4cn[nH]c4)nc23)cn1		CHEMBL4790791	=	IC50	nM	176.0	CHEMBL4225	Homo sapiens	IC50	nM	176.0
	22932956	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4777288	=	IC50	nM	1427.0	CHEMBL4225	Homo sapiens	IC50	nM	1427.0
	22932957	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC1(c2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)CC1		CHEMBL4740998	=	IC50	nM	155.0	CHEMBL4225	Homo sapiens	IC50	nM	155.0
	22932958	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	C=C(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4743730	=	IC50	nM	40.0	CHEMBL4225	Homo sapiens	IC50	nM	40.0
	22932959	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	c1ccc(Cc2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)cc1		CHEMBL4789373	=	IC50	nM	1845.0	CHEMBL4225	Homo sapiens	IC50	nM	1845.0
	22932960	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC(C)Cc1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4794825	=	IC50	nM	827.0	CHEMBL4225	Homo sapiens	IC50	nM	827.0
	22932961	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	c1ccc(-c2ccc(-c3coc4ccc(-c5cn[nH]c5)nc34)cc2)cc1		CHEMBL4778370	=	IC50	nM	529.0	CHEMBL4225	Homo sapiens	IC50	nM	529.0
	22932962	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	c1n[nH]cc1-c1ccc2occ(-c3ccc(C4CCCCC4)cc3)c2n1		CHEMBL4777540	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932963	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	c1n[nH]cc1-c1ccc2occ(-c3ccc(C45CC6CC(CC(C6)C4)C5)cc3)c2n1		CHEMBL4758047	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932964	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)cn1		CHEMBL4747210	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932965	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1cc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)nn1		CHEMBL4790254	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932966	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cc[nH]n4)nc23)cc1		CHEMBL4800422	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932967	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	Cn1ccc(-c2ccc3occ(-c4ccc(C(C)(C)C)cc4)c3n2)n1		CHEMBL4793177	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932968	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4nn[nH]n4)nc23)cc1		CHEMBL4777533	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932969	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cnsc4)nc23)cc1		CHEMBL4747520	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932970	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cnn(CCN5CCOCC5)c4)nc23)cc1		CHEMBL4795812	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22932971	CHEMBL4739016	Inhibition of human recombinant CLK2 using YRRAAVPPSPSLSR substrate by radiometric scintillation assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]n4)nc23)cc1		CHEMBL4778153	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22933170	CHEMBL4739026	Inhibition of CLK2 (unknown origin) by NanoBRET cellular target engagement assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]c4)nc23)cc1		CHEMBL4777288	=	IC50	nM	18000.0	CHEMBL4225	Homo sapiens	IC50	nM	18000.0
	22933171	CHEMBL4739026	Inhibition of CLK2 (unknown origin) by NanoBRET cellular target engagement assay	B	CC(C)(C)c1ccc(-c2coc3ccc(-c4cn[nH]n4)nc23)cc1		CHEMBL4778153	>	IC50	nM	50000.0	CHEMBL4225	Homo sapiens	IC50	nM	50000.0
	22933172	CHEMBL4739026	Inhibition of CLK2 (unknown origin) by NanoBRET cellular target engagement assay	B	COC(=N)c1nc2ccc3ncnc(Nc4ccc(OC)cc4F)c3c2s1		CHEMBL3894571	>	IC50	nM	3000.0	CHEMBL4225	Homo sapiens	IC50	nM	3000.0
	22939026	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1cccnc1)c1cccnc1		CHEMBL4783473	=	EC50	nM	23.0	CHEMBL4225	Homo sapiens	EC50	uM	0.023
	22939027	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1cncc(-c2cccc(F)c2)c1)c1cncc(F)c1		CHEMBL4778931	=	EC50	nM	72.0	CHEMBL4225	Homo sapiens	EC50	uM	0.07200000000000001
	22939028	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(OCCN3CCCC3)nc2)cn1		CHEMBL4743606	=	EC50	nM	24.0	CHEMBL4225	Homo sapiens	EC50	uM	0.024
	22939029	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(CN(C)C)cc2)c1		CHEMBL4760170	=	EC50	nM	57.0	CHEMBL4225	Homo sapiens	EC50	uM	0.057
	22939030	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(OCCN3CCCC3)nc2)c1		CHEMBL4747048	=	EC50	nM	20.0	CHEMBL4225	Homo sapiens	EC50	uM	0.02
	22939031	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(N3CCC(F)(F)C3)nc2)c1		CHEMBL4781361	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939032	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)nc2)c1		CHEMBL4788757	=	EC50	nM	14.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013999999999999999
	22939033	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc3c(c2)CCNC3)c1		CHEMBL4749673	=	EC50	nM	27.0	CHEMBL4225	Homo sapiens	EC50	uM	0.027000000000000003
	22939034	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc3c(c2)CCN(C)C3)c1		CHEMBL4743693	=	EC50	nM	45.0	CHEMBL4225	Homo sapiens	EC50	uM	0.045
	22939035	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Oc1cncc(C(=O)Nc2c[nH]nc2C(=O)Nc2ccc(OC3CCN(C)CC3)nc2)c1		CHEMBL4790819	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939036	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1ccc(N2CCCC2)nc1)c1cncc(OC2CCNCC2)c1		CHEMBL4762971	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939037	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1ccc(N2CCC(F)(F)C2)nc1)c1cncc(OC2CCNCC2)c1		CHEMBL4785525	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939038	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1ccc(N2CCCCC2)nc1)c1cncc(OC2CCNCC2)c1		CHEMBL4785414	=	EC50	nM	14.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013999999999999999
	22939039	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1C(=O)Nc1cncc(-c2cccc(F)c2)c1)c1cncc(OC2CCNCC2)c1		CHEMBL4783818	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939040	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1c[nH]nc1-c1nc2c(-c3cccc(F)c3)cccc2[nH]1)c1cccnc1		CHEMBL4788972	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939041	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)Nc1c[nH]nc1C(=O)Nc1ccc(C(F)(F)F)nc1		CHEMBL4745480	=	EC50	nM	95.0	CHEMBL4225	Homo sapiens	EC50	uM	0.095
	22939042	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]cc1/C=C/c1cccnc1		CHEMBL4756587	=	EC50	nM	17.0	CHEMBL4225	Homo sapiens	EC50	uM	0.017
	22939043	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1[nH]nc(C(=O)Nc2ccc(CN3CCCC3)cc2)c1/C=C/c1cccnc1		CHEMBL4798742	=	EC50	nM	20.0	CHEMBL4225	Homo sapiens	EC50	uM	0.02
	22939044	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OCCN2CCCC2)cc1)c1n[nH]cc1/C=C/c1cccnc1		CHEMBL4797418	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939045	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCNCC2)nc1)c1n[nH]cc1/C=C/c1cccnc1		CHEMBL4777426	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939046	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(NC(=O)c3n[nH]cc3/C=C/c3cccnc3)cn2)CC1		CHEMBL4799387	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939047	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1[nH]nc(C(=O)Nc2ccc(OC3CCN(C)CC3)nc2)c1/C=C/c1cccnc1		CHEMBL4799892	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939048	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2nnc(-c3n[nH]cc3/C=C/c3cccnc3)o2)cc1		CHEMBL4756490	=	EC50	nM	27.0	CHEMBL4225	Homo sapiens	EC50	uM	0.027000000000000003
	22939049	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]cc2/C=C/c2cncc(CN3CCCCC3)c2)cn1		CHEMBL4785138	=	EC50	nM	26.0	CHEMBL4225	Homo sapiens	EC50	uM	0.026000000000000002
	22939050	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]cc4/C=C/c4cncc(F)c4)nc23)CC1		CHEMBL4743901	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939051	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cccc3[nH]c(-c4n[nH]cc4/C=C/c4cncc(CN5CCCC5)c4)nc23)c1		CHEMBL4788267	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939052	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCC(F)(F)C2)nc1)c1n[nH]cc1C#Cc1cccnc1		CHEMBL4797665	=	EC50	nM	32.0	CHEMBL4225	Homo sapiens	EC50	uM	0.032
	22939053	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OCCN2CCCC2)nc1)c1n[nH]cc1C#Cc1cccnc1		CHEMBL4787812	=	EC50	nM	46.0	CHEMBL4225	Homo sapiens	EC50	uM	0.046
	22939054	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C#Cc2c[nH]nc2C(=O)Nc2ccc(N3CCNCC3)nc2)c1		CHEMBL4781302	=	EC50	nM	25.0	CHEMBL4225	Homo sapiens	EC50	uM	0.025
	22939055	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C#Cc2c[nH]nc2C(=O)Nc2ccc(OC3CCN(C)CC3)nc2)c1		CHEMBL4747378	=	EC50	nM	18.0	CHEMBL4225	Homo sapiens	EC50	uM	0.018000000000000002
	22939056	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(C#Cc2c[nH]nc2C(=O)Nc2ccc(OCCN3CCCC3)nc2)c1		CHEMBL4757799	=	EC50	nM	28.0	CHEMBL4225	Homo sapiens	EC50	uM	0.027999999999999997
	22939057	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]cc1C#Cc1cncc(OC2CCNCC2)c1		CHEMBL4756455	=	EC50	nM	38.0	CHEMBL4225	Homo sapiens	EC50	uM	0.038
	22939058	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]cc4C#Cc4cncc(OC5CCNCC5)c4)nc23)c1		CHEMBL4763219	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939059	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	=	EC50	nM	14.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013999999999999999
	22939060	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939061	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N4CC(C)(N)C4)n3)cc12		CHEMBL4747452	=	EC50	nM	70.0	CHEMBL4225	Homo sapiens	EC50	uM	0.07
	22939062	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC1(N)CN(c2cncc(-c3ccc4[nH]nc(C)c4c3)n2)C1		CHEMBL4762186	=	EC50	nM	43.0	CHEMBL4225	Homo sapiens	EC50	uM	0.043
	22939063	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N4CCC[C@H](N)C4)n3)cc12		CHEMBL4794291	=	EC50	nM	35.0	CHEMBL4225	Homo sapiens	EC50	uM	0.035
	22939064	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N4CCC(O)CC4)n3)cc12		CHEMBL4753492	=	EC50	nM	25.0	CHEMBL4225	Homo sapiens	EC50	uM	0.025
	22939065	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2cc(F)c(-c3cncc(CN4CCCCC4)n3)cc12		CHEMBL4798330	=	EC50	nM	45.0	CHEMBL4225	Homo sapiens	EC50	uM	0.045
	22939066	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(NC4CCNCC4)n3)cc12		CHEMBL4755807	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939067	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N[C@H]4CCNC[C@@H]4F)n3)cc12		CHEMBL4741792	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939068	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N[C@H]4CC[C@H](O)CC4)n3)cc12		CHEMBL4791039	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939069	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(O[C@H]4CCNC[C@@H]4F)n3)cc12		CHEMBL4761714	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939070	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(O[C@H]4CCNC[C@H]4F)n3)cc12		CHEMBL4748817	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939071	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2cc(F)c(-c3cncc(O[C@H]4CCNC[C@@H]4F)n3)cc12		CHEMBL4785637	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939072	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(O[C@H]4CCNCC4(F)F)n3)cc12		CHEMBL4764315	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939073	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(NCC4(F)CNC4)n3)cc12		CHEMBL4798950	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939074	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OCC4(F)CNC4)n3)cc12		CHEMBL4796297	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939075	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H]4Cc5ccccc5CN4)n3)cc12		CHEMBL4749143	=	EC50	nM	27.0	CHEMBL4225	Homo sapiens	EC50	uM	0.027000000000000003
	22939076	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(N[C@H](CO)Cc4cccc(C(F)(F)F)c4)n3)cc12		CHEMBL4794100	=	EC50	nM	37.0	CHEMBL4225	Homo sapiens	EC50	uM	0.037000000000000005
	22939077	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@H](N)Cc4ccccc4)n3)cc12		CHEMBL4780416	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939078	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1n[nH]c2ccc(-c3cc(OC[C@H](N)Cc4ccccc4)cnn3)cc12		CHEMBL4754499	=	EC50	nM	19.0	CHEMBL4225	Homo sapiens	EC50	uM	0.019
	22939079	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(C(=O)Nc4cccnc4)c3c2)c1		CHEMBL4750147	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939080	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(NC(=O)C6CC6)c5)cc34)cn2)CC1		CHEMBL4742870	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939081	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(NC(=O)N4CCOCC4)c3)cc12		CHEMBL4790121	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939082	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(NC(=O)c6c(F)cccc6F)c5)cc34)cn2)CC1		CHEMBL4745311	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939083	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)OCCCNC(=O)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4744152	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939084	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(N[C@H]1C[C@@H]1c1ccccc1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4776900	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939085	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cc2[nH]nc(C(=O)Nc3ccc(CN4CCCC4)cc3)c2cc1-c1cccnc1		CHEMBL4797560	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939086	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL4753797	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939087	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(Cc2ccc(NC(=O)c3n[nH]c4ccc(-c5cccnc5)cc34)cn2)CC1		CHEMBL4760183	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939088	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4778412	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939089	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccnnc1)c1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL4746176	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939090	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cccnc3F)cc12		CHEMBL4790477	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939091	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(NC(=O)c3n[nH]c4ccc(-c5ccc(N)nc5)cc34)cc2)CC1		CHEMBL4788156	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939092	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CO)c4)cc23)cn1		CHEMBL4797346	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939093	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCCC2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCC4)c3)cc12		CHEMBL4800437	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939094	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CC(CO)(CO)C4)c3)cc12		CHEMBL4780576	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939095	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCC5)c4)cc23)c1		CHEMBL4795039	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939096	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCC5)c4)cc23)cn1		CHEMBL4799007	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939097	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCC(F)(F)C5)c4)cc23)cn1		CHEMBL4779515	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939098	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(CN6CCC(F)(F)C6)c5)cc34)cn2)CC1		CHEMBL4761354	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939099	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC(=O)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4792282	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939100	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)NC(=O)c1n[nH]c2ccc(-c3cncc(CN4CCC(F)(F)CC4)c3)cc12		CHEMBL4785348	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939101	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(N[C@H]1C[C@@H]1c1ccccc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4755660	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939102	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(NCc1cc(F)cc(F)c1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4764842	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939103	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4754606	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939104	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cncc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)c1		CHEMBL4776499	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939105	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccnc(C(F)(F)F)c1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4744530	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939106	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4800084	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939107	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Oc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4762155	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939108	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OC(CO)CO)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4752327	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939109	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCN(C)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4742725	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939110	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1ccncc1NC(=O)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4756198	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939111	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccc1NC(=O)C1CC1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4744426	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939112	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC(=O)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4779592	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939113	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(C(=O)N2CCCC2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4752625	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939114	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)c1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4788275	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939115	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CC(CO)(CO)C2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4782319	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939116	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(N2CCC(O)CC2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4756030	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939117	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	C[C@H]1CN(c2ccc(NC(=O)c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cn2)C[C@@H](C)O1		CHEMBL4794727	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939118	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(-c2ccccc2)nc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4743940	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939119	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccnnc1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4748995	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939120	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccn1)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4743856	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939121	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1ncc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CCCCC5)c4)cc23)cn1		CHEMBL4786934	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939122	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc2c(c1)OCCO2)c1n[nH]c2ccc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4758259	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939123	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC1CCN(Cc2cncc(-c3ccc4[nH]nc(C(=O)Nc5cccnc5)c4c3)c2)CC1		CHEMBL4785547	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939124	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cnccn1)c1n[nH]c2ccc(-c3cncc(CN4CCCCCC4)c3)cc12		CHEMBL4747741	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939125	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CCS(=O)(=O)CC4)c3)cc12		CHEMBL4764569	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939126	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2ccc(-c3cncc(CN4CC5CC(C4)O5)c3)cc12		CHEMBL4743240	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939127	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Oc1ccc(NC(=O)c2n[nH]c3ccc(-c4cncc(CN5CC6CC(C5)O6)c4)cc23)cn1		CHEMBL4743194	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939128	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cncnc3)cc12		CHEMBL4755716	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939129	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cnccn3)cc12		CHEMBL4743500	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939130	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)NC(=O)c1n[nH]c2ccc(-c3cncc(NC4CCNCC4)n3)cc12		CHEMBL4762097	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939131	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(NC(=O)c3n[nH]c4ccc(-c5cnn(C)c5)cc34)cn2)CC1		CHEMBL4796085	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939132	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(C(=O)Nc4ccc(CN5CCCC5)cc4)n[nH]c3cc2F)cn1		CHEMBL4741843	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939133	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(C(=O)Nc4ccc(OCCN5CCCC5)cc4)n[nH]c3cc2F)cn1		CHEMBL4756656	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939134	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Nc2ccc(NC(=O)c3n[nH]c4cc(F)c(-c5cnn(C)c5)cc34)cn2)CC1		CHEMBL4794020	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939135	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(NC(=O)c3n[nH]c4cc(F)c(-c5cnn(C)c5)cc34)cn2)CC1		CHEMBL4751049	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939136	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ncc(NC(=O)c3n[nH]c4cc(F)c(-c5cnn(C)c5)cc34)cc2F)CC1		CHEMBL4778878	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939137	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(C(=O)Nc4ccc5c(c4)CNC5)n[nH]c3cc2F)cn1		CHEMBL4744452	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939138	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(CN2CCCC2)cc1)c1n[nH]c2ccc(-c3cnn(C4CC4)c3)cc12		CHEMBL4744357	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939139	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(NC(=O)c2n[nH]c3ccc(-c4cnn(C5CCN(C)CC5)c4)cc23)s1		CHEMBL4777667	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939140	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(NC(=O)c2n[nH]c3ccc(-c4cnc(C)n4C)cc23)s1		CHEMBL4756183	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939141	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1ccc(OC(F)F)cc1)c1n[nH]c2ccc(-c3cnc4n3CCNC4)cc12		CHEMBL4747908	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939142	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccc(OC5CCN(C)CC5)cc4)c3c2)sn1		CHEMBL4789136	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939143	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cccnc1)c1n[nH]c2cnc(-c3cncc(CN4CCCCC4)c3)cc12		CHEMBL4793803	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939144	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cccnc6)cc45)nc23)c1		CHEMBL4778616	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939145	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4750399	=	EC50	nM	23.0	CHEMBL4225	Homo sapiens	EC50	uM	0.023
	22939146	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4758546	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939147	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4745586	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939148	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5cncc(-c6cccc(F)c6)c5[nH]4)c3c2)c1		CHEMBL4297639	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939149	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3c2)c1		CHEMBL4788446	=	EC50	nM	37.0	CHEMBL4225	Homo sapiens	EC50	uM	0.037000000000000005
	22939150	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4757954	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939151	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4746269	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939152	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1)N1CCOCC1		CHEMBL4799714	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939153	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4782145	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939154	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4763425	=	EC50	nM	53.0	CHEMBL4225	Homo sapiens	EC50	uM	0.053
	22939155	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4755351	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939156	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4781555	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939157	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4783783	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939158	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4755308	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939159	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3c2)c1		CHEMBL4743067	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939160	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4782720	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939161	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3n2)c1		CHEMBL4741100	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939162	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4740064	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939163	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3n2)c1		CHEMBL4786124	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939164	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4757172	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939165	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4765065	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939166	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)nc23)c1		CHEMBL4761890	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939167	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)nc23)c1		CHEMBL4798488	=	EC50	nM	21.0	CHEMBL4225	Homo sapiens	EC50	uM	0.021
	22939168	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3c2)c1		CHEMBL4747400	=	EC50	nM	17.0	CHEMBL4225	Homo sapiens	EC50	uM	0.017
	22939169	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3n2)c1		CHEMBL4743122	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939170	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4753319	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939171	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Oc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4777958	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939172	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4764129	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939173	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3n2)c1		CHEMBL4795264	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939174	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)c3n2)c1		CHEMBL4788759	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939175	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4747036	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939176	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4755870	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939177	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(OC7CCNCC7)c6)cc45)nc23)c1		CHEMBL4762436	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939178	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2ccnc3[nH]c(-c4n[nH]c5ncc(-c6cn[nH]c6)cc45)nc23)c1		CHEMBL4785555	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939179	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cn[nH]c6)nc45)nc23)c1		CHEMBL4764261	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939180	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)cn1		CHEMBL4753975	=	EC50	nM	14.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013999999999999999
	22939181	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)cn1		CHEMBL4762500	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939182	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cc3c(-c4nc5c(-c6cccc(F)c6)cncc5[nH]4)n[nH]c3cn2)cn1		CHEMBL4760846	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939183	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3n2)n1C		CHEMBL4752659	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939184	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)n1C		CHEMBL4791974	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939185	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1		CHEMBL4783909	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939186	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1		CHEMBL4789284	=	EC50	nM	17.0	CHEMBL4225	Homo sapiens	EC50	uM	0.017
	22939187	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3n2)c1		CHEMBL4740862	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939188	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1		CHEMBL4789715	=	EC50	nM	32.0	CHEMBL4225	Homo sapiens	EC50	uM	0.032
	22939189	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)cc6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4747931	=	EC50	nM	28.0	CHEMBL4225	Homo sapiens	EC50	uM	0.027999999999999997
	22939190	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1		CHEMBL4761232	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939191	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cccc5[nH]4)c3n2)c1		CHEMBL4793856	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939192	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4758175	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939193	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4795951	=	EC50	nM	33.0	CHEMBL4225	Homo sapiens	EC50	uM	0.033
	22939194	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)nccc5[nH]4)c3n2)c1		CHEMBL4763852	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939195	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3n2)c1		CHEMBL4786746	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939196	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3n2)c1		CHEMBL4755429	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939197	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4751675	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939198	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4792507	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939199	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3n2)c1		CHEMBL4753382	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939200	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cccc5[nH]4)c3n2)c1)C(F)(F)F		CHEMBL4748619	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939201	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)ccnc5[nH]4)c3n2)c1)C(F)(F)F		CHEMBL4776672	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939202	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4790668	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939203	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4749962	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939204	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4nc5c(-c6cccnc6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4759401	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939205	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cccc5[nH]4)c3n2)c1		CHEMBL4744838	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939206	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4745260	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939207	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4nc5c(-c6cccnc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4747019	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939208	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)nccc5[nH]4)c3n2)c1		CHEMBL4793989	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939209	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3n2)c1		CHEMBL4784533	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939210	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4777787	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939211	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4762778	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939212	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4786522	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939213	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4755029	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939214	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4754321	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939215	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4756460	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939216	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4755315	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939217	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4786564	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939218	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)nccc5[nH]4)c3n2)c1		CHEMBL4763435	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939219	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)cncc5[nH]4)c3n2)c1		CHEMBL4797078	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939220	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4755713	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939221	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)cncc5[nH]4)c3n2)c1		CHEMBL4760198	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939222	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)ccnc5[nH]4)c3n2)c1)C1CCCCC1		CHEMBL4793590	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939223	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccn6)nccc5[nH]4)c3c2)c1		CHEMBL4744253	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939224	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4nc5ccccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4764391	=	EC50	nM	22.0	CHEMBL4225	Homo sapiens	EC50	uM	0.022000000000000002
	22939225	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5cnccc5[nH]4)c3n2)c1		CHEMBL4744274	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939226	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5ccncc5[nH]4)c3c2)c1		CHEMBL4783807	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939227	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5ccncc5[nH]4)c3n2)c1		CHEMBL4748882	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939228	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5ccncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4790964	=	EC50	nM	27.0	CHEMBL4225	Homo sapiens	EC50	uM	0.027000000000000003
	22939229	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC1CN(c2cncc(-c3ccc4[nH]nc(-c5nc6ccncc6[nH]5)c4c3)n2)C1		CHEMBL4747703	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939230	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3n2)c1		CHEMBL4795539	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939231	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)ccnc5[nH]4)c3n2)c1		CHEMBL4780323	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939232	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3c2)c1		CHEMBL4762565	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939233	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3c2)c1		CHEMBL4784341	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939234	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4752631	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939235	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5nc6c(N7CCCCC7)cncc6[nH]5)c4c3)c2)C1		CHEMBL4793999	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939236	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cc4c(-c5nc6c(N7CCCCC7)cncc6[nH]5)n[nH]c4cn3)c2)C1		CHEMBL4761624	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939237	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)cc45)nc23)CC1		CHEMBL4751115	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939238	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)CC1		CHEMBL4749876	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939239	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)CC1		CHEMBL4757486	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939240	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)CC1		CHEMBL4763984	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939241	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCN(C)CC6)cccc5[nH]4)c3c2)c1		CHEMBL4780561	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939242	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N7CCOCC7)c6)cc45)nc23)CC1		CHEMBL4760982	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939243	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cc(F)c(-c6cnn(C)c6)cc45)nc23)CC1		CHEMBL4789036	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939244	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCOCC6)cncc5[nH]4)c3c2)c1		CHEMBL4782737	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939245	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C(C)(C)C)c6)nc45)nc23)cn1		CHEMBL4779228	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939246	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C(C)(C)C)c6)nc45)nc23)cn1		CHEMBL4757581	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939247	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C(C)(C)C)c6)nc45)nc23)cn1		CHEMBL4759166	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939248	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)C)c6)cc45)nc23)cn1		CHEMBL4740717	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939249	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)C)c6)cc45)nc23)cn1		CHEMBL4747740	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939250	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)C)c6)nc45)nc23)cn1		CHEMBL4777273	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939251	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCC7)c6)nc45)nc23)cn1		CHEMBL4754156	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939252	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cn(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCC7)c6)nc45)nc23)cn1		CHEMBL4795493	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939253	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4749618	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939254	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)cccc5[nH]4)c3c2)c1		CHEMBL4750787	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939255	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3n2)c1		CHEMBL4786418	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939256	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4792061	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939257	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6ccoc6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4787474	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939258	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4761923	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939259	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4790036	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939260	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)nccc5[nH]4)c3c2)c1		CHEMBL4751276	=	EC50	nM	19.0	CHEMBL4225	Homo sapiens	EC50	uM	0.019
	22939261	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccoc6)nccc5[nH]4)c3c2)c1		CHEMBL4776491	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939262	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)nccc5[nH]4)c3n2)c1		CHEMBL4800320	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939263	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)cncc5[nH]4)c3n2)c1		CHEMBL4795987	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939264	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccoc6)ccnc5[nH]4)c3n2)c1		CHEMBL4755833	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939265	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5nc6c(-c7ccoc7)nccc6[nH]5)c4c3)c2)C1		CHEMBL4742707	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939266	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3nc4c(-c5ccsc5)nccc4[nH]3)c2c1		CHEMBL4797672	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939267	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccsc6)cccc5[nH]4)c3c2)c1		CHEMBL4779032	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939268	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)cncc5[nH]4)c3c2)c1		CHEMBL4783817	=	EC50	nM	16.0	CHEMBL4225	Homo sapiens	EC50	uM	0.016
	22939269	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)ccnc5[nH]4)c3c2)c1		CHEMBL4784131	=	EC50	nM	34.0	CHEMBL4225	Homo sapiens	EC50	uM	0.034
	22939270	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6ccsc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4786673	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939271	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)cncc5[nH]4)c3n2)c1		CHEMBL4760441	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939272	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccsc6)nccc5[nH]4)c3n2)c1		CHEMBL4747934	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939273	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cc3c(-c4nc5c(-c6ccsc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4755887	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939274	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CNCC7CCCC7)c6)cc45)nc23)cs1		CHEMBL4780659	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939275	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccsc6)cccc5[nH]4)c3c2)c1	Outside typical range	CHEMBL4764778	=	EC50	nM	0.0	CHEMBL4225	Homo sapiens	EC50	uM	0.0
	22939276	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6ccsc6)cncc5[nH]4)c3c2)c1		CHEMBL4788012	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939277	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5nc6c(-c7ccsc7)cncc6[nH]5)c4c3)c2)C1		CHEMBL4788582	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939278	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccs6)cccc5[nH]4)c3c2)c1		CHEMBL4793606	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939279	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3c2)c1		CHEMBL4744433	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939280	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3c2)c1		CHEMBL4746968	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939281	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4nc5c(-c6cccs6)nccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4777730	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939282	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3n2)c1		CHEMBL4742246	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939283	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1csc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CNCC7CCCC7)c6)cc45)nc23)c1		CHEMBL4749762	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939284	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cccs6)cncc5[nH]4)c3c2)c1		CHEMBL4760436	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939285	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cccc5[nH]4)c3n2)c1		CHEMBL4755388	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939286	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(F)s6)ccnc5[nH]4)c3c2)c1		CHEMBL4776636	=	EC50	nM	85.0	CHEMBL4225	Homo sapiens	EC50	uM	0.085
	22939287	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6ccc(F)s6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4798005	=	EC50	nM	18.0	CHEMBL4225	Homo sapiens	EC50	uM	0.018000000000000002
	22939288	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCCC7)c6)cc45)nc23)s1		CHEMBL4778226	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939289	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)cncc5[nH]4)c3n2)c1		CHEMBL4749262	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939290	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)cncc5[nH]4)c3n2)c1		CHEMBL4748599	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939291	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)nccc5[nH]4)c3n2)c1)C1CCC1		CHEMBL4764830	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939292	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)cncc5[nH]4)c3n2)c1)C1CCC1		CHEMBL4798360	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939293	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccc(Cl)s6)ccnc5[nH]4)c3n2)c1)C1CCC1		CHEMBL4754669	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939294	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Clc1ccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCC7)c6)nc45)nc23)s1		CHEMBL4758045	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939295	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)s1		CHEMBL4749604	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939296	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)cc45)nc23)s1		CHEMBL4753494	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939297	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)nc23)s1		CHEMBL4778624	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939298	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)nc23)s1		CHEMBL4756438	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939299	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)s1		CHEMBL4778742	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939300	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)nc45)nc23)s1		CHEMBL4754110	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939301	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C7CCC7)c6)cc45)nc23)s1		CHEMBL4790414	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939302	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cccnc6)cc45)nc23)c1		CHEMBL4740704	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939303	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)cncc5[nH]4)c3n2)c1		CHEMBL4759161	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939304	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4761965	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939305	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)cncc5[nH]4)c3c2)c1		CHEMBL4749868	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939306	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)nccc5[nH]4)c3c2)c1		CHEMBL4760437	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939307	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)nccc5[nH]4)c3c2)c1		CHEMBL4749014	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939308	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)cncc5[nH]4)c3n2)c1		CHEMBL4754511	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939309	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)nccc5[nH]4)c3n2)c1		CHEMBL4750400	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939310	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)c3n2)c1		CHEMBL4798951	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939311	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)c3n2)n1C		CHEMBL4790085	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939312	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)cccc4[nH]3)n[nH]c2cn1		CHEMBL4790637	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939313	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cnc2[nH]nc(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)nccc4[nH]3)c2c1		CHEMBL4763405	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939314	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)cncc4[nH]3)n[nH]c2cn1		CHEMBL4791409	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939315	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3nc4c(-c5cc(F)cc(CNS(C)(=O)=O)c5)ccnc4[nH]3)n[nH]c2cn1		CHEMBL4797300	=	EC50	nM	32.0	CHEMBL4225	Homo sapiens	EC50	uM	0.032
	22939316	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4793420	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939317	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)cc45)nc23)c1		CHEMBL4744601	=	EC50	nM	16.0	CHEMBL4225	Homo sapiens	EC50	uM	0.016
	22939318	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4nc5c(-c6cc(F)cc(N7CCOCC7)c6)cncc5[nH]4)c3c2)c1		CHEMBL4745861	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939319	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)nc23)c1		CHEMBL4782795	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939320	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)nc23)c1		CHEMBL4783753	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939321	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)nc23)c1		CHEMBL4788493	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939322	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4nc5c(-c6cc(F)cc(OCCN7CCCC7)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746668	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939323	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc3[nH]c(-c4n[nH]c5ccc(-c6cnn(C)c6)cc45)nc3c2)CC1		CHEMBL4744523	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939324	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cccnc6)cc45)cc23)c1		CHEMBL4749607	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939325	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cccnc6)nc45)cc23)c1		CHEMBL4765221	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939326	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4796957	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939327	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4796795	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939328	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)ccnc5[nH]4)c3c2)c1		CHEMBL4788382	=	EC50	nM	16.0	CHEMBL4225	Homo sapiens	EC50	uM	0.016
	22939329	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4779327	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939330	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4780543	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939331	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4743234	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939332	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4757524	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939333	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccc(F)c6)cncc5[nH]4)c3c2)c1		CHEMBL4799281	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939334	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)c3c2)c1		CHEMBL4755078	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939335	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4741293	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939336	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)c1		CHEMBL4797290	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939337	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4790211	=	EC50	nM	18.0	CHEMBL4225	Homo sapiens	EC50	uM	0.018000000000000002
	22939338	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(-c6ccc(F)cc6)nccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4753208	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939339	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCC7)c6)cc45)cc23)cc1		CHEMBL4779789	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939340	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)cc23)cc1		CHEMBL4788785	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939341	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCC(F)(F)C7)c6)cc45)cc23)cc1		CHEMBL4742109	=	EC50	nM	16.0	CHEMBL4225	Homo sapiens	EC50	uM	0.016
	22939342	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cncc(-c2cc3c(-c4cc5c(-c6ccc(F)cc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746881	=	EC50	nM	19.0	CHEMBL4225	Homo sapiens	EC50	uM	0.019
	22939343	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncnc6)cc45)cc23)cc1		CHEMBL4741528	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939344	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4755268	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939345	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1		CHEMBL4760948	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939346	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4756589	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939347	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4780582	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939348	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4748029	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939349	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763075	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939350	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3n2)c1		CHEMBL4800107	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939351	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4788394	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939352	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1)C1CC1		CHEMBL4745228	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939353	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1)C1CC1		CHEMBL4753703	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939354	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3n2)c1)C1CC1		CHEMBL4749957	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939355	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4757198	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939356	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)nccc5[nH]4)c3c2)c1		CHEMBL4791233	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939357	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)c3c2)c1		CHEMBL4799290	=	EC50	nM	20.0	CHEMBL4225	Homo sapiens	EC50	uM	0.02
	22939358	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4760804	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939359	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cc3c(-c4cc5c(-c6ccccc6F)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4792242	=	EC50	nM	19.0	CHEMBL4225	Homo sapiens	EC50	uM	0.019
	22939360	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3c2)c1		CHEMBL4750038	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939361	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccc6F)cncc5[nH]4)c3n2)c1		CHEMBL4782086	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939362	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccccc1-c1nccc2[nH]c(-c3n[nH]c4cnc(-c5cncc(CN6CCCC6)c5)cc34)cc12		CHEMBL4756072	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939363	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccccc1-c1cncc2[nH]c(-c3n[nH]c4ncc(-c5cn[nH]c5)cc34)cc12		CHEMBL4763957	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939364	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccccc1-c1nccc2[nH]c(-c3n[nH]c4cnc(-c5cn[nH]c5)cc34)cc12		CHEMBL4762727	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939365	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1	Outside typical range	CHEMBL4748515	=	EC50	nM	0.0	CHEMBL4225	Homo sapiens	EC50	uM	0.0
	22939366	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4778916	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939367	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4758642	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939368	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4757917	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939369	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cnc2[nH]nc(-c3cc4c(-c5cccnc5)cncc4[nH]3)c2c1		CHEMBL4798397	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939370	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3cc4c(-c5cccnc5)cncc4[nH]3)c2n1		CHEMBL4741420	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939371	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)nccc5[nH]4)c3c2)c1		CHEMBL4749420	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939372	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3c2)c1		CHEMBL4747342	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939373	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4758034	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939374	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4754964	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939375	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4741533	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939376	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4783658	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939377	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4744328	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939378	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4782218	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939379	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4755952	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939380	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4755941	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939381	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)nccc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4755598	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939382	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4786950	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939383	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3c2)c1		CHEMBL4754308	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939384	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)c1		CHEMBL4794971	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939385	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4777044	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939386	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4745435	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939387	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4799685	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939388	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3n2)c1		CHEMBL4784177	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939389	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4785809	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939390	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccnc6)ccnc5[nH]4)c3c2)c1		CHEMBL4758482	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939391	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cc3c(-c4cc5c(-c6cccnc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4750750	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939392	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cccc5[nH]4)c3n2)c1		CHEMBL4743788	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939393	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccnc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCCC7)c6)cc45)cc23)c1		CHEMBL4757688	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939394	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7cccnc7)ccnc6[nH]5)c4c3)c2)C1		CHEMBL4760685	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939395	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7cccnc7)cncc6[nH]5)c4n3)c2)C1		CHEMBL4763204	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939396	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccnc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4747481	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939397	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncnc6)cc45)cc23)c1		CHEMBL4742941	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939398	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccnc3[nH]c(-c4n[nH]c5cnc(-c6cncnc6)cc45)cc23)c1		CHEMBL4781998	=	EC50	nM	19.0	CHEMBL4225	Homo sapiens	EC50	uM	0.019
	22939399	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3[nH]nc(-c4cc5c(-c6cccnc6)cncc5[nH]4)c3c2)cn1		CHEMBL4746411	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939400	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3cc4c(-c5ccncc5)ccnc4[nH]3)c2n1		CHEMBL4776132	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939401	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1		CHEMBL4747922	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939402	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1		CHEMBL4757102	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939403	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4741393	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939404	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1		CHEMBL4789703	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939405	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763601	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939406	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3n2)c1		CHEMBL4744766	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939407	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4761515	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939408	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1	Outside typical range	CHEMBL4783896	=	EC50	nM	0.0	CHEMBL4225	Homo sapiens	EC50	uM	0.0
	22939409	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4787630	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939410	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4792964	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939411	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1		CHEMBL4780519	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939412	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4760110	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939413	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cccc5[nH]4)c3c2)c1		CHEMBL4762259	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939414	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1		CHEMBL4743802	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939415	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4763649	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939416	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4743111	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939417	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)ccnc5[nH]4)c3c2)c1		CHEMBL4748329	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939418	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4750354	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939419	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)nccc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4786493	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939420	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CNCC7CCCC7)c6)nc45)cc23)ccn1		CHEMBL4743335	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939421	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4782038	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939422	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)c1		CHEMBL4780076	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939423	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4759225	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939424	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(-c6ccncc6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4797314	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939425	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5cc6c(-c7ccncc7)cccc6[nH]5)c4c3)c2)C1		CHEMBL4753143	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939426	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5cc6c(-c7ccncc7)cncc6[nH]5)c4c3)c2)C1		CHEMBL4751489	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939427	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)ccn1		CHEMBL4788538	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939428	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(OCCN7CCCC7)c6)nc45)cc23)ccn1		CHEMBL4759120	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939429	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)cc45)cc23)ccn1		CHEMBL4750923	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939430	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2cnc3[nH]nc(-c4cc5c(-c6ccncc6)cncc5[nH]4)c3c2)n1C		CHEMBL4759093	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939431	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)ccnc5[nH]4)c3c2)c1		CHEMBL4750609	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939432	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccccn6)cccc5[nH]4)c3n2)c1		CHEMBL4755473	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939433	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7ccccn7)cccc6[nH]5)c4n3)c2)C1		CHEMBL4747611	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939434	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4759361	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939435	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1		CHEMBL4761786	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939436	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4747558	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939437	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2cc3c(-c4cc5cccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4753920	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939438	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3n2)c1		CHEMBL4757131	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939439	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1ccc2[nH]nc(-c3cc4ccncc4[nH]3)c2c1		CHEMBL4761131	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939440	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ccncc1-c1cc2c(-c3cc4cnccc4[nH]3)n[nH]c2cn1		CHEMBL4799353	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939441	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1		CHEMBL4755073	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939442	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4755477	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939443	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4745415	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939444	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1		CHEMBL4758986	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939445	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4751155	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939446	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746788	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939447	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5cccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4754274	=	EC50	nM	21.0	CHEMBL4225	Homo sapiens	EC50	uM	0.021
	22939448	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4752468	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939449	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4746032	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939450	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4757454	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939451	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cccnc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4740976	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939452	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4797292	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939453	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1)C1CCCC1		CHEMBL4776789	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939454	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5ccncc5[nH]4)c3n2)c1)C1CCCC1		CHEMBL4741036	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939455	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1)C1CCCCC1		CHEMBL4779458	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939456	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1)C1CCCCC1		CHEMBL4799905	=	EC50	nM	17.0	CHEMBL4225	Homo sapiens	EC50	uM	0.017
	22939457	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1)C1CCCCC1		CHEMBL4756871	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939458	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4740858	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939459	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4751252	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939460	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)c1)c1ccccc1		CHEMBL4758308	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939461	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1)c1ccccc1		CHEMBL4758596	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939462	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5ccccc5[nH]4)c3c2)c1		CHEMBL4786094	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939463	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3c2)c1		CHEMBL4753378	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939464	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3n2)c1		CHEMBL4797436	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939465	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)c1cncc(-c2cc3c(-c4cc5cnccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4744291	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939466	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5cnccc5[nH]4)c3n2)c1		CHEMBL4796832	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939467	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5cccnc5[nH]4)c3n2)c1		CHEMBL4789529	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939468	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ccc2[nH]c(-c3n[nH]c4ncc(-c5cncc(CN6CCCC6)c5)cc34)cc2c1		CHEMBL4793740	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939469	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cc4c(-c5cc6cccnc6[nH]5)n[nH]c4cn3)c2)C1		CHEMBL4784018	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939470	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6cnccc6[nH]5)c4n3)c2)C1		CHEMBL4763390	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939471	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6cccnc6[nH]5)c4n3)c2)C1		CHEMBL4792259	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939472	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2[nH]c(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cc2cn1		CHEMBL4754457	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939473	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cnc2cc(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)[nH]c2c1		CHEMBL4764806	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939474	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cnc2[nH]c(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cc2c1		CHEMBL4777829	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939475	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2[nH]c(-c3n[nH]c4ncc(-c5cncc(CN6CCCCC6)c5)cc34)cc2cn1		CHEMBL4789272	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939476	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2cc(-c3n[nH]c4ccc(-c5cncc(OCCN6CCCC6)c5)cc34)[nH]c2cn1		CHEMBL4749742	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939477	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cnc2[nH]c(-c3n[nH]c4ccc(-c5cncc(OCCN6CCCC6)c5)cc34)cc2c1		CHEMBL4741593	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939478	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2cnc3[nH]nc(-c4cc5cccnc5[nH]4)c3c2)cn1		CHEMBL4795309	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939479	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)ccnc5[nH]4)c3c2)c1		CHEMBL4762016	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939480	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Nc1cncc(-c2cc3c(-c4cc5c(N6CCCCC6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763741	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939481	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1		CHEMBL4776104	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939482	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)cccc5[nH]4)c3n2)c1		CHEMBL4762624	=	EC50	nM	20.0	CHEMBL4225	Homo sapiens	EC50	uM	0.02
	22939483	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3n2)c1		CHEMBL4790903	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939484	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1)C1CC1		CHEMBL4800596	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939485	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(N6CCCCC6)nccc5[nH]4)n[nH]c3cn2)c1)C1CCC1		CHEMBL4796975	=	EC50	nM	19.0	CHEMBL4225	Homo sapiens	EC50	uM	0.019
	22939486	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3n2)c1		CHEMBL4795946	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939487	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1		CHEMBL4762357	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939488	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)cccc5[nH]4)c3c2)c1		CHEMBL4793215	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939489	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)nccc5[nH]4)c3c2)c1		CHEMBL4740574	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939490	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ncc(-c2ccc3[nH]nc(-c4cc5c(N6CCCCC6)cncc5[nH]4)c3c2)cc1CN1CCCC1		CHEMBL4798538	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939491	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(N7CCCCC7)cccc6[nH]5)c4c3)c2)C1		CHEMBL4781079	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939492	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3ccc4[nH]nc(-c5cc6c(N7CCCCC7)ccnc6[nH]5)c4n3)c2)C1		CHEMBL4780802	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939493	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2[nH]c(-c3n[nH]c4ccc(-c5cncc(CN6CCCCC6)c5)cc34)cc2c(N2CCCCC2)n1		CHEMBL4757427	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939494	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)cc45)cc23)CC1		CHEMBL4797723	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939495	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(N)c6)cc45)cc23)CC1		CHEMBL4744948	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939496	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)cc23)CC1		CHEMBL4741476	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939497	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4795743	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939498	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(N6CCN(C)CC6)cccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4799857	=	EC50	nM	17.0	CHEMBL4225	Homo sapiens	EC50	uM	0.017
	22939499	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)c3c2)c1		CHEMBL4740045	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939500	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)c3c2)c1		CHEMBL4797092	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939501	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(N6CCN(C)CC6)ccnc5[nH]4)c3n2)c1		CHEMBL4795751	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939502	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C(C)(C)C)c6)cc45)cc23)CC1		CHEMBL4757534	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939503	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)(C)C)c6)cc45)cc23)CC1		CHEMBL4756940	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939504	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC(C)(C)C)c6)nc45)cc23)CC1		CHEMBL4798097	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939505	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(NC(=O)C7CCCC7)c6)cc45)cc23)CC1		CHEMBL4782101	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939506	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4790585	=	EC50	nM	14.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013999999999999999
	22939507	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4749506	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939508	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC7CCNCC7)c6)cc45)cc23)CC1		CHEMBL4749220	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939509	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)CC7CCNCC7)c6)cc45)cc23)CC1		CHEMBL4776216	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939510	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)c7ccccc7)c6)cc45)cc23)CC1		CHEMBL4779082	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939511	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)c7ccccc7)c6)cc45)cc23)CC1		CHEMBL4777935	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939512	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)c7ccccc7)c6)nc45)cc23)CC1		CHEMBL4763400	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939513	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CNCC7CCCC7)c6)cc45)cc23)CC1		CHEMBL4751483	=	EC50	nM	19.0	CHEMBL4225	Homo sapiens	EC50	uM	0.019
	22939514	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CNCc7ccccc7)c6)cc45)cc23)CC1		CHEMBL4785840	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939515	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1cncc(-c2cc3c(-c4cc5c(N6CCN(C)CC6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4748551	=	EC50	nM	20.0	CHEMBL4225	Homo sapiens	EC50	uM	0.02
	22939516	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCC7)c6)cc45)cc23)CC1		CHEMBL4793656	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939517	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4796190	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939518	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4787864	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939519	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)CC1		CHEMBL4748414	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939520	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)CC1		CHEMBL4754230	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939521	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ncc(-c6cn[nH]c6)cc45)cc23)CC1		CHEMBL4747803	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939522	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cn[nH]c6)nc45)cc23)CC1		CHEMBL4751184	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939523	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)cncc5[nH]4)c3c2)c1		CHEMBL4790169	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939524	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)ccnc5[nH]4)c3c2)c1		CHEMBL4758657	=	EC50	nM	12.0	CHEMBL4225	Homo sapiens	EC50	uM	0.012
	22939525	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(CC1CCNCC1)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)ccnc5[nH]4)c3n2)c1		CHEMBL4786287	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939526	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc(-c2ccoc2)c2cc(-c3n[nH]c4ccc(-c5cncc(CNCC6CCCC6)c5)nc34)[nH]c2c1		CHEMBL4749966	=	EC50	nM	14.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013999999999999999
	22939527	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	FC1(F)CCN(Cc2cncc(-c3cnc4[nH]nc(-c5cc6c(-c7ccoc7)cccc6[nH]5)c4c3)c2)C1		CHEMBL4760076	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939528	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)nccc5[nH]4)c3c2)c1		CHEMBL4750641	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939529	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ncc(-c2ccc3[nH]nc(-c4cc5c(-c6ccoc6)nccc5[nH]4)c3c2)cn1		CHEMBL4797627	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939530	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cccs6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4753467	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939531	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cccs6)nccc5[nH]4)c3c2)c1)C1CCC1		CHEMBL4754927	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939532	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1ccc(CNCc2cncc(-c3ccc4[nH]nc(-c5cc6c(-c7cccs7)cncc6[nH]5)c4c3)c2)cc1		CHEMBL4743209	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939533	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1csc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4741555	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939534	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1csc(-c2ccnc3[nH]c(-c4n[nH]c5ccc(-c6cncc(OC7CCNCC7)c6)nc45)cc23)c1		CHEMBL4742982	=	EC50	nM	16.0	CHEMBL4225	Homo sapiens	EC50	uM	0.016
	22939535	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(N)c6)cc45)cc23)c1		CHEMBL4759727	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939536	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(NCCN(C)C)c6)ccnc5[nH]4)n[nH]c3cn2)c1		CHEMBL4763521	=	EC50	nM	14.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013999999999999999
	22939537	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C(C)(C)C)c6)cc45)cc23)c1		CHEMBL4793616	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939538	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)c1		CHEMBL4780639	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939539	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(O)c6)cc45)cc23)c1		CHEMBL4791991	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939540	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)nc45)cc23)c1		CHEMBL4756681	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939541	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4753972	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939542	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4796752	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939543	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4799161	=	EC50	nM	18.0	CHEMBL4225	Homo sapiens	EC50	uM	0.018000000000000002
	22939544	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)C(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4762665	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939545	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCCCC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)n[nH]c3cn2)c1		CHEMBL4759630	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939546	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)c3c2)c1		CHEMBL4764899	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939547	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4744478	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939548	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2cc3c(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)n[nH]c3cn2)c1		CHEMBL4761655	=	EC50	nM	15.0	CHEMBL4225	Homo sapiens	EC50	uM	0.015
	22939549	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)CC(=O)Nc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)c3n2)c1		CHEMBL4740181	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939550	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CC7)c6)nc45)cc23)c1		CHEMBL4795292	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939551	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCC7)c6)cc45)cc23)c1		CHEMBL4785853	=	EC50	nM	11.0	CHEMBL4225	Homo sapiens	EC50	uM	0.011000000000000001
	22939552	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(NC(=O)C7CCC7)c6)cc45)cc23)c1		CHEMBL4754966	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939553	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5cnc(-c6cncc(NC(=O)C7CCC7)c6)cc45)cc23)c1		CHEMBL4745159	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939554	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)Cc7ccccc7)c6)nc45)cc23)c1		CHEMBL4760946	=	EC50	nM	17.0	CHEMBL4225	Homo sapiens	EC50	uM	0.017
	22939555	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2ccc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4743076	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939556	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)nccc5[nH]4)c3c2)c1		CHEMBL4754837	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939557	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CCNCc1cncc(-c2cnc3[nH]nc(-c4cc5c(-c6cc(F)cc(CNS(C)(=O)=O)c6)cncc5[nH]4)c3c2)c1		CHEMBL4788404	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939558	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5cnc(-c6cncc(CNCC7CCCC7)c6)cc45)cc23)c1		CHEMBL4793214	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939559	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)c1		CHEMBL4755835	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939560	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ccc(-c6cncc(CN7CCCCC7)c6)nc45)cc23)c1		CHEMBL4782289	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939561	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2nccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(OCc7ccccc7)c6)cc45)cc23)c1		CHEMBL4747076	=	EC50	nM	13.0	CHEMBL4225	Homo sapiens	EC50	uM	0.013000000000000001
	22939562	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CS(=O)(=O)NCc1cc(F)cc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)nc45)cc23)c1		CHEMBL4765107	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939563	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC#CC(=O)Nc1cc2cc(-c3cnn(C)c3)ccc2cn1		CHEMBL4789335	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939564	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)Cc1ccc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)cc1		CHEMBL4755642	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939565	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Oc2ccc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cc2)CC1		CHEMBL4748484	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939566	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cn2)CC1		CHEMBL4800211	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939567	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)ccn1		CHEMBL4755182	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939568	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCOc1cc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)ccn1		CHEMBL4783105	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939569	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4784318	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939570	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)c(F)cc4cn3)ccn2)CC1		CHEMBL4778468	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939571	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4c(Cl)c(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4758035	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939572	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1cc(C(=O)Nc2cc3cc(-c4cnn(C)c4)ccc3cn2)cc(N2CCN(C)CC2)n1		CHEMBL4748781	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939573	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccnc(N5CC6CC5CN6)c4)cc3c2)cn1		CHEMBL4791671	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939574	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4789887	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939575	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(CC(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4759886	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939576	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4741472	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939577	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(C(=O)N3CCN(c4cc(C(=O)Nc5cc6cc(-c7cnn(C)c7)ccc6cn5)ccn4)CC3)cn2)CC1		CHEMBL4764269	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939578	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC2(CC1)CN(c1cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn1)C2		CHEMBL4748909	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939579	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(Nc2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4743755	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939580	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccnc(OC5CNC5)c4)cc3c2)cn1		CHEMBL4777508	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939581	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5c(c4)CNCC5)cc3c2)cn1		CHEMBL4745735	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939582	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5c(cnn5C)c4)cc3c2)cn1		CHEMBL4752070	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939583	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4cnc5ccccc5c4)cc3c2)cn1		CHEMBL4780800	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939584	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5cnccc5c4)cc3c2)cn1		CHEMBL4758126	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939585	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cn2)CC1		CHEMBL4761662	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939586	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)OC(=O)N1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)cn2)CC1		CHEMBL4746707	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939587	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)N1CCC(c2nc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)co2)CC1		CHEMBL4762553	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939588	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)C1CN(c2ncc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ccc4cn3)s2)C1		CHEMBL4762838	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939589	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C6CC6)c5)ccc4cn3)ccn2)CC1		CHEMBL4750631	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939590	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5N)ccc4cn3)ccn2)CC1		CHEMBL4793867	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939591	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)c4ccc(OC(F)F)cc4)cc3c2)c1CO		CHEMBL4797187	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939592	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC2(CC1)CN(c1cc(C(=O)Nc3cc4cc(-c5cnn(C)c5CO)ccc4cn3)ccn1)C2		CHEMBL4762392	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939593	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CO[C@H]1CC[C@H](C(=O)Nc2cc3cc(-c4cnn(C)c4CN4CCCCC4)ccc3cn2)CC1		CHEMBL4763084	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939594	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)[C@H]4CC[C@H](CO)CC4)cc3c2)c1CN1CCCCC1		CHEMBL4752464	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939595	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)C4CCN(C(=O)c5ccccc5)CC4)cc3c2)c1CN1CCCCC1		CHEMBL4751301	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939596	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)c4cccc(CN5CCCC5)c4)cc3c2)c1CN1CCCCC1		CHEMBL4740518	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939597	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1ncc(-c2ccc3cnc(NC(=O)c4ccnc(N5CCOCC5)c4)cc3c2)c1CN1CCOCC1		CHEMBL4782826	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939598	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cnn4c3CCNC4)ccc2cn1)c1ccc(OC(F)F)cc1		CHEMBL4794929	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939599	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)N1CCC(Oc2cc(C(=O)Nc3cc4cc(-c5cnn6c5CCNC6)ccc4cn3)ccn2)CC1		CHEMBL4762157	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939600	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2ccc(C(=O)Nc3cc4cc(-c5cnn6c5CN(CCF)CC6)ccc4cn3)cn2)CC1		CHEMBL4747563	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939601	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CNC(=O)c1ccc(C(=O)Nc2cc3cc(-c4cn(C)nn4)ccc3cn2)cn1		CHEMBL4790614	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939602	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCc2cc(C(=O)Nc3cc4cc(-c5cn(C)nn5)ccc4cn3)ccc2C1		CHEMBL4777663	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939603	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)N1CCC(n2cc(C(=O)Nc3cc4cc(-c5cn(C)nn5)ccc4cn3)cn2)CC1		CHEMBL4795948	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939604	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cncc1-c1ccc2cnc(NC(=O)c3ccc(F)cc3)cc2c1		CHEMBL4783628	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939605	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cncc1-c1ccc2cnc(NC(=O)c3ccnc(N4CC(N)C4)c3)cc2c1		CHEMBL4780597	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939606	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cncc1-c1ccc2cnc(NC(=O)c3ccnc(N4CCN(C5CC5)CC4)c3)cc2c1		CHEMBL4758853	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939607	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1Cc2ccc(C(=O)Nc3cc4cc(-c5cncn5C)ccc4cn3)cc2C1		CHEMBL4786449	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939608	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1nnc(C(=O)Nc2cc3cc(-c4cncn4C)ccc3cn2)s1		CHEMBL4787749	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939609	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)n1cc(C(=O)Nc2cc3cc(-c4cncn4C)ccc3cn2)cn1		CHEMBL4755579	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939610	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)n1cc(C(=O)Nc2cc3cc(-c4cncn4C(C)C)ccc3cn2)cn1		CHEMBL4754087	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939611	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3cnc(NC(=O)C4(F)CC4)cc3c2)n1C		CHEMBL4752888	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939612	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(-c2ccc3cnc(NC(=O)c4ccc(OC(C)C)cc4)cc3c2)n1C		CHEMBL4791186	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939613	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(C(=O)Nc2cc3cc(-c4cnc(C)n4C)ccc3cn2)s1		CHEMBL4800296	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939614	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	NC1CN(c2cc(C(=O)Nc3cc4cc(-c5cnco5)ccc4cn3)ccn2)C1		CHEMBL4741620	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939615	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cncs5)ccc4cn3)ccn2)CC1		CHEMBL4744439	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939616	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncs3)ccc2cn1)c1ccc2c(c1)CNCC2		CHEMBL4760089	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939617	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5cnc(N)s5)ccc4cn3)ccn2)CC1		CHEMBL4747892	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939618	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1nnc(-c2ccc3cnc(NC(=O)c4ccnc(C5=CCN(C)CC5)c4)cc3c2)s1		CHEMBL4799760	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939619	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1nnc(-c2ccc3cnc(NC(=O)c4ccnc(N(C)C5CCN(C)CC5)c4)cc3c2)s1		CHEMBL4788867	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939620	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4cc(-c5ccc(N)nc5)ccc4cn3)ccn2)CC1		CHEMBL4782831	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939621	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(CN4CCC(O)CC4)c3)ccc2cn1)c1ccc(F)cc1		CHEMBL4781707	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939622	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3cnc(NC(=O)C4CCN(CCF)CC4)cc3c2)n1		CHEMBL4751376	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939623	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)Nc1cncc(-c2ccc3cnc(NC(=O)c4cccc(C5CCN(C)CC5)c4)cc3c2)n1		CHEMBL4797241	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939624	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NC4CCNCC4)n3)ccc2cn1)C1CC(F)(F)C1		CHEMBL4761487	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939625	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NC4CCNCC4)n3)ccc2cn1)C1CCCCC1		CHEMBL4763112	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939626	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NCC4(F)CNC4)n3)ccc2cn1)C1CC1		CHEMBL4777070	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939627	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(N[C@H]4CCNC[C@@H]4F)n3)ccc2cn1)C1CC1		CHEMBL4780537	=	EC50	nM	1.0	CHEMBL4225	Homo sapiens	EC50	uM	0.001
	22939628	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3cc4cc(-c5cncc6[nH]ccc56)ccc4cn3)cn2)CC1		CHEMBL4746469	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939629	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnc6cc[nH]c6c5)ccc4cn3)cn2)CC1		CHEMBL4745584	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939630	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3cc4nc(-c5cnn(C)c5)ccc4cn3)ccn2)CC1		CHEMBL4743920	=	EC50	nM	4.0	CHEMBL4225	Homo sapiens	EC50	uM	0.004
	22939631	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(C(=O)Nc3ncc4ccc(-c5cnn(C)c5)cc4n3)ccn2)CC1		CHEMBL4778580	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939632	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cn1cc(-c2ccc3cnc(NC(=O)c4ccc5nccnc5c4)cc3n2)cn1		CHEMBL4794127	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939633	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)OC(=O)N1CCC(n2cc(C(=O)Nc3cc4cc(-c5cnn(C)c5)ncc4cn3)cn2)CC1		CHEMBL4790835	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939634	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC2(CC1)CN(c1cc(C(=O)Nc3cc4cc(-c5cnn(C)c5CN5CCCCC5)cnc4cn3)ccn1)C2		CHEMBL4779822	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939635	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Cc1ncc(C(=O)Nc2cc3nc(-c4cnc(C)n4C)ccc3cn2)s1		CHEMBL4790079	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939636	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CC=C(c2cc(C(=O)Nc3cc4cc(-c5cncc(NC(C)(C)C)n5)cnc4cn3)ccn2)CC1		CHEMBL4800068	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939637	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NC4CCNCC4)n3)ncc2cn1)C1CCOCC1		CHEMBL4794913	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939638	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(C)n1cc(C(=O)Nc2cc3cc(-c4cncc(NC5CCN(C)CC5)n4)ncc3cn2)cn1		CHEMBL4785775	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939639	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncc(NCC4(F)CNC4)n3)ncc2cn1)C1CC1		CHEMBL4741309	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939640	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(n2cc(C(=O)Nc3ncc4ccc(-c5cncc6[nH]ccc56)cc4n3)cn2)CC1		CHEMBL4748839	=	EC50	nM	6.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006
	22939641	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCCCN(C)c2nccc3[nH]c(nc23)-c2c[nH]c3ccc(cc23)-c2cncc(c2)C1		CHEMBL4741101	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939642	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	c1cc2cc(c1)-c1cncc3[nH]c(nc13)-c1n[nH]c3ccc(cc13)-c1cncc(c1)CNC2		CHEMBL4793171	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939643	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C1CCc2cccc(c2)-c2cncc3[nH]c(nc23)-c2n[nH]c3ccc(cc23)-c2cncc(c2)N1		CHEMBL4753134	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939644	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C1COc2cccc(c2)-c2cncc3[nH]c(nc23)-c2n[nH]c3ccc(cc23)-c2cncc(c2)N1		CHEMBL4800405	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939645	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCCn2cc(nn2)-c2nccc3[nH]c(nc23)-c2n[nH]c3ccc(cc23)-c2cncc(c2)C1		CHEMBL4791855	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939646	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C1CCc2cccc(c2)-c2cncc(c2)NC(=O)c2n[nH]c3ccc(cc23)-c2cncc(c2)CN1		CHEMBL4784103	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939647	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCN(c2cc(Nc3ncc4c(-c5ccc6ncccc6c5)c[nH]c4n3)ccn2)CC1		CHEMBL4798969	=	EC50	nM	2.0	CHEMBL4225	Homo sapiens	EC50	uM	0.002
	22939648	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CNc1nc(NCc2ncccn2)c2c(-c3ccc4ncccc4c3)c[nH]c2n1		CHEMBL4797564	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939649	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cnccn6)nc45)nc23)c1		CHEMBL4764942	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939650	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Cc1ccccc1)Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccncc6)ccnc5[nH]4)c3n2)c1		CHEMBL4740879	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939651	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cncc(NC(=O)C7CCCCC7)c6)nc45)nc23)c1		CHEMBL4753453	=	EC50	nM	7.0	CHEMBL4225	Homo sapiens	EC50	uM	0.006999999999999999
	22939652	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cccc3[nH]c(-c4n[nH]c5ccc(-c6cncnc6)nc45)nc23)cc1		CHEMBL4795145	=	EC50	nM	5.0	CHEMBL4225	Homo sapiens	EC50	uM	0.005
	22939653	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccc(F)c6)cccc5[nH]4)c3n2)c1)C1CC1		CHEMBL4758567	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939654	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6ccccn6)ccnc5[nH]4)c3n2)c1)c1ccccc1		CHEMBL4778724	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939655	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5c(-c6cccs6)cccc5[nH]4)c3n2)c1)C1CC1		CHEMBL4763191	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939656	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cncc(-c2ccc3[nH]nc(-c4nc5c(N6CCCCC6)ccnc5[nH]4)c3n2)c1		CHEMBL4757442	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939657	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	COc1cccc(-c2cncc3[nH]c(-c4n[nH]c5ccc(-c6cn[nH]c6)nc45)nc23)c1		CHEMBL4794216	=	EC50	nM	3.0	CHEMBL4225	Homo sapiens	EC50	uM	0.003
	22939658	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	Fc1ccc(-c2cccc3[nH]c(-c4n[nH]c5ncc(-c6cncc(CN7CCCCC7)c6)cc45)cc23)cc1		CHEMBL4749743	=	EC50	nM	8.0	CHEMBL4225	Homo sapiens	EC50	uM	0.008
	22939659	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN(C)CCNc1cc(F)cc(-c2cccc3[nH]c(-c4n[nH]c5ncc(-c6ccncc6)cc45)cc23)c1		CHEMBL4787213	=	EC50	nM	10.0	CHEMBL4225	Homo sapiens	EC50	uM	0.01
	22939660	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cncc(-c2cc3c(-c4cc5c(-c6cccc(F)c6)ccnc5[nH]4)n[nH]c3cn2)c1)C1CC1		CHEMBL4753128	=	EC50	nM	9.0	CHEMBL4225	Homo sapiens	EC50	uM	0.009000000000000001
	22939661	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cncs3)ccc2cn1)C1(F)CCCCC1		CHEMBL4792722	=	EC50	nM	1902.0	CHEMBL4225	Homo sapiens	EC50	uM	1.902
	22939662	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CC2CCC(C1)N2C(=O)Nc1cc2cc(-c3cnn(C)c3)ccc2cn1		CHEMBL4740450	=	EC50	nM	1133.0	CHEMBL4225	Homo sapiens	EC50	uM	1.133
	22939663	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CN1CCC(C(=O)Nc2cc3cc(-c4cnsc4)cnc3cn2)CC1		CHEMBL4749519	>	EC50	nM	10000.0	CHEMBL4225	Homo sapiens	EC50	uM	10.0
	22939664	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cnco3)cnc2cn1)[C@H]1CC[C@H](CO)CC1		CHEMBL4761669	=	EC50	nM	7429.0	CHEMBL4225	Homo sapiens	EC50	uM	7.428999999999999
	22939665	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	O=C(Nc1cc2cc(-c3cnco3)cnc2cn1)C1CCNCC1		CHEMBL4764466	>	EC50	nM	10000.0	CHEMBL4225	Homo sapiens	EC50	uM	10.0
	22939666	CHEMBL4739818	Inhibition of recombinant CLK2 (unknown origin) using Ser/Thr 6 peptide as substrate incubated for 1 hr in presence of ATP by FRET assay	B	CC(F)(F)CN1CCC(C(=O)Nc2cc3cc(-c4cnco4)cnc3cn2)CC1		CHEMBL4752797	=	EC50	nM	9777.0	CHEMBL4225	Homo sapiens	EC50	uM	9.777000000000001
	22952801	CHEMBL4766738	Inhibition of recombinant human CLK2 (138 to end residues) assessed as residual activity at 10 uM using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate incubated 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	44.0	CHEMBL4225	Homo sapiens	Activity	%	44.0
	22974455	CHEMBL4771293	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(Nc1ccc2c(c1)Oc1ncccc1C(=O)N2c1ccncc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL4792974	<	Activity	%	35.0	CHEMBL4225	Homo sapiens	Activity	%	35.0
	23120131	CHEMBL4804330	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	Nc1ncc(-c2cc([N+](=O)[O-])ccc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4874241	=	Activity	%	5.0	CHEMBL4225	Homo sapiens	Activity	%	5.0
	23120332	CHEMBL4804371	Inhibition of CLK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	19100.0	CHEMBL4225	Homo sapiens	IC50	uM	19.1
	23120333	CHEMBL4804371	Inhibition of CLK2 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	42700.0	CHEMBL4225	Homo sapiens	IC50	uM	42.7
	23120334	CHEMBL4804371	Inhibition of CLK2 in human NCI-H929 cells by mass spectroscopic analysis	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1	Outside typical range	CHEMBL4867931	=	IC50	nM	-4300.0	CHEMBL4225	Homo sapiens	IC50	uM	-4.3
	23120335	CHEMBL4804371	Inhibition of CLK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	IC50	nM	65300.0	CHEMBL4225	Homo sapiens	IC50	uM	65.3
	23120336	CHEMBL4804371	Inhibition of CLK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	IC50	nM	69400.0	CHEMBL4225	Homo sapiens	IC50	uM	69.4
	23120337	CHEMBL4804371	Inhibition of CLK2 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	>	IC50	nM	95000.0	CHEMBL4225	Homo sapiens	IC50	uM	95.0
	23121373	CHEMBL4804553	Inhibition of CLK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL4225	Homo sapiens	INH	%	0.0
	23121374	CHEMBL4804553	Inhibition of CLK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	35.0	CHEMBL4225	Homo sapiens	INH	%	35.0
	23121375	CHEMBL4804553	Inhibition of CLK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	COc1cc(NS(=O)(=O)C2CC2)ccc1-c1cnc(N)c(-c2ccc3c(c2)CCNC3=O)c1		CHEMBL4867931	=	Inhibition	%	0.0	CHEMBL4225	Homo sapiens	INH	%	0.0
	23121376	CHEMBL4804553	Inhibition of CLK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855730	=	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	23121377	CHEMBL4804553	Inhibition of CLK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2ccc(NS(=O)(=O)C3CC3)cc2OC2CCCCC2)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4868141	=	Inhibition	%	50.0	CHEMBL4225	Homo sapiens	INH	%	50.0
	23121378	CHEMBL4804553	Inhibition of CLK2 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL4225	Homo sapiens	INH	%	0.0
	23122500	CHEMBL4804851	Inhibition of human CLK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	93.0	CHEMBL4225	Homo sapiens	Activity	%	93.0
	23123195	CHEMBL4805439	Inhibition of human CLK2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	90.0	CHEMBL4225	Homo sapiens	Activity	%	90.0
	23123695	CHEMBL4805939	Inhibition of DNA-tagged human CLK2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	75.0	CHEMBL4225	Homo sapiens	Activity	%	75.0
	23124480	CHEMBL4806456	Inhibition of human CLK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	75.0	CHEMBL4225	Homo sapiens	Activity	%	75.0
	23124481	CHEMBL4806456	Inhibition of human CLK2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	83.0	CHEMBL4225	Homo sapiens	Activity	%	83.0
	23127978	CHEMBL4807801	Inhibition of CLK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	>	Activity	%	75.0	CHEMBL4225	Homo sapiens	Activity	%	75.0
	23127979	CHEMBL4807801	Inhibition of CLK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4225	Homo sapiens	Activity	%	75.0
	23127980	CHEMBL4807801	Inhibition of CLK2 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4225	Homo sapiens	Activity	%	75.0
	23144114	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	IC50	nM	0.55	CHEMBL4225	Homo sapiens	IC50	nM	0.55
Not Determined	23144115	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NO)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4855171		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144116	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	CS(=O)(=O)NC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4854640		IC50			CHEMBL4225	Homo sapiens	IC50		
	23144117	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NCCO)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4860630	=	IC50	nM	32.69	CHEMBL4225	Homo sapiens	IC50	nM	32.69
	23144118	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	NCCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4878998	=	IC50	nM	19.64	CHEMBL4225	Homo sapiens	IC50	nM	19.64
	23144119	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NCCBr)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4857079	=	IC50	nM	24.69	CHEMBL4225	Homo sapiens	IC50	nM	24.69
Not Determined	23144120	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NCC(F)F)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4846022		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144121	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	CN(C)CCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4852239		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144122	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	C#CCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4848229		IC50			CHEMBL4225	Homo sapiens	IC50		
	23144123	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	COC(=O)CCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4875815	=	IC50	nM	9.7	CHEMBL4225	Homo sapiens	IC50	nM	9.7
Not Determined	23144124	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NCCN1CCCC1)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4865194		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144125	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NCCN1CCCCC1)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4845902		IC50			CHEMBL4225	Homo sapiens	IC50		
	23144126	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NCCN1CCOCC1)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4862003	=	IC50	nM	21.9	CHEMBL4225	Homo sapiens	IC50	nM	21.9
Not Determined	23144127	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(NCCCO)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4873444		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144128	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	NCCCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4866502		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144129	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	COC(=O)CCCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4867054		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144130	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(O)CCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4870899		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144131	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(O)CCCNC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4850291		IC50			CHEMBL4225	Homo sapiens	IC50		
	23144132	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(OCCO)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4875513	=	IC50	nM	2.38	CHEMBL4225	Homo sapiens	IC50	nM	2.38
	23144133	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(OCCI)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4848072	=	IC50	nM	1.69	CHEMBL4225	Homo sapiens	IC50	nM	1.69
	23144134	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(OCCF)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4848224	=	IC50	nM	1.06	CHEMBL4225	Homo sapiens	IC50	nM	1.06
Not Determined	23144135	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(OCCc1ccccn1)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4849246		IC50			CHEMBL4225	Homo sapiens	IC50		
	23144136	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(OCC(F)F)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4872225	=	IC50	nM	1.54	CHEMBL4225	Homo sapiens	IC50	nM	1.54
Not Determined	23144137	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(OCCC(Cl)Cl)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4857107		IC50			CHEMBL4225	Homo sapiens	IC50		
Not Determined	23144138	CHEMBL4808935	Inhibition of human CLK2 incubated for 2 hrs	B	O=C(OCCOCCOCCO)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4870230		IC50			CHEMBL4225	Homo sapiens	IC50		
	23144150	CHEMBL4808938	Inhibition of CLK2 (unknown origin) assessed as residual activity at 1 uM relative to control	B	O=C(NCCO)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL4860630	=	Activity	%	22.1	CHEMBL4225	Homo sapiens	Activity	%	22.1
	23152027	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Activity	%	9.4	CHEMBL4225	Homo sapiens	Activity	%	9.4
	23152028	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(c1nccc(-c2cnn3ncccc23)n1)C1CC1		CHEMBL4848696	=	Activity	%	95.0	CHEMBL4225	Homo sapiens	Activity	%	95.0
	23152029	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	c1cnn2ncc(-c3ccnc(N4CCC45COC5)n3)c2c1		CHEMBL4845809	=	Activity	%	13.0	CHEMBL4225	Homo sapiens	Activity	%	13.0
	23152030	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CC1CCCN1c1nccc(-c2cnn3ncccc23)n1		CHEMBL4859912	=	Activity	%	61.0	CHEMBL4225	Homo sapiens	Activity	%	61.0
	23152031	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4853444	=	Activity	%	16.0	CHEMBL4225	Homo sapiens	Activity	%	16.0
	23152032	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	C[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4870121	=	Activity	%	15.0	CHEMBL4225	Homo sapiens	Activity	%	15.0
	23152033	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	F[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4852944	=	Activity	%	62.0	CHEMBL4225	Homo sapiens	Activity	%	62.0
	23152034	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4877372	=	Activity	%	72.0	CHEMBL4225	Homo sapiens	Activity	%	72.0
	23152035	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	N[C@@H]1CCN(c2nccc(-c3cnn4ncccc34)n2)C1		CHEMBL4876980	=	Activity	%	51.0	CHEMBL4225	Homo sapiens	Activity	%	51.0
	23152036	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	Cc1cnn2ncc(-c3ccnc(N(C)C)n3)c2c1		CHEMBL4851717	=	Activity	%	13.0	CHEMBL4225	Homo sapiens	Activity	%	13.0
	23152037	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	COc1ccnn2ncc(-c3ccnc(N(C)C)n3)c12		CHEMBL4874923	=	Activity	%	12.0	CHEMBL4225	Homo sapiens	Activity	%	12.0
	23152038	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1nccc(-c2cnc3ncccn23)n1		CHEMBL4872408	=	Activity	%	31.0	CHEMBL4225	Homo sapiens	Activity	%	31.0
	23152039	CHEMBL4810637	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as remaining activity at 1 uM by Kinomescan method relative to control	B	CN(C)c1ncc(F)c(-c2cnn3ncccc23)n1		CHEMBL4861396	=	Activity	%	54.0	CHEMBL4225	Homo sapiens	Activity	%	54.0
	23152084	CHEMBL4810646	Binding affinity to wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system measured after 1 hr by competitive binding assay	B	CN(C)c1nccc(-c2cnn3ncccc23)n1		CHEMBL4848254	=	Kd	nM	220.0	CHEMBL4225	Homo sapiens	Kd	nM	220.0
	23178410	CHEMBL4815943	Inhibition of recombinant human CLK2 (138 to end residues) using YRRAAVPPSPSLSRHSSPHQS(p)EDEEE as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	COc1ccc(CNC(=O)c2cnc3ccc(-c4ccc5ncccc5c4)cn23)cc1		CHEMBL4853178	=	IC50	nM	50.0	CHEMBL4225	Homo sapiens	IC50	nM	50.0
	23234008	CHEMBL4827588	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	O=C(O)c1ccc(-c2cnn3ccc(-c4ccccc4)nc23)cc1C1CCCC1		CHEMBL4877552	<	Activity	%	10.0	CHEMBL4225	Homo sapiens	Activity	%	10.0
	23252172	CHEMBL4831322	Inhibition of CLK2 (unknown origin) at 0.1 uM in presence of 1 mM ATP relative to control	B	CCOC(=O)C1=C(NN2CCN(CC(F)(F)F)CC2)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4868568	>	Inhibition	%	30.0	CHEMBL4225	Homo sapiens	INH	%	30.0
	23252180	CHEMBL4831330	Inhibition of CLK2 (unknown origin) in presence of 1 mM ATP without preincubation	B	CCOC(=O)C1=C(NN2CCN(CC(F)(F)F)CC2)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4868568	=	IC50	nM	270.0	CHEMBL4225	Homo sapiens	IC50	nM	270.0
	23252181	CHEMBL4831331	Inhibition of CLK2 (unknown origin) in presence of 1 mM ATP with preincubation	B	CCOC(=O)C1=C(NN2CCN(CC(F)(F)F)CC2)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4868568	=	IC50	nM	227.0	CHEMBL4225	Homo sapiens	IC50	nM	227.0
	23290603	CHEMBL4839412	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	Inhibition	%	88.0	CHEMBL4225	Homo sapiens	INH	%	88.0
	23290614	CHEMBL4839423	Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	Kd	nM	460.0	CHEMBL4225	Homo sapiens	Kd	nM	460.0
	23290869	CHEMBL4839431	Inhibition of CLK2 (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(Cl)c2)C(=O)NC1=O		CHEMBL156277	=	IC50	nM	39.0	CHEMBL4225	Homo sapiens	IC50	nM	39.0
	23290870	CHEMBL4839431	Inhibition of CLK2 (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	COc1ccccc1C1=C(Nc2cccc(C#N)c2)C(=O)NC1=O		CHEMBL4875188	=	IC50	nM	70.0	CHEMBL4225	Homo sapiens	IC50	nM	70.0
	23290871	CHEMBL4839431	Inhibition of CLK2 (unknown origin) assessed as transfer of radiolabelled phosphate group from ATP by reaction biology method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.6	CHEMBL4225	Homo sapiens	IC50	nM	5.6
Not Active	23317335	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	78.0	CHEMBL4225	Homo sapiens	% Control	%	78.0
Not Active	23317803	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	88.0	CHEMBL4225	Homo sapiens	% Control	%	88.0
Not Active	23318473	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	87.0	CHEMBL4225	Homo sapiens	% Control	%	87.0
Not Active	23318953	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	90.0	CHEMBL4225	Homo sapiens	% Control	%	90.0
Not Active	23319592	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23320065	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23320743	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	89.0	CHEMBL4225	Homo sapiens	% Control	%	89.0
Not Active	23321211	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23321841	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	91.0	CHEMBL4225	Homo sapiens	% Control	%	91.0
Not Active	23322309	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23322998	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	96.0	CHEMBL4225	Homo sapiens	% Control	%	96.0
Not Active	23323466	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	95.0	CHEMBL4225	Homo sapiens	% Control	%	95.0
Not Active	23324320	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23324955	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23325423	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23326070	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	91.0	CHEMBL4225	Homo sapiens	% Control	%	91.0
Not Active	23326538	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	97.0	CHEMBL4225	Homo sapiens	% Control	%	97.0
Not Active	23327238	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23327706	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	82.0	CHEMBL4225	Homo sapiens	% Control	%	82.0
Not Active	23328293	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	89.0	CHEMBL4225	Homo sapiens	% Control	%	89.0
Not Active	23328761	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	76.0	CHEMBL4225	Homo sapiens	% Control	%	76.0
Not Active	23329305	CHEMBL4881012	CLK2(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	109.0	CHEMBL4225	Homo sapiens	% residual kinase activity	%	109.0
Not Active	23329707	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23330175	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23330931	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23331399	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23331986	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	91.0	CHEMBL4225	Homo sapiens	% Control	%	91.0
Not Active	23332454	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23333170	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23333809	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	98.0	CHEMBL4225	Homo sapiens	% Control	%	98.0
Not Active	23334277	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23335256	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	86.0	CHEMBL4225	Homo sapiens	% Control	%	86.0
Not Active	23335724	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	87.0	CHEMBL4225	Homo sapiens	% Control	%	87.0
Not Active	23336351	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	86.0	CHEMBL4225	Homo sapiens	% Control	%	86.0
Not Active	23336819	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	80.0	CHEMBL4225	Homo sapiens	% Control	%	80.0
Not Active	23337549	CHEMBL4881920	CLK2 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	95.5	CHEMBL4225	Homo sapiens	% Ctrl	%	95.5
Not Active	23337900	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	96.0	CHEMBL4225	Homo sapiens	% Control	%	96.0
Not Active	23338368	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	94.0	CHEMBL4225	Homo sapiens	% Control	%	94.0
Not Active	23338980	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23339448	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23340085	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23340553	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23341210	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23341678	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	91.0	CHEMBL4225	Homo sapiens	% Control	%	91.0
Not Active	23342294	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	95.0	CHEMBL4225	Homo sapiens	% Control	%	95.0
Not Active	23342762	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23343392	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	96.0	CHEMBL4225	Homo sapiens	% Control	%	96.0
Not Active	23343860	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23344498	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	86.0	CHEMBL4225	Homo sapiens	% Control	%	86.0
Not Active	23345071	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23345539	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23346116	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	98.0	CHEMBL4225	Homo sapiens	% Control	%	98.0
Not Active	23346585	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23347086	CHEMBL4882613	Invitrogen kinase screen (CLK2)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1	Non standard unit for type	CHEMBL4538174		IC50	M	0.94	CHEMBL4225	Homo sapiens	IC50	M	0.94
Not Active	23347194	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	68.5	CHEMBL4225	Homo sapiens	% Control	%	68.5
Not Active	23347676	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23348255	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23348723	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23349310	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23349928	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23350396	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23351001	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	94.0	CHEMBL4225	Homo sapiens	% Control	%	94.0
Not Active	23351469	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23351998	CHEMBL4882691	CLK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	54.97	CHEMBL4225	Homo sapiens	% Inhibition	%	54.9723
	23351999	CHEMBL4882691	CLK2 Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		IC50	nM	605.0	CHEMBL4225	Homo sapiens	IC50	nM	605.0
Not Active	23352493	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	85.0	CHEMBL4225	Homo sapiens	% Control	%	85.0
Not Active	23352961	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	81.0	CHEMBL4225	Homo sapiens	% Control	%	81.0
Not Active	23353843	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23354311	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23355043	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23355511	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23356147	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23356615	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23357224	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	98.0	CHEMBL4225	Homo sapiens	% Control	%	98.0
Not Active	23357871	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	66.0	CHEMBL4225	Homo sapiens	% Control	%	66.0
Not Active	23358339	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23358925	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	92.4	CHEMBL4225	Homo sapiens	% Control	%	92.4
Not Active	23359523	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23359991	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23360576	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	86.0	CHEMBL4225	Homo sapiens	% Control	%	86.0
Not Active	23361044	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23361617	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23362153	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	94.0	CHEMBL4225	Homo sapiens	% Control	%	94.0
Not Active	23362621	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Active	23363190	CHEMBL4883211	CLK2 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	100.48	CHEMBL4225	Homo sapiens	% inhibition	%	100.47900000000001
Active	23363191	CHEMBL4883211	CLK2 Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		Inhibition	%	92.1	CHEMBL4225	Homo sapiens	% inhibition	%	92.09815
Active	23363331	CHEMBL4883198	In vitro kinase assay (CLK2)	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		IC50	nM	15.0	CHEMBL4225	Homo sapiens	IC50	nM	15.0
Active	23363336	CHEMBL4883203	NanoBRET (SGC Frankfurt) (CLK2)	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1		CHEMBL4531334		IC50	nM	16.6	CHEMBL4225	Homo sapiens	IC50	nM	16.6
Not Active	23363351	CHEMBL4883203	NanoBRET (SGC Frankfurt) (CLK2)	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5cc(C(C)(C)C)cc(C(C)(C)C)c5)ccc4n3)cc2)CC1	Non standard unit for type	CHEMBL4576555	>	IC50	M	10.0	CHEMBL4225	Homo sapiens	IC50	M	10.0
Not Active	23364263	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23364731	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	99.0	CHEMBL4225	Homo sapiens	% Control	%	99.0
Not Active	23365470	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	83.0	CHEMBL4225	Homo sapiens	% Control	%	83.0
Not Active	23366013	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	72.0	CHEMBL4225	Homo sapiens	% Control	%	72.0
Not Active	23366603	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23367071	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23367521	CHEMBL4883874	CLK2 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	89.0	CHEMBL4225	Homo sapiens	% Residual activity with Skepinone-L	%	89.0
Not Active	23367949	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23368417	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL4225	Homo sapiens	% Control	%	95.0
Not Active	23369016	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	65.0	CHEMBL4225	Homo sapiens	% Control	%	65.0
Not Active	23369484	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	90.0	CHEMBL4225	Homo sapiens	% Control	%	90.0
Not Active	23370027	CHEMBL4884271	CLK2(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	93.0	CHEMBL4225	Homo sapiens	% residual kinase activity	%	93.0
Not Active	23370452	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	55.0	CHEMBL4225	Homo sapiens	% Control	%	55.0
Not Active	23370920	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	75.0	CHEMBL4225	Homo sapiens	% Control	%	75.0
Not Active	23371729	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	98.0	CHEMBL4225	Homo sapiens	% Control	%	98.0
Not Active	23372197	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
	23372702	CHEMBL4884667	CLK2(CLK2LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4225	Homo sapiens	pIC50		6.0
	23373111	CHEMBL4884958	CLK2(CLK2LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4225	Homo sapiens	pIC50		6.0
	23373472	CHEMBL4885249	CLK2(CLK2LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4225	Homo sapiens	pIC50		6.0
Not Active	23374945	CHEMBL4885939	CLK2 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	20.3	CHEMBL4225	Homo sapiens	% Inhibition	%	20.3
Not Active	23375624	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	99.0	CHEMBL4225	Homo sapiens	% Control	%	99.0
Not Active	23376092	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23376669	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	80.0	CHEMBL4225	Homo sapiens	% Control	%	80.0
Not Active	23377139	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	95.0	CHEMBL4225	Homo sapiens	% Control	%	95.0
Not Active	23377997	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	97.0	CHEMBL4225	Homo sapiens	% Control	%	97.0
Not Active	23378465	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23379632	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23380100	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23380794	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23381442	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	97.0	CHEMBL4225	Homo sapiens	% Control	%	97.0
Not Active	23381910	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Active	23382534	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	0.0	CHEMBL4225	Homo sapiens	% Control	%	0.0
Active	23383002	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	0.0	CHEMBL4225	Homo sapiens	% Control	%	0.0
Not Active	23383740	CHEMBL4887386	CLK2 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	91.0	CHEMBL4225	Homo sapiens	% Ctrl	%	91.0
Not Active	23384234	CHEMBL4887829	CLK2(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	0.07	CHEMBL4225	Homo sapiens	% inhibition	%	0.07
Not Active	23384917	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23385384	CHEMBL4879641	KinomeScan assay: inhibition of CLK2	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4225	Homo sapiens	% Control	%	100.0
Not Active	23385872	CHEMBL4888345	CLK2 Invitrogen kinase panel	B	COc1nc2ccc([C@@](O)(c3ccccc3)C3CCN(C(C)=O)CC3)cc2c(Cl)c1Cc1ccc(-n2cccn2)cc1		CHEMBL4802042		Inhibition	%	4.0	CHEMBL4225	Homo sapiens	% inhibition	%	4.0
